{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [],
   "source": [
    "# If running on local machine:\n",
    "# !pip install numpy\n",
    "# !pip install pandas\n",
    "# !pip install uszipcode\n",
    "# !pip install python-Levenshtein"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "from uszipcode import SearchEngine, SimpleZipcode, ComprehensiveZipcode\n",
    "pd.set_option('display.max_rows', 500)\n",
    "pd.set_option('display.max_columns', 500)\n",
    "pd.set_option('display.width', 1000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\pvste\\AppData\\Local\\Temp\\ipykernel_37132\\4168042470.py:2: DtypeWarning: Columns (30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,271,272,273,274,275,276,277,278,279,280,281,282,283,287,288,289,290,291,292,293,297,298,299,301,302,303,304,305,306,307,308,309,310,311,312,313,314,315,316,317,318,319,325,326,327,328,329,330,331,332,333,334,335,336,337,338,339,340,341,342,343,344,345,346,347,348,349,350,351,352,353,354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,372,373,374,375,376,377,378,379,380,381,382,383,384,385,386,387,388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,430,431,432,433,434,435,436,437,438,439,440,441,442,443,444,445,446,447,448,449,450,451,452,453,454,455,456,457,458,459,460,461,462,463,464,465,466,467,468,469,470,471,472,473,474,475,476,477,478,479,480,481,482,483,484,485,486,487,489,490,491,493,494,495,496,497,498,499,500,501,502,503,504,512,513,514,529,530,531,546,547,548,563,564,565,580,581,582,597,598,599,614,615,616,631,632,633,648,649,650,665,666,667,682,683,684,699,700,701,716,717,718,733,734,735,750,751,752,767,769,771,772,773,775,776,777,779,780,781,782,783,784,785,786) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  NIH_usa = pd.read_csv(csv_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(4391, 787)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>Unnamed: 30</th>\n",
       "      <th>Unnamed: 31</th>\n",
       "      <th>Unnamed: 32</th>\n",
       "      <th>Unnamed: 33</th>\n",
       "      <th>Unnamed: 34</th>\n",
       "      <th>Unnamed: 35</th>\n",
       "      <th>Unnamed: 36</th>\n",
       "      <th>Unnamed: 37</th>\n",
       "      <th>Unnamed: 38</th>\n",
       "      <th>Unnamed: 39</th>\n",
       "      <th>Unnamed: 40</th>\n",
       "      <th>Unnamed: 41</th>\n",
       "      <th>Unnamed: 42</th>\n",
       "      <th>Unnamed: 43</th>\n",
       "      <th>Unnamed: 44</th>\n",
       "      <th>Unnamed: 45</th>\n",
       "      <th>Unnamed: 46</th>\n",
       "      <th>Unnamed: 47</th>\n",
       "      <th>Unnamed: 48</th>\n",
       "      <th>Unnamed: 49</th>\n",
       "      <th>Unnamed: 50</th>\n",
       "      <th>Unnamed: 51</th>\n",
       "      <th>Unnamed: 52</th>\n",
       "      <th>Unnamed: 53</th>\n",
       "      <th>Unnamed: 54</th>\n",
       "      <th>Unnamed: 55</th>\n",
       "      <th>Unnamed: 56</th>\n",
       "      <th>Unnamed: 57</th>\n",
       "      <th>Unnamed: 58</th>\n",
       "      <th>Unnamed: 59</th>\n",
       "      <th>Unnamed: 60</th>\n",
       "      <th>Unnamed: 61</th>\n",
       "      <th>Unnamed: 62</th>\n",
       "      <th>Unnamed: 63</th>\n",
       "      <th>Unnamed: 64</th>\n",
       "      <th>Unnamed: 65</th>\n",
       "      <th>Unnamed: 66</th>\n",
       "      <th>Unnamed: 67</th>\n",
       "      <th>Unnamed: 68</th>\n",
       "      <th>Unnamed: 69</th>\n",
       "      <th>Unnamed: 70</th>\n",
       "      <th>Unnamed: 71</th>\n",
       "      <th>Unnamed: 72</th>\n",
       "      <th>Unnamed: 73</th>\n",
       "      <th>Unnamed: 74</th>\n",
       "      <th>Unnamed: 75</th>\n",
       "      <th>Unnamed: 76</th>\n",
       "      <th>Unnamed: 77</th>\n",
       "      <th>Unnamed: 78</th>\n",
       "      <th>Unnamed: 79</th>\n",
       "      <th>Unnamed: 80</th>\n",
       "      <th>Unnamed: 81</th>\n",
       "      <th>Unnamed: 82</th>\n",
       "      <th>Unnamed: 83</th>\n",
       "      <th>Unnamed: 84</th>\n",
       "      <th>Unnamed: 85</th>\n",
       "      <th>Unnamed: 86</th>\n",
       "      <th>Unnamed: 87</th>\n",
       "      <th>Unnamed: 88</th>\n",
       "      <th>Unnamed: 89</th>\n",
       "      <th>Unnamed: 90</th>\n",
       "      <th>Unnamed: 91</th>\n",
       "      <th>Unnamed: 92</th>\n",
       "      <th>Unnamed: 93</th>\n",
       "      <th>Unnamed: 94</th>\n",
       "      <th>Unnamed: 95</th>\n",
       "      <th>Unnamed: 96</th>\n",
       "      <th>Unnamed: 97</th>\n",
       "      <th>Unnamed: 98</th>\n",
       "      <th>Unnamed: 99</th>\n",
       "      <th>Unnamed: 100</th>\n",
       "      <th>Unnamed: 101</th>\n",
       "      <th>Unnamed: 102</th>\n",
       "      <th>Unnamed: 103</th>\n",
       "      <th>Unnamed: 104</th>\n",
       "      <th>Unnamed: 105</th>\n",
       "      <th>Unnamed: 106</th>\n",
       "      <th>Unnamed: 107</th>\n",
       "      <th>Unnamed: 108</th>\n",
       "      <th>Unnamed: 109</th>\n",
       "      <th>Unnamed: 110</th>\n",
       "      <th>Unnamed: 111</th>\n",
       "      <th>Unnamed: 112</th>\n",
       "      <th>Unnamed: 113</th>\n",
       "      <th>Unnamed: 114</th>\n",
       "      <th>Unnamed: 115</th>\n",
       "      <th>Unnamed: 116</th>\n",
       "      <th>Unnamed: 117</th>\n",
       "      <th>Unnamed: 118</th>\n",
       "      <th>Unnamed: 119</th>\n",
       "      <th>Unnamed: 120</th>\n",
       "      <th>Unnamed: 121</th>\n",
       "      <th>Unnamed: 122</th>\n",
       "      <th>Unnamed: 123</th>\n",
       "      <th>Unnamed: 124</th>\n",
       "      <th>Unnamed: 125</th>\n",
       "      <th>Unnamed: 126</th>\n",
       "      <th>Unnamed: 127</th>\n",
       "      <th>Unnamed: 128</th>\n",
       "      <th>Unnamed: 129</th>\n",
       "      <th>Unnamed: 130</th>\n",
       "      <th>Unnamed: 131</th>\n",
       "      <th>Unnamed: 132</th>\n",
       "      <th>Unnamed: 133</th>\n",
       "      <th>Unnamed: 134</th>\n",
       "      <th>Unnamed: 135</th>\n",
       "      <th>Unnamed: 136</th>\n",
       "      <th>Unnamed: 137</th>\n",
       "      <th>Unnamed: 138</th>\n",
       "      <th>Unnamed: 139</th>\n",
       "      <th>Unnamed: 140</th>\n",
       "      <th>Unnamed: 141</th>\n",
       "      <th>Unnamed: 142</th>\n",
       "      <th>Unnamed: 143</th>\n",
       "      <th>Unnamed: 144</th>\n",
       "      <th>Unnamed: 145</th>\n",
       "      <th>Unnamed: 146</th>\n",
       "      <th>Unnamed: 147</th>\n",
       "      <th>Unnamed: 148</th>\n",
       "      <th>Unnamed: 149</th>\n",
       "      <th>Unnamed: 150</th>\n",
       "      <th>Unnamed: 151</th>\n",
       "      <th>Unnamed: 152</th>\n",
       "      <th>Unnamed: 153</th>\n",
       "      <th>Unnamed: 154</th>\n",
       "      <th>Unnamed: 155</th>\n",
       "      <th>Unnamed: 156</th>\n",
       "      <th>Unnamed: 157</th>\n",
       "      <th>Unnamed: 158</th>\n",
       "      <th>Unnamed: 159</th>\n",
       "      <th>Unnamed: 160</th>\n",
       "      <th>Unnamed: 161</th>\n",
       "      <th>Unnamed: 162</th>\n",
       "      <th>Unnamed: 163</th>\n",
       "      <th>Unnamed: 164</th>\n",
       "      <th>Unnamed: 165</th>\n",
       "      <th>Unnamed: 166</th>\n",
       "      <th>Unnamed: 167</th>\n",
       "      <th>Unnamed: 168</th>\n",
       "      <th>Unnamed: 169</th>\n",
       "      <th>Unnamed: 170</th>\n",
       "      <th>Unnamed: 171</th>\n",
       "      <th>Unnamed: 172</th>\n",
       "      <th>Unnamed: 173</th>\n",
       "      <th>Unnamed: 174</th>\n",
       "      <th>Unnamed: 175</th>\n",
       "      <th>Unnamed: 176</th>\n",
       "      <th>Unnamed: 177</th>\n",
       "      <th>Unnamed: 178</th>\n",
       "      <th>Unnamed: 179</th>\n",
       "      <th>Unnamed: 180</th>\n",
       "      <th>Unnamed: 181</th>\n",
       "      <th>Unnamed: 182</th>\n",
       "      <th>Unnamed: 183</th>\n",
       "      <th>Unnamed: 184</th>\n",
       "      <th>Unnamed: 185</th>\n",
       "      <th>Unnamed: 186</th>\n",
       "      <th>Unnamed: 187</th>\n",
       "      <th>Unnamed: 188</th>\n",
       "      <th>Unnamed: 189</th>\n",
       "      <th>Unnamed: 190</th>\n",
       "      <th>Unnamed: 191</th>\n",
       "      <th>Unnamed: 192</th>\n",
       "      <th>Unnamed: 193</th>\n",
       "      <th>Unnamed: 194</th>\n",
       "      <th>Unnamed: 195</th>\n",
       "      <th>Unnamed: 196</th>\n",
       "      <th>Unnamed: 197</th>\n",
       "      <th>Unnamed: 198</th>\n",
       "      <th>Unnamed: 199</th>\n",
       "      <th>Unnamed: 200</th>\n",
       "      <th>Unnamed: 201</th>\n",
       "      <th>Unnamed: 202</th>\n",
       "      <th>Unnamed: 203</th>\n",
       "      <th>Unnamed: 204</th>\n",
       "      <th>Unnamed: 205</th>\n",
       "      <th>Unnamed: 206</th>\n",
       "      <th>Unnamed: 207</th>\n",
       "      <th>Unnamed: 208</th>\n",
       "      <th>Unnamed: 209</th>\n",
       "      <th>Unnamed: 210</th>\n",
       "      <th>Unnamed: 211</th>\n",
       "      <th>Unnamed: 212</th>\n",
       "      <th>Unnamed: 213</th>\n",
       "      <th>Unnamed: 214</th>\n",
       "      <th>Unnamed: 215</th>\n",
       "      <th>Unnamed: 216</th>\n",
       "      <th>Unnamed: 217</th>\n",
       "      <th>Unnamed: 218</th>\n",
       "      <th>Unnamed: 219</th>\n",
       "      <th>Unnamed: 220</th>\n",
       "      <th>Unnamed: 221</th>\n",
       "      <th>Unnamed: 222</th>\n",
       "      <th>Unnamed: 223</th>\n",
       "      <th>Unnamed: 224</th>\n",
       "      <th>Unnamed: 225</th>\n",
       "      <th>Unnamed: 226</th>\n",
       "      <th>Unnamed: 227</th>\n",
       "      <th>Unnamed: 228</th>\n",
       "      <th>Unnamed: 229</th>\n",
       "      <th>Unnamed: 230</th>\n",
       "      <th>Unnamed: 231</th>\n",
       "      <th>Unnamed: 232</th>\n",
       "      <th>Unnamed: 233</th>\n",
       "      <th>Unnamed: 234</th>\n",
       "      <th>Unnamed: 235</th>\n",
       "      <th>Unnamed: 236</th>\n",
       "      <th>Unnamed: 237</th>\n",
       "      <th>Unnamed: 238</th>\n",
       "      <th>Unnamed: 239</th>\n",
       "      <th>Unnamed: 240</th>\n",
       "      <th>Unnamed: 241</th>\n",
       "      <th>Unnamed: 242</th>\n",
       "      <th>Unnamed: 243</th>\n",
       "      <th>Unnamed: 244</th>\n",
       "      <th>Unnamed: 245</th>\n",
       "      <th>Unnamed: 246</th>\n",
       "      <th>Unnamed: 247</th>\n",
       "      <th>Unnamed: 248</th>\n",
       "      <th>Unnamed: 249</th>\n",
       "      <th>...</th>\n",
       "      <th>Unnamed: 537</th>\n",
       "      <th>Unnamed: 538</th>\n",
       "      <th>Unnamed: 539</th>\n",
       "      <th>Unnamed: 540</th>\n",
       "      <th>Unnamed: 541</th>\n",
       "      <th>Unnamed: 542</th>\n",
       "      <th>Unnamed: 543</th>\n",
       "      <th>Unnamed: 544</th>\n",
       "      <th>Unnamed: 545</th>\n",
       "      <th>Unnamed: 546</th>\n",
       "      <th>Unnamed: 547</th>\n",
       "      <th>Unnamed: 548</th>\n",
       "      <th>Unnamed: 549</th>\n",
       "      <th>Unnamed: 550</th>\n",
       "      <th>Unnamed: 551</th>\n",
       "      <th>Unnamed: 552</th>\n",
       "      <th>Unnamed: 553</th>\n",
       "      <th>Unnamed: 554</th>\n",
       "      <th>Unnamed: 555</th>\n",
       "      <th>Unnamed: 556</th>\n",
       "      <th>Unnamed: 557</th>\n",
       "      <th>Unnamed: 558</th>\n",
       "      <th>Unnamed: 559</th>\n",
       "      <th>Unnamed: 560</th>\n",
       "      <th>Unnamed: 561</th>\n",
       "      <th>Unnamed: 562</th>\n",
       "      <th>Unnamed: 563</th>\n",
       "      <th>Unnamed: 564</th>\n",
       "      <th>Unnamed: 565</th>\n",
       "      <th>Unnamed: 566</th>\n",
       "      <th>Unnamed: 567</th>\n",
       "      <th>Unnamed: 568</th>\n",
       "      <th>Unnamed: 569</th>\n",
       "      <th>Unnamed: 570</th>\n",
       "      <th>Unnamed: 571</th>\n",
       "      <th>Unnamed: 572</th>\n",
       "      <th>Unnamed: 573</th>\n",
       "      <th>Unnamed: 574</th>\n",
       "      <th>Unnamed: 575</th>\n",
       "      <th>Unnamed: 576</th>\n",
       "      <th>Unnamed: 577</th>\n",
       "      <th>Unnamed: 578</th>\n",
       "      <th>Unnamed: 579</th>\n",
       "      <th>Unnamed: 580</th>\n",
       "      <th>Unnamed: 581</th>\n",
       "      <th>Unnamed: 582</th>\n",
       "      <th>Unnamed: 583</th>\n",
       "      <th>Unnamed: 584</th>\n",
       "      <th>Unnamed: 585</th>\n",
       "      <th>Unnamed: 586</th>\n",
       "      <th>Unnamed: 587</th>\n",
       "      <th>Unnamed: 588</th>\n",
       "      <th>Unnamed: 589</th>\n",
       "      <th>Unnamed: 590</th>\n",
       "      <th>Unnamed: 591</th>\n",
       "      <th>Unnamed: 592</th>\n",
       "      <th>Unnamed: 593</th>\n",
       "      <th>Unnamed: 594</th>\n",
       "      <th>Unnamed: 595</th>\n",
       "      <th>Unnamed: 596</th>\n",
       "      <th>Unnamed: 597</th>\n",
       "      <th>Unnamed: 598</th>\n",
       "      <th>Unnamed: 599</th>\n",
       "      <th>Unnamed: 600</th>\n",
       "      <th>Unnamed: 601</th>\n",
       "      <th>Unnamed: 602</th>\n",
       "      <th>Unnamed: 603</th>\n",
       "      <th>Unnamed: 604</th>\n",
       "      <th>Unnamed: 605</th>\n",
       "      <th>Unnamed: 606</th>\n",
       "      <th>Unnamed: 607</th>\n",
       "      <th>Unnamed: 608</th>\n",
       "      <th>Unnamed: 609</th>\n",
       "      <th>Unnamed: 610</th>\n",
       "      <th>Unnamed: 611</th>\n",
       "      <th>Unnamed: 612</th>\n",
       "      <th>Unnamed: 613</th>\n",
       "      <th>Unnamed: 614</th>\n",
       "      <th>Unnamed: 615</th>\n",
       "      <th>Unnamed: 616</th>\n",
       "      <th>Unnamed: 617</th>\n",
       "      <th>Unnamed: 618</th>\n",
       "      <th>Unnamed: 619</th>\n",
       "      <th>Unnamed: 620</th>\n",
       "      <th>Unnamed: 621</th>\n",
       "      <th>Unnamed: 622</th>\n",
       "      <th>Unnamed: 623</th>\n",
       "      <th>Unnamed: 624</th>\n",
       "      <th>Unnamed: 625</th>\n",
       "      <th>Unnamed: 626</th>\n",
       "      <th>Unnamed: 627</th>\n",
       "      <th>Unnamed: 628</th>\n",
       "      <th>Unnamed: 629</th>\n",
       "      <th>Unnamed: 630</th>\n",
       "      <th>Unnamed: 631</th>\n",
       "      <th>Unnamed: 632</th>\n",
       "      <th>Unnamed: 633</th>\n",
       "      <th>Unnamed: 634</th>\n",
       "      <th>Unnamed: 635</th>\n",
       "      <th>Unnamed: 636</th>\n",
       "      <th>Unnamed: 637</th>\n",
       "      <th>Unnamed: 638</th>\n",
       "      <th>Unnamed: 639</th>\n",
       "      <th>Unnamed: 640</th>\n",
       "      <th>Unnamed: 641</th>\n",
       "      <th>Unnamed: 642</th>\n",
       "      <th>Unnamed: 643</th>\n",
       "      <th>Unnamed: 644</th>\n",
       "      <th>Unnamed: 645</th>\n",
       "      <th>Unnamed: 646</th>\n",
       "      <th>Unnamed: 647</th>\n",
       "      <th>Unnamed: 648</th>\n",
       "      <th>Unnamed: 649</th>\n",
       "      <th>Unnamed: 650</th>\n",
       "      <th>Unnamed: 651</th>\n",
       "      <th>Unnamed: 652</th>\n",
       "      <th>Unnamed: 653</th>\n",
       "      <th>Unnamed: 654</th>\n",
       "      <th>Unnamed: 655</th>\n",
       "      <th>Unnamed: 656</th>\n",
       "      <th>Unnamed: 657</th>\n",
       "      <th>Unnamed: 658</th>\n",
       "      <th>Unnamed: 659</th>\n",
       "      <th>Unnamed: 660</th>\n",
       "      <th>Unnamed: 661</th>\n",
       "      <th>Unnamed: 662</th>\n",
       "      <th>Unnamed: 663</th>\n",
       "      <th>Unnamed: 664</th>\n",
       "      <th>Unnamed: 665</th>\n",
       "      <th>Unnamed: 666</th>\n",
       "      <th>Unnamed: 667</th>\n",
       "      <th>Unnamed: 668</th>\n",
       "      <th>Unnamed: 669</th>\n",
       "      <th>Unnamed: 670</th>\n",
       "      <th>Unnamed: 671</th>\n",
       "      <th>Unnamed: 672</th>\n",
       "      <th>Unnamed: 673</th>\n",
       "      <th>Unnamed: 674</th>\n",
       "      <th>Unnamed: 675</th>\n",
       "      <th>Unnamed: 676</th>\n",
       "      <th>Unnamed: 677</th>\n",
       "      <th>Unnamed: 678</th>\n",
       "      <th>Unnamed: 679</th>\n",
       "      <th>Unnamed: 680</th>\n",
       "      <th>Unnamed: 681</th>\n",
       "      <th>Unnamed: 682</th>\n",
       "      <th>Unnamed: 683</th>\n",
       "      <th>Unnamed: 684</th>\n",
       "      <th>Unnamed: 685</th>\n",
       "      <th>Unnamed: 686</th>\n",
       "      <th>Unnamed: 687</th>\n",
       "      <th>Unnamed: 688</th>\n",
       "      <th>Unnamed: 689</th>\n",
       "      <th>Unnamed: 690</th>\n",
       "      <th>Unnamed: 691</th>\n",
       "      <th>Unnamed: 692</th>\n",
       "      <th>Unnamed: 693</th>\n",
       "      <th>Unnamed: 694</th>\n",
       "      <th>Unnamed: 695</th>\n",
       "      <th>Unnamed: 696</th>\n",
       "      <th>Unnamed: 697</th>\n",
       "      <th>Unnamed: 698</th>\n",
       "      <th>Unnamed: 699</th>\n",
       "      <th>Unnamed: 700</th>\n",
       "      <th>Unnamed: 701</th>\n",
       "      <th>Unnamed: 702</th>\n",
       "      <th>Unnamed: 703</th>\n",
       "      <th>Unnamed: 704</th>\n",
       "      <th>Unnamed: 705</th>\n",
       "      <th>Unnamed: 706</th>\n",
       "      <th>Unnamed: 707</th>\n",
       "      <th>Unnamed: 708</th>\n",
       "      <th>Unnamed: 709</th>\n",
       "      <th>Unnamed: 710</th>\n",
       "      <th>Unnamed: 711</th>\n",
       "      <th>Unnamed: 712</th>\n",
       "      <th>Unnamed: 713</th>\n",
       "      <th>Unnamed: 714</th>\n",
       "      <th>Unnamed: 715</th>\n",
       "      <th>Unnamed: 716</th>\n",
       "      <th>Unnamed: 717</th>\n",
       "      <th>Unnamed: 718</th>\n",
       "      <th>Unnamed: 719</th>\n",
       "      <th>Unnamed: 720</th>\n",
       "      <th>Unnamed: 721</th>\n",
       "      <th>Unnamed: 722</th>\n",
       "      <th>Unnamed: 723</th>\n",
       "      <th>Unnamed: 724</th>\n",
       "      <th>Unnamed: 725</th>\n",
       "      <th>Unnamed: 726</th>\n",
       "      <th>Unnamed: 727</th>\n",
       "      <th>Unnamed: 728</th>\n",
       "      <th>Unnamed: 729</th>\n",
       "      <th>Unnamed: 730</th>\n",
       "      <th>Unnamed: 731</th>\n",
       "      <th>Unnamed: 732</th>\n",
       "      <th>Unnamed: 733</th>\n",
       "      <th>Unnamed: 734</th>\n",
       "      <th>Unnamed: 735</th>\n",
       "      <th>Unnamed: 736</th>\n",
       "      <th>Unnamed: 737</th>\n",
       "      <th>Unnamed: 738</th>\n",
       "      <th>Unnamed: 739</th>\n",
       "      <th>Unnamed: 740</th>\n",
       "      <th>Unnamed: 741</th>\n",
       "      <th>Unnamed: 742</th>\n",
       "      <th>Unnamed: 743</th>\n",
       "      <th>Unnamed: 744</th>\n",
       "      <th>Unnamed: 745</th>\n",
       "      <th>Unnamed: 746</th>\n",
       "      <th>Unnamed: 747</th>\n",
       "      <th>Unnamed: 748</th>\n",
       "      <th>Unnamed: 749</th>\n",
       "      <th>Unnamed: 750</th>\n",
       "      <th>Unnamed: 751</th>\n",
       "      <th>Unnamed: 752</th>\n",
       "      <th>Unnamed: 753</th>\n",
       "      <th>Unnamed: 754</th>\n",
       "      <th>Unnamed: 755</th>\n",
       "      <th>Unnamed: 756</th>\n",
       "      <th>Unnamed: 757</th>\n",
       "      <th>Unnamed: 758</th>\n",
       "      <th>Unnamed: 759</th>\n",
       "      <th>Unnamed: 760</th>\n",
       "      <th>Unnamed: 761</th>\n",
       "      <th>Unnamed: 762</th>\n",
       "      <th>Unnamed: 763</th>\n",
       "      <th>Unnamed: 764</th>\n",
       "      <th>Unnamed: 765</th>\n",
       "      <th>Unnamed: 766</th>\n",
       "      <th>Unnamed: 767</th>\n",
       "      <th>Unnamed: 768</th>\n",
       "      <th>Unnamed: 769</th>\n",
       "      <th>Unnamed: 770</th>\n",
       "      <th>Unnamed: 771</th>\n",
       "      <th>Unnamed: 772</th>\n",
       "      <th>Unnamed: 773</th>\n",
       "      <th>Unnamed: 774</th>\n",
       "      <th>Unnamed: 775</th>\n",
       "      <th>Unnamed: 776</th>\n",
       "      <th>Unnamed: 777</th>\n",
       "      <th>Unnamed: 778</th>\n",
       "      <th>Unnamed: 779</th>\n",
       "      <th>Unnamed: 780</th>\n",
       "      <th>Unnamed: 781</th>\n",
       "      <th>Unnamed: 782</th>\n",
       "      <th>Unnamed: 783</th>\n",
       "      <th>Unnamed: 784</th>\n",
       "      <th>Unnamed: 785</th>\n",
       "      <th>Unnamed: 786</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03377088</td>\n",
       "      <td>Aromatherapy Randomization of Pain Management ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03377088</td>\n",
       "      <td>AROMA</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Pain control for acute isolated back pain and ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Back Pain|Back Pain, Low|Sciatica</td>\n",
       "      <td>OTHER: Rose oil|OTHER: Almond Oil</td>\n",
       "      <td>Acute Pain Reduction, A 100 mm visual analog s...</td>\n",
       "      <td>Patient Satisfaction, Patients will be asked a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Stony Brook University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>60</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1116889-3</td>\n",
       "      <td>12/11/2017</td>\n",
       "      <td>3/31/2019</td>\n",
       "      <td>5/17/2019</td>\n",
       "      <td>12/19/2017</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4/24/2018</td>\n",
       "      <td>Stony Brook University Hospital Emergency Depa...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03718988</td>\n",
       "      <td>SWAP-MEAT: Study With Appetizing Plant Food - ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03718988</td>\n",
       "      <td>SWAP-MEAT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study aims to investigate the impact of r...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Microbiome|Immune Function|Cardiovascular Dise...</td>\n",
       "      <td>BEHAVIORAL: Meat products|BEHAVIORAL: Plant Al...</td>\n",
       "      <td>Trimethylamine N-oxide (TMAO)., Change from ba...</td>\n",
       "      <td>Insulin-like Growth Factor-1 (IGF-1), Change f...</td>\n",
       "      <td>Satisfaction with Plant Alternative products, ...</td>\n",
       "      <td>Stanford University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>38</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>48285</td>\n",
       "      <td>1/17/2019</td>\n",
       "      <td>12/5/2019</td>\n",
       "      <td>12/5/2019</td>\n",
       "      <td>10/25/2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2/21/2023</td>\n",
       "      <td>Stanford University, Stanford, California, 943...</td>\n",
       "      <td>Statistical Analysis Plan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03984838</td>\n",
       "      <td>Study to Evaluate Pharmacokinetics, Safety and...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03984838</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Dolutegravir (DTG), a human immunodeficiency v...</td>\n",
       "      <td>YES</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>DRUG: JULUCA (Dolutegravir and Rilpivirine) 50...</td>\n",
       "      <td>Area Under the Concentration (AUC) Time Curve ...</td>\n",
       "      <td>Number of Participants With Adverse Events (AE...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ViiV Healthcare</td>\n",
       "      <td>Janssen, LP</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>16</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>212312</td>\n",
       "      <td>6/17/2019</td>\n",
       "      <td>8/13/2019</td>\n",
       "      <td>8/13/2019</td>\n",
       "      <td>6/13/2019</td>\n",
       "      <td>6/25/2020</td>\n",
       "      <td>7/14/2020</td>\n",
       "      <td>GSK Investigational Site, Glendale, California...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02111772</td>\n",
       "      <td>Evaluating the Asthmatic Response to an Experi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02111772</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In patients with asthma, reactions to allergen...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Asthma</td>\n",
       "      <td>BIOLOGICAL: Rhinovirus</td>\n",
       "      <td>Airway Symptom Scores Experienced by Subjects ...</td>\n",
       "      <td>Airway Symptom Scores Experienced by Subjects ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Virginia</td>\n",
       "      <td>National Institute of Allergy and Infectious D...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>26</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>12673|R01AI020565</td>\n",
       "      <td>9/1/2013</td>\n",
       "      <td>4/20/2017</td>\n",
       "      <td>4/27/2017</td>\n",
       "      <td>4/11/2014</td>\n",
       "      <td>4/26/2018</td>\n",
       "      <td>7/9/2018</td>\n",
       "      <td>University of Virginia, Charlottesville, Virgi...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03275389</td>\n",
       "      <td>A Study to Evaluate the Reactogenicity, Safety...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03275389</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to assess the rea...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Influenza, Human</td>\n",
       "      <td>BIOLOGICAL: D-SUIV cH8/1N1+AS03|BIOLOGICAL: D-...</td>\n",
       "      <td>Number of Subjects With Solicited Local Advers...</td>\n",
       "      <td>Adjusted GMCs for Anti-H1 HA Stalk Antibody Me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>470</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>207543|2017-001584-20</td>\n",
       "      <td>9/8/2017</td>\n",
       "      <td>3/26/2020</td>\n",
       "      <td>3/26/2020</td>\n",
       "      <td>9/7/2017</td>\n",
       "      <td>3/16/2021</td>\n",
       "      <td>5/7/2021</td>\n",
       "      <td>GSK Investigational Site, South Miami, Florida...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 787 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title                                     Study URL    Acronym Study Status                                      Brief Summary Study Results                                         Conditions                                      Interventions                           Primary Outcome Measures                         Secondary Outcome Measures                             Other Outcome Measures                 Sponsor                                      Collaborators  Sex                 Age  Phases Enrollment Funder Type      Study Type                                       Study Design              Other IDs  Start Date Primary Completion Date Completion Date First Posted Results First Posted Last Update Posted                                          Locations                                    Study Documents Unnamed: 30 Unnamed: 31 Unnamed: 32 Unnamed: 33 Unnamed: 34 Unnamed: 35 Unnamed: 36 Unnamed: 37 Unnamed: 38  \\\n",
       "0  NCT03377088  Aromatherapy Randomization of Pain Management ...  https://clinicaltrials.gov/study/NCT03377088      AROMA      UNKNOWN  Pain control for acute isolated back pain and ...            NO                  Back Pain|Back Pain, Low|Sciatica                  OTHER: Rose oil|OTHER: Almond Oil  Acute Pain Reduction, A 100 mm visual analog s...  Patient Satisfaction, Patients will be asked a...                                                NaN  Stony Brook University                                                NaN  ALL  ADULT, OLDER_ADULT     NaN         60       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...              1116889-3  12/11/2017               3/31/2019       5/17/2019   12/19/2017                  NaN          4/24/2018  Stony Brook University Hospital Emergency Depa...  Study Protocol and Statistical Analysis Plan|I...         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN   \n",
       "1  NCT03718988  SWAP-MEAT: Study With Appetizing Plant Food - ...  https://clinicaltrials.gov/study/NCT03718988  SWAP-MEAT    COMPLETED  This study aims to investigate the impact of r...            NO  Microbiome|Immune Function|Cardiovascular Dise...  BEHAVIORAL: Meat products|BEHAVIORAL: Plant Al...  Trimethylamine N-oxide (TMAO)., Change from ba...  Insulin-like Growth Factor-1 (IGF-1), Change f...  Satisfaction with Plant Alternative products, ...     Stanford University                                                NaN  ALL  ADULT, OLDER_ADULT     NaN         38       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                  48285   1/17/2019               12/5/2019       12/5/2019   10/25/2018                  NaN          2/21/2023  Stanford University, Stanford, California, 943...                          Statistical Analysis Plan         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN   \n",
       "2  NCT03984838  Study to Evaluate Pharmacokinetics, Safety and...  https://clinicaltrials.gov/study/NCT03984838        NaN    COMPLETED  Dolutegravir (DTG), a human immunodeficiency v...           YES                                     HIV Infections  DRUG: JULUCA (Dolutegravir and Rilpivirine) 50...  Area Under the Concentration (AUC) Time Curve ...  Number of Participants With Adverse Events (AE...                                                NaN         ViiV Healthcare                                        Janssen, LP  ALL               ADULT  PHASE1         16    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                 212312   6/17/2019               8/13/2019       8/13/2019    6/13/2019            6/25/2020          7/14/2020  GSK Investigational Site, Glendale, California...           Study Protocol|Statistical Analysis Plan         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN   \n",
       "3  NCT02111772  Evaluating the Asthmatic Response to an Experi...  https://clinicaltrials.gov/study/NCT02111772        NaN    COMPLETED  In patients with asthma, reactions to allergen...           YES                                             Asthma                             BIOLOGICAL: Rhinovirus  Airway Symptom Scores Experienced by Subjects ...  Airway Symptom Scores Experienced by Subjects ...                                                NaN  University of Virginia  National Institute of Allergy and Infectious D...  ALL               ADULT     NaN         26       OTHER  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...      12673|R01AI020565    9/1/2013               4/20/2017       4/27/2017    4/11/2014            4/26/2018           7/9/2018  University of Virginia, Charlottesville, Virgi...       Study Protocol and Statistical Analysis Plan         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN   \n",
       "4  NCT03275389  A Study to Evaluate the Reactogenicity, Safety...  https://clinicaltrials.gov/study/NCT03275389        NaN    COMPLETED  The purpose of this study is to assess the rea...           YES                                   Influenza, Human  BIOLOGICAL: D-SUIV cH8/1N1+AS03|BIOLOGICAL: D-...  Number of Subjects With Solicited Local Advers...  Adjusted GMCs for Anti-H1 HA Stalk Antibody Me...                                                NaN         GlaxoSmithKline                                                NaN  ALL               ADULT  PHASE1        470    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...  207543|2017-001584-20    9/8/2017               3/26/2020       3/26/2020     9/7/2017            3/16/2021           5/7/2021  GSK Investigational Site, South Miami, Florida...           Study Protocol|Statistical Analysis Plan         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN   \n",
       "\n",
       "  Unnamed: 39 Unnamed: 40 Unnamed: 41 Unnamed: 42 Unnamed: 43 Unnamed: 44 Unnamed: 45 Unnamed: 46 Unnamed: 47 Unnamed: 48 Unnamed: 49 Unnamed: 50 Unnamed: 51 Unnamed: 52 Unnamed: 53 Unnamed: 54 Unnamed: 55 Unnamed: 56 Unnamed: 57 Unnamed: 58 Unnamed: 59 Unnamed: 60 Unnamed: 61 Unnamed: 62 Unnamed: 63 Unnamed: 64 Unnamed: 65 Unnamed: 66 Unnamed: 67 Unnamed: 68 Unnamed: 69 Unnamed: 70 Unnamed: 71 Unnamed: 72 Unnamed: 73 Unnamed: 74 Unnamed: 75 Unnamed: 76 Unnamed: 77 Unnamed: 78 Unnamed: 79 Unnamed: 80 Unnamed: 81 Unnamed: 82 Unnamed: 83 Unnamed: 84 Unnamed: 85 Unnamed: 86 Unnamed: 87 Unnamed: 88 Unnamed: 89 Unnamed: 90 Unnamed: 91 Unnamed: 92 Unnamed: 93 Unnamed: 94 Unnamed: 95 Unnamed: 96 Unnamed: 97 Unnamed: 98 Unnamed: 99 Unnamed: 100 Unnamed: 101 Unnamed: 102 Unnamed: 103 Unnamed: 104 Unnamed: 105 Unnamed: 106 Unnamed: 107 Unnamed: 108 Unnamed: 109 Unnamed: 110 Unnamed: 111 Unnamed: 112 Unnamed: 113 Unnamed: 114 Unnamed: 115 Unnamed: 116 Unnamed: 117 Unnamed: 118 Unnamed: 119  \\\n",
       "0         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "1         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "2         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "3         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "4         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN         NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "\n",
       "  Unnamed: 120 Unnamed: 121 Unnamed: 122 Unnamed: 123 Unnamed: 124 Unnamed: 125 Unnamed: 126 Unnamed: 127 Unnamed: 128 Unnamed: 129 Unnamed: 130 Unnamed: 131 Unnamed: 132 Unnamed: 133 Unnamed: 134 Unnamed: 135 Unnamed: 136 Unnamed: 137 Unnamed: 138 Unnamed: 139 Unnamed: 140 Unnamed: 141 Unnamed: 142 Unnamed: 143 Unnamed: 144 Unnamed: 145 Unnamed: 146 Unnamed: 147 Unnamed: 148 Unnamed: 149 Unnamed: 150 Unnamed: 151 Unnamed: 152 Unnamed: 153 Unnamed: 154 Unnamed: 155 Unnamed: 156 Unnamed: 157 Unnamed: 158 Unnamed: 159 Unnamed: 160 Unnamed: 161 Unnamed: 162 Unnamed: 163 Unnamed: 164 Unnamed: 165 Unnamed: 166 Unnamed: 167 Unnamed: 168 Unnamed: 169 Unnamed: 170 Unnamed: 171 Unnamed: 172 Unnamed: 173 Unnamed: 174 Unnamed: 175 Unnamed: 176 Unnamed: 177 Unnamed: 178 Unnamed: 179 Unnamed: 180 Unnamed: 181 Unnamed: 182 Unnamed: 183 Unnamed: 184 Unnamed: 185 Unnamed: 186 Unnamed: 187 Unnamed: 188 Unnamed: 189 Unnamed: 190 Unnamed: 191 Unnamed: 192 Unnamed: 193 Unnamed: 194 Unnamed: 195  \\\n",
       "0          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "1          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "2          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "3          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "4          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "\n",
       "  Unnamed: 196 Unnamed: 197 Unnamed: 198 Unnamed: 199 Unnamed: 200 Unnamed: 201 Unnamed: 202 Unnamed: 203 Unnamed: 204 Unnamed: 205 Unnamed: 206 Unnamed: 207 Unnamed: 208 Unnamed: 209 Unnamed: 210 Unnamed: 211 Unnamed: 212 Unnamed: 213 Unnamed: 214 Unnamed: 215 Unnamed: 216 Unnamed: 217 Unnamed: 218 Unnamed: 219 Unnamed: 220 Unnamed: 221 Unnamed: 222 Unnamed: 223 Unnamed: 224 Unnamed: 225 Unnamed: 226 Unnamed: 227 Unnamed: 228 Unnamed: 229 Unnamed: 230 Unnamed: 231 Unnamed: 232 Unnamed: 233 Unnamed: 234 Unnamed: 235 Unnamed: 236 Unnamed: 237 Unnamed: 238 Unnamed: 239 Unnamed: 240 Unnamed: 241 Unnamed: 242 Unnamed: 243 Unnamed: 244 Unnamed: 245 Unnamed: 246 Unnamed: 247 Unnamed: 248 Unnamed: 249  ... Unnamed: 537 Unnamed: 538 Unnamed: 539 Unnamed: 540 Unnamed: 541 Unnamed: 542 Unnamed: 543 Unnamed: 544 Unnamed: 545 Unnamed: 546 Unnamed: 547 Unnamed: 548 Unnamed: 549 Unnamed: 550 Unnamed: 551 Unnamed: 552 Unnamed: 553 Unnamed: 554 Unnamed: 555 Unnamed: 556  Unnamed: 557 Unnamed: 558  \\\n",
       "0          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN  ...          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN   \n",
       "1          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN  ...          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN   \n",
       "2          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN  ...          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN   \n",
       "3          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN  ...          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN   \n",
       "4          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN  ...          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN   \n",
       "\n",
       "  Unnamed: 559 Unnamed: 560 Unnamed: 561 Unnamed: 562 Unnamed: 563 Unnamed: 564 Unnamed: 565 Unnamed: 566 Unnamed: 567 Unnamed: 568 Unnamed: 569 Unnamed: 570  Unnamed: 571  Unnamed: 572  Unnamed: 573 Unnamed: 574 Unnamed: 575 Unnamed: 576 Unnamed: 577 Unnamed: 578 Unnamed: 579 Unnamed: 580  Unnamed: 581  Unnamed: 582  Unnamed: 583 Unnamed: 584 Unnamed: 585 Unnamed: 586  Unnamed: 587 Unnamed: 588 Unnamed: 589 Unnamed: 590 Unnamed: 591 Unnamed: 592 Unnamed: 593 Unnamed: 594 Unnamed: 595 Unnamed: 596 Unnamed: 597 Unnamed: 598 Unnamed: 599 Unnamed: 600 Unnamed: 601 Unnamed: 602 Unnamed: 603 Unnamed: 604 Unnamed: 605 Unnamed: 606  Unnamed: 607  Unnamed: 608  Unnamed: 609  Unnamed: 610  Unnamed: 611 Unnamed: 612 Unnamed: 613 Unnamed: 614 Unnamed: 615 Unnamed: 616 Unnamed: 617 Unnamed: 618 Unnamed: 619 Unnamed: 620 Unnamed: 621 Unnamed: 622 Unnamed: 623 Unnamed: 624 Unnamed: 625 Unnamed: 626 Unnamed: 627 Unnamed: 628 Unnamed: 629 Unnamed: 630 Unnamed: 631 Unnamed: 632 Unnamed: 633  \\\n",
       "0          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "1          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "2          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "3          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "4          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN           NaN           NaN           NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "\n",
       "  Unnamed: 634 Unnamed: 635 Unnamed: 636 Unnamed: 637 Unnamed: 638 Unnamed: 639 Unnamed: 640 Unnamed: 641 Unnamed: 642 Unnamed: 643 Unnamed: 644 Unnamed: 645 Unnamed: 646 Unnamed: 647 Unnamed: 648 Unnamed: 649 Unnamed: 650 Unnamed: 651 Unnamed: 652 Unnamed: 653 Unnamed: 654 Unnamed: 655 Unnamed: 656 Unnamed: 657 Unnamed: 658 Unnamed: 659 Unnamed: 660 Unnamed: 661 Unnamed: 662 Unnamed: 663 Unnamed: 664 Unnamed: 665 Unnamed: 666 Unnamed: 667 Unnamed: 668 Unnamed: 669 Unnamed: 670 Unnamed: 671 Unnamed: 672 Unnamed: 673 Unnamed: 674 Unnamed: 675 Unnamed: 676 Unnamed: 677 Unnamed: 678 Unnamed: 679 Unnamed: 680 Unnamed: 681 Unnamed: 682 Unnamed: 683 Unnamed: 684 Unnamed: 685 Unnamed: 686 Unnamed: 687 Unnamed: 688 Unnamed: 689 Unnamed: 690 Unnamed: 691 Unnamed: 692 Unnamed: 693 Unnamed: 694 Unnamed: 695 Unnamed: 696 Unnamed: 697 Unnamed: 698 Unnamed: 699 Unnamed: 700 Unnamed: 701 Unnamed: 702 Unnamed: 703 Unnamed: 704 Unnamed: 705 Unnamed: 706 Unnamed: 707 Unnamed: 708 Unnamed: 709  \\\n",
       "0          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "1          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "2          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "3          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "4          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "\n",
       "  Unnamed: 710 Unnamed: 711 Unnamed: 712 Unnamed: 713 Unnamed: 714 Unnamed: 715 Unnamed: 716 Unnamed: 717 Unnamed: 718 Unnamed: 719 Unnamed: 720 Unnamed: 721 Unnamed: 722 Unnamed: 723 Unnamed: 724 Unnamed: 725 Unnamed: 726 Unnamed: 727 Unnamed: 728 Unnamed: 729 Unnamed: 730 Unnamed: 731 Unnamed: 732 Unnamed: 733 Unnamed: 734 Unnamed: 735 Unnamed: 736 Unnamed: 737 Unnamed: 738 Unnamed: 739 Unnamed: 740 Unnamed: 741 Unnamed: 742 Unnamed: 743 Unnamed: 744 Unnamed: 745 Unnamed: 746 Unnamed: 747 Unnamed: 748 Unnamed: 749 Unnamed: 750 Unnamed: 751 Unnamed: 752 Unnamed: 753 Unnamed: 754 Unnamed: 755 Unnamed: 756 Unnamed: 757 Unnamed: 758 Unnamed: 759 Unnamed: 760 Unnamed: 761 Unnamed: 762 Unnamed: 763 Unnamed: 764 Unnamed: 765 Unnamed: 766 Unnamed: 767 Unnamed: 768 Unnamed: 769 Unnamed: 770 Unnamed: 771 Unnamed: 772 Unnamed: 773 Unnamed: 774  Unnamed: 775 Unnamed: 776 Unnamed: 777 Unnamed: 778  Unnamed: 779 Unnamed: 780 Unnamed: 781 Unnamed: 782 Unnamed: 783 Unnamed: 784 Unnamed: 785  \\\n",
       "0          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "1          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "2          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "3          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "4          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN           NaN          NaN          NaN          NaN          NaN          NaN          NaN   \n",
       "\n",
       "  Unnamed: 786  \n",
       "0          NaN  \n",
       "1          NaN  \n",
       "2          NaN  \n",
       "3          NaN  \n",
       "4          NaN  \n",
       "\n",
       "[5 rows x 787 columns]"
      ]
     },
     "execution_count": 97,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csv_path='clinical_trial_USA.csv'\n",
    "NIH_usa = pd.read_csv(csv_path)\n",
    "print(NIH_usa.shape)\n",
    "NIH_usa.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(4391, 787)\n",
      "(4391, 30)\n"
     ]
    }
   ],
   "source": [
    "#Removing blank columns:\n",
    "print(NIH_usa.shape)\n",
    "NIH_usa = NIH_usa.loc[:, ~NIH_usa.columns.str.contains('Unnamed:')]\n",
    "print(NIH_usa.shape)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "83\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>NCT03082261</td>\n",
       "      <td>Multi-center Prospective Study Determining the...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03082261</td>\n",
       "      <td>TRIUMPH</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The TRIUMPH study is a post-market, internatio...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Chronic Pain|Intractable Pain</td>\n",
       "      <td>DEVICE: Prodigy, Prodigy MRI or Proclaim Elite...</td>\n",
       "      <td>Mean Change in Pain From Baseline to 6 Months ...</td>\n",
       "      <td>Mean Change in Quality of Life From Baseline t...</td>\n",
       "      <td>Mean Change in Quality of Life From Baseline t...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>NCT03984825</td>\n",
       "      <td>Effect of GSK3640254 on the Pharmacokinetics o...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03984825</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is an open-label, single-sequence, 1-way ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>DRUG: GSK3640254|DRUG: Portia</td>\n",
       "      <td>Period 1: Area Under the Plasma Concentration-...</td>\n",
       "      <td>Period 1: Effect of GSK3640254 on PD of EE/LNG...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>NCT04493931</td>\n",
       "      <td>Drug-drug Interaction Study of Gepotidacin</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04493931</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study is a drug-drug interaction (DDI), p...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Infections, Bacterial</td>\n",
       "      <td>DRUG: Gepotidacin|DRUG: Cimetidine|DRUG: Rifam...</td>\n",
       "      <td>Cohort 1: Maximum Observed Concentration (Cmax...</td>\n",
       "      <td>Cohort 1: AUC (0-24) of Gepotidacin in Plasma,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>845</th>\n",
       "      <td>NCT03655951</td>\n",
       "      <td>Birds and Bees Research Study</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03655951</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The goal of this efficacy study is to evaluate...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Sexual Behavior|Communication</td>\n",
       "      <td>BEHAVIORAL: Web-based resource on adolescent s...</td>\n",
       "      <td>Change in Parent Reported Frequency of Parent-...</td>\n",
       "      <td>Change in Parental Perceived Importance of Par...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1793</th>\n",
       "      <td>NCT03300050</td>\n",
       "      <td>Safety and Immunogenicity of a Live-attenuated...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03300050</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The clinical study will evaluate safety and th...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Influenza|Vaccine</td>\n",
       "      <td>BIOLOGICAL: cH8/1N1 LAIV|BIOLOGICAL: AS03-adju...</td>\n",
       "      <td>Number of Participants With Solicited Local Re...</td>\n",
       "      <td>Number of Participants With Any Grade 2 or Hig...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1794</th>\n",
       "      <td>h 15 (12 months post-dose 2)|Percentage of Par...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H2</td>\n",
       "      <td>of which the stalk domain shares about 78% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1795</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1796</th>\n",
       "      <td>Anti-H2 full-length (ecto-domain) hemagglutini...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Mean Geo...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H2</td>\n",
       "      <td>of which the stalk domain shares about 78% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1797</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1798</th>\n",
       "      <td>Anti-H2 full-length (ecto-domain) hemagglutini...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1799</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1800</th>\n",
       "      <td>Mean geometric increase represents the fold-ri...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H9</td>\n",
       "      <td>the stalk domain of which shares about 59% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1801</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1802</th>\n",
       "      <td>Anti-H9 full-length (ecto-domain) hemagglutini...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1803</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1804</th>\n",
       "      <td>Seropositivity rate was defined as the percent...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Geometri...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H9</td>\n",
       "      <td>the stalk domain of which shares about 59% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1805</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1806</th>\n",
       "      <td>Anti-H9 full-length (ecto-domain) hemagglutini...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H9</td>\n",
       "      <td>the stalk domain of which shares about 59% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1807</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1808</th>\n",
       "      <td>Anti-H9 full-length (ecto-domain) hemagglutini...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H9</td>\n",
       "      <td>the stalk domain of which shares about 59% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1809</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1810</th>\n",
       "      <td>Anti-H9 full-length(ecto-domain) hemagglutinin...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Mean Geo...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H9</td>\n",
       "      <td>the stalk domain of which shares about 59% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1811</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1812</th>\n",
       "      <td>Anti-H9 full-length (ecto-domain) hemagglutini...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1813</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1814</th>\n",
       "      <td>Mean geometric increase represents the fold-ri...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H18</td>\n",
       "      <td>the stalk domain of which shares about 65% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1815</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1816</th>\n",
       "      <td>Anti-H18 full-length (ecto-domain) hemagglutin...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1817</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1818</th>\n",
       "      <td>Seropositivity rate was defined as the percent...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Geometri...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>H18</td>\n",
       "      <td>the stalk domain of which shares about 65% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1819</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1820</th>\n",
       "      <td>Anti-H18 full-length (ecto-domain) hemagglutin...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H18</td>\n",
       "      <td>the stalk domain of which shares about 65% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1821</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1822</th>\n",
       "      <td>Anti-H18 full-length (ecto-domain) hemagglutin...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H18</td>\n",
       "      <td>the stalk domain of which shares about 65% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1823</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1824</th>\n",
       "      <td>Anti-H18 full-length (ecto-domain) hemagglutin...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Mean Geo...</td>\n",
       "      <td>To determine antibody breadth</td>\n",
       "      <td>assays were performed to measure the inductio...</td>\n",
       "      <td>subtype H18</td>\n",
       "      <td>the stalk domain of which shares about 65% am...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1825</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1826</th>\n",
       "      <td>Anti-H18 full-length (ecto-domain) hemagglutin...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1827</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1828</th>\n",
       "      <td>Mean geometric increase represents the fold-ri...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1829</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1830</th>\n",
       "      <td>Anti-human H1N1 virus neutralizing antibodies ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1831</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1832</th>\n",
       "      <td>Seropositivity rate was defined as the percent...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Geometri...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1833</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1834</th>\n",
       "      <td>Anti-human H1N1 virus neutralizing antibodies ...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1835</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1836</th>\n",
       "      <td>Anti-human H1N1 virus neutralizing antibodies ...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1837</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1838</th>\n",
       "      <td>Anti-human H1N1 virus neutralizing antibodies ...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Mean Geo...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1839</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1840</th>\n",
       "      <td>Anti-human H1N1 virus neutralizing antibodies ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1841</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1842</th>\n",
       "      <td>Mean geometric increase represents the fold-ri...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1843</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1844</th>\n",
       "      <td>Anti-avian-swine H1N1 virus neutralizing antib...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1845</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1846</th>\n",
       "      <td>Seropositivity rate was defined as the percent...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Geometri...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1847</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1848</th>\n",
       "      <td>Anti-avian-swine H1N1 virus neutralizing antib...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1849</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1850</th>\n",
       "      <td>Anti-avian-swine H1N1 virus neutralizing antib...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1851</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1852</th>\n",
       "      <td>Anti-avian-swine H1N1 virus neutralizing antib...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Mean Geo...</td>\n",
       "      <td>This assay was performed to measure the neutr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1853</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1854</th>\n",
       "      <td>Anti-avian-swine H1N1 virus neutralizing antib...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1855</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1856</th>\n",
       "      <td>Mean geometric increase represents the fold-ri...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the induc...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1857</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1858</th>\n",
       "      <td>Seropositivity rate was defined as the percent...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Geometri...</td>\n",
       "      <td>This assay was performed to measure the induc...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the induc...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Percenta...</td>\n",
       "      <td>This assay was performed to measure the induc...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)|Mean Geo...</td>\n",
       "      <td>This assay was performed to measure the induc...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1859</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1860</th>\n",
       "      <td>Mean geometric increase represents the fold-ri...</td>\n",
       "      <td>Baseline (pre-dose 1)</td>\n",
       "      <td>Month 1 (28 days post-dose 1)</td>\n",
       "      <td>Month 4 (28 days post-dose 2)</td>\n",
       "      <td>and Month 15 (12 months post-dose 2)\"</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PATH</td>\n",
       "      <td>Icahn School of Medicine at Mount Sinai|Childr...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>65</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CVIA 057 (1082166-1)</td>\n",
       "      <td>10/10/2017</td>\n",
       "      <td>4/24/2018</td>\n",
       "      <td>8/9/2019</td>\n",
       "      <td>10/3/2017</td>\n",
       "      <td>11/17/2020</td>\n",
       "      <td>2/21/2021</td>\n",
       "      <td>Duke University, Durham, North Carolina, 27710...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2180</th>\n",
       "      <td>NCT04263142</td>\n",
       "      <td>A Relative Bioavailability and Food-Effect Stu...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04263142</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is an open-label, 2 part, single-dose and...</td>\n",
       "      <td>YES</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>DRUG: GSK3640254 Tablet|DRUG: GSK3640254 Capsule</td>\n",
       "      <td>Area Under the Plasma Concentration-time Curve...</td>\n",
       "      <td>Number of Participants With Adverse Events (AE...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2659</th>\n",
       "      <td>NCT02478463</td>\n",
       "      <td>Pharmacokinetic Study of Cabotegravir Long-act...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02478463</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Cabotegravir (CAB) long-acting (LA) is a promi...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Infection, Human Immunodeficiency Virus|HIV In...</td>\n",
       "      <td>DRUG: Cabotegravir tablet 30 mg once daily for...</td>\n",
       "      <td>Cabotegravir Concentration in Blood Plasma Fol...</td>\n",
       "      <td>Ratio of Cabotegravir Concentration in Vaginal...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3009</th>\n",
       "      <td>NCT03836729</td>\n",
       "      <td>Study to Evaluate the Effect of GSK3640254 on ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03836729</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Human immunodeficiency virus (HIV) infection f...</td>\n",
       "      <td>YES</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>DRUG: Tenofovir alafenamide/emtricitabine|DRUG...</td>\n",
       "      <td>Period 1: Area Under the Plasma Concentration-...</td>\n",
       "      <td>Number of Participants With Non-serious Advers...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3010</th>\n",
       "      <td>3</td>\n",
       "      <td>4</td>\n",
       "      <td>5</td>\n",
       "      <td>6</td>\n",
       "      <td>8</td>\n",
       "      <td>12 and 24 hours in Period 2 Day 7\"</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ViiV Healthcare</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>16</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: |Intervention Model: SEQUENTIAL|Ma...</td>\n",
       "      <td>208134</td>\n",
       "      <td>2/11/2019</td>\n",
       "      <td>3/30/2019</td>\n",
       "      <td>4/30/2019</td>\n",
       "      <td>2/11/2019</td>\n",
       "      <td>3/17/2020</td>\n",
       "      <td>4/21/2020</td>\n",
       "      <td>GSK Investigational Site, Austin, Texas, 78744...</td>\n",
       "      <td>Statistical Analysis Plan|Study Protocol</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3667</th>\n",
       "      <td>NCT04493684</td>\n",
       "      <td>GSK3739937 First-Time-In-Human (FTIH) Study in...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04493684</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study is a Phase 1, double-blind (sponsor...</td>\n",
       "      <td>YES</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>DRUG: GSK3739937 (PIB)|DRUG: Placebo|DRUG: GSK...</td>\n",
       "      <td>Part 1 - Number of Any Adverse Events (AEs) an...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3951</th>\n",
       "      <td>NCT03441984</td>\n",
       "      <td>To Assess the Relative Bioavailability (BA) of...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03441984</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a 2-part, single-dose, open label, ran...</td>\n",
       "      <td>YES</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>DRUG: Treatment A|DRUG: Treatment B|DRUG: Trea...</td>\n",
       "      <td>Area Under the Plasma Concentration-time Curve...</td>\n",
       "      <td>AUC From Time of Dose to 24 Hours (AUC[0-24]) ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4075</th>\n",
       "      <td>NCT03816696</td>\n",
       "      <td>Study to Evaluate the Pharmacokinetic (PK) Int...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03816696</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is an open-label, single-sequence, two-wa...</td>\n",
       "      <td>YES</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>DRUG: GSK3640254|DRUG: DTG</td>\n",
       "      <td>Period 1: Area Under the Plasma Concentration-...</td>\n",
       "      <td>Number of Participants With Non-serious Advers...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4130</th>\n",
       "      <td>NCT02853435</td>\n",
       "      <td>To Assess Bioavailability, Food Effect and Pha...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02853435</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study is divided in 2 parts. Part 1a is b...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Infections, Bacterial</td>\n",
       "      <td>DRUG: Gepotidacin RC Tablet|DRUG: Gepotidacin ...</td>\n",
       "      <td>Area Under the Concentration-time Curve From T...</td>\n",
       "      <td>Number of Participants With Non-serious Advers...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4241</th>\n",
       "      <td>NCT04718870</td>\n",
       "      <td>Dupilumab-PEdiatric Skin Barrier Function and ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04718870</td>\n",
       "      <td>PELISTAD</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Primary Objective:\\n\\n- Evaluate changes in sk...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Dermatitis Atopic</td>\n",
       "      <td>DRUG: Dupilumab SAR231893</td>\n",
       "      <td>Percent Change From Baseline in Transepidermal...</td>\n",
       "      <td>Percent Change From Baseline in TEWL After 20 ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4304</th>\n",
       "      <td>NCT04425902</td>\n",
       "      <td>Evaluation of Pharmacokinetic Interaction Betw...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04425902</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is an open-label, single sequence study t...</td>\n",
       "      <td>YES</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>DRUG: GSK3640254 200 mg|DRUG: Caffeine 200 mg|...</td>\n",
       "      <td>Area Under the Plasma Concentration-time Curve...</td>\n",
       "      <td>Number of Participants With Adverse Events (AE...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4327</th>\n",
       "      <td>NCT03553940</td>\n",
       "      <td>H3N2 M2SR in Pediatric Population</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03553940</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a Phase I double-blind, randomized, pl...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Influenza|Influenza Immunisation</td>\n",
       "      <td>BIOLOGICAL: Influenza Virus Monovalent A/H3N2/...</td>\n",
       "      <td>Number of Participants With Adverse Events of ...</td>\n",
       "      <td>Frequency of Conserved Internal Viral Protein-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             NCT Number                                        Study Title                                          Study URL                         Acronym                                       Study Status                                      Brief Summary                                      Study Results                                         Conditions                                      Interventions                           Primary Outcome Measures                         Secondary Outcome Measures                             Other Outcome Measures                         Sponsor                   Collaborators                                                Sex                                                Age                  Phases                      Enrollment                     Funder Type                                         Study Type                                       Study Design  Other IDs  \\\n",
       "105                                         NCT03082261  Multi-center Prospective Study Determining the...       https://clinicaltrials.gov/study/NCT03082261                         TRIUMPH                                          COMPLETED  The TRIUMPH study is a post-market, internatio...                                                YES                      Chronic Pain|Intractable Pain  DEVICE: Prodigy, Prodigy MRI or Proclaim Elite...  Mean Change in Pain From Baseline to 6 Months ...  Mean Change in Quality of Life From Baseline t...  Mean Change in Quality of Life From Baseline t...                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "123                                         NCT03984825  Effect of GSK3640254 on the Pharmacokinetics o...       https://clinicaltrials.gov/study/NCT03984825                             NaN                                          COMPLETED  This is an open-label, single-sequence, 1-way ...                                                YES                                     HIV Infections                      DRUG: GSK3640254|DRUG: Portia  Period 1: Area Under the Plasma Concentration-...  Period 1: Effect of GSK3640254 on PD of EE/LNG...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "200                                         NCT04493931         Drug-drug Interaction Study of Gepotidacin       https://clinicaltrials.gov/study/NCT04493931                             NaN                                          COMPLETED  This study is a drug-drug interaction (DDI), p...                                                YES                              Infections, Bacterial  DRUG: Gepotidacin|DRUG: Cimetidine|DRUG: Rifam...  Cohort 1: Maximum Observed Concentration (Cmax...  Cohort 1: AUC (0-24) of Gepotidacin in Plasma,...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "845                                         NCT03655951                      Birds and Bees Research Study       https://clinicaltrials.gov/study/NCT03655951                             NaN                                          COMPLETED  The goal of this efficacy study is to evaluate...                                                YES                      Sexual Behavior|Communication  BEHAVIORAL: Web-based resource on adolescent s...  Change in Parent Reported Frequency of Parent-...  Change in Parental Perceived Importance of Par...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1793                                        NCT03300050  Safety and Immunogenicity of a Live-attenuated...       https://clinicaltrials.gov/study/NCT03300050                             NaN                                          COMPLETED  The clinical study will evaluate safety and th...                                                YES                                  Influenza|Vaccine  BIOLOGICAL: cH8/1N1 LAIV|BIOLOGICAL: AS03-adju...  Number of Participants With Solicited Local Re...  Number of Participants With Any Grade 2 or Hig...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1794  h 15 (12 months post-dose 2)|Percentage of Par...                      To determine antibody breadth   assays were performed to measure the inductio...                      subtype H2   of which the stalk domain shares about 78% am...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1795                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1796  Anti-H2 full-length (ecto-domain) hemagglutini...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Mean Geo...                      To determine antibody breadth   assays were performed to measure the inductio...                                         subtype H2   of which the stalk domain shares about 78% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1797                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1798  Anti-H2 full-length (ecto-domain) hemagglutini...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1799                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1800  Mean geometric increase represents the fold-ri...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...                      To determine antibody breadth   assays were performed to measure the inductio...                                         subtype H9   the stalk domain of which shares about 59% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1801                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1802  Anti-H9 full-length (ecto-domain) hemagglutini...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1803                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1804  Seropositivity rate was defined as the percent...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Geometri...                      To determine antibody breadth   assays were performed to measure the inductio...                                         subtype H9   the stalk domain of which shares about 59% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1805                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1806  Anti-H9 full-length (ecto-domain) hemagglutini...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...                      To determine antibody breadth   assays were performed to measure the inductio...                                         subtype H9   the stalk domain of which shares about 59% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1807                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1808  Anti-H9 full-length (ecto-domain) hemagglutini...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...                      To determine antibody breadth   assays were performed to measure the inductio...                                         subtype H9   the stalk domain of which shares about 59% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1809                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1810  Anti-H9 full-length(ecto-domain) hemagglutinin...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Mean Geo...                      To determine antibody breadth   assays were performed to measure the inductio...                                         subtype H9   the stalk domain of which shares about 59% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1811                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1812  Anti-H9 full-length (ecto-domain) hemagglutini...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1813                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1814  Mean geometric increase represents the fold-ri...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...                      To determine antibody breadth   assays were performed to measure the inductio...                                        subtype H18   the stalk domain of which shares about 65% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1815                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1816  Anti-H18 full-length (ecto-domain) hemagglutin...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1817                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1818  Seropositivity rate was defined as the percent...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Geometri...                      To determine antibody breadth   assays were performed to measure the inductio...                                                H18   the stalk domain of which shares about 65% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1819                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1820  Anti-H18 full-length (ecto-domain) hemagglutin...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...                      To determine antibody breadth   assays were performed to measure the inductio...                                        subtype H18   the stalk domain of which shares about 65% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1821                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1822  Anti-H18 full-length (ecto-domain) hemagglutin...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...                      To determine antibody breadth   assays were performed to measure the inductio...                                        subtype H18   the stalk domain of which shares about 65% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1823                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1824  Anti-H18 full-length (ecto-domain) hemagglutin...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Mean Geo...                      To determine antibody breadth   assays were performed to measure the inductio...                                        subtype H18   the stalk domain of which shares about 65% am...                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1825                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1826  Anti-H18 full-length (ecto-domain) hemagglutin...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1827                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1828  Mean geometric increase represents the fold-ri...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1829                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1830  Anti-human H1N1 virus neutralizing antibodies ...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1831                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1832  Seropositivity rate was defined as the percent...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Geometri...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1833                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1834  Anti-human H1N1 virus neutralizing antibodies ...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1835                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1836  Anti-human H1N1 virus neutralizing antibodies ...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1837                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1838  Anti-human H1N1 virus neutralizing antibodies ...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Mean Geo...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1839                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1840  Anti-human H1N1 virus neutralizing antibodies ...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1841                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1842  Mean geometric increase represents the fold-ri...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1843                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1844  Anti-avian-swine H1N1 virus neutralizing antib...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1845                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1846  Seropositivity rate was defined as the percent...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Geometri...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1847                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1848  Anti-avian-swine H1N1 virus neutralizing antib...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1849                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1850  Anti-avian-swine H1N1 virus neutralizing antib...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1851                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1852  Anti-avian-swine H1N1 virus neutralizing antib...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Mean Geo...   This assay was performed to measure the neutr...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1853                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1854  Anti-avian-swine H1N1 virus neutralizing antib...                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1855                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1856  Mean geometric increase represents the fold-ri...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the induc...                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1857                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1858  Seropositivity rate was defined as the percent...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Geometri...   This assay was performed to measure the induc...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)                      Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the induc...                              Baseline (pre-dose 1)   Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Percenta...   This assay was performed to measure the induc...   Baseline (pre-dose 1)   Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)   and Month 15 (12 months post-dose 2)|Mean Geo...   This assay was performed to measure the induc...        NaN   \n",
       "1859                                                NaN                                                NaN                                                NaN                             NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "1860  Mean geometric increase represents the fold-ri...                              Baseline (pre-dose 1)                      Month 1 (28 days post-dose 1)   Month 4 (28 days post-dose 2)              and Month 15 (12 months post-dose 2)\"                                                NaN                                               PATH  Icahn School of Medicine at Mount Sinai|Childr...                                                ALL                                              ADULT                                             PHASE1                                                 65                           OTHER                  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                               CVIA 057 (1082166-1)              10/10/2017                       4/24/2018                        8/9/2019                                          10/3/2017                                         11/17/2020  2/21/2021   \n",
       "2180                                        NCT04263142  A Relative Bioavailability and Food-Effect Stu...       https://clinicaltrials.gov/study/NCT04263142                             NaN                                          COMPLETED  This is an open-label, 2 part, single-dose and...                                                YES                                     HIV Infections   DRUG: GSK3640254 Tablet|DRUG: GSK3640254 Capsule  Area Under the Plasma Concentration-time Curve...  Number of Participants With Adverse Events (AE...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "2659                                        NCT02478463  Pharmacokinetic Study of Cabotegravir Long-act...       https://clinicaltrials.gov/study/NCT02478463                             NaN                                          COMPLETED  Cabotegravir (CAB) long-acting (LA) is a promi...                                                YES  Infection, Human Immunodeficiency Virus|HIV In...  DRUG: Cabotegravir tablet 30 mg once daily for...  Cabotegravir Concentration in Blood Plasma Fol...  Ratio of Cabotegravir Concentration in Vaginal...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "3009                                        NCT03836729  Study to Evaluate the Effect of GSK3640254 on ...       https://clinicaltrials.gov/study/NCT03836729                             NaN                                          COMPLETED  Human immunodeficiency virus (HIV) infection f...                                                YES                                     HIV Infections  DRUG: Tenofovir alafenamide/emtricitabine|DRUG...  Period 1: Area Under the Plasma Concentration-...  Number of Participants With Non-serious Advers...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "3010                                                  3                                                  4                                                  5                               6                                                  8                 12 and 24 hours in Period 2 Day 7\"                                                NaN                                    ViiV Healthcare                                                NaN                                                ALL                                              ADULT                                             PHASE1                              16                        INDUSTRY                                     INTERVENTIONAL  Allocation: |Intervention Model: SEQUENTIAL|Ma...                  208134                       2/11/2019                       3/30/2019                                          4/30/2019                                          2/11/2019  3/17/2020   \n",
       "3667                                        NCT04493684  GSK3739937 First-Time-In-Human (FTIH) Study in...       https://clinicaltrials.gov/study/NCT04493684                             NaN                                          COMPLETED  This study is a Phase 1, double-blind (sponsor...                                                YES                                     HIV Infections  DRUG: GSK3739937 (PIB)|DRUG: Placebo|DRUG: GSK...  Part 1 - Number of Any Adverse Events (AEs) an...                                                NaN                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "3951                                        NCT03441984  To Assess the Relative Bioavailability (BA) of...       https://clinicaltrials.gov/study/NCT03441984                             NaN                                          COMPLETED  This is a 2-part, single-dose, open label, ran...                                                YES                                     HIV Infections  DRUG: Treatment A|DRUG: Treatment B|DRUG: Trea...  Area Under the Plasma Concentration-time Curve...  AUC From Time of Dose to 24 Hours (AUC[0-24]) ...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "4075                                        NCT03816696  Study to Evaluate the Pharmacokinetic (PK) Int...       https://clinicaltrials.gov/study/NCT03816696                             NaN                                          COMPLETED  This is an open-label, single-sequence, two-wa...                                                YES                                     HIV Infections                         DRUG: GSK3640254|DRUG: DTG  Period 1: Area Under the Plasma Concentration-...  Number of Participants With Non-serious Advers...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "4130                                        NCT02853435  To Assess Bioavailability, Food Effect and Pha...       https://clinicaltrials.gov/study/NCT02853435                             NaN                                          COMPLETED  This study is divided in 2 parts. Part 1a is b...                                                YES                              Infections, Bacterial  DRUG: Gepotidacin RC Tablet|DRUG: Gepotidacin ...  Area Under the Concentration-time Curve From T...  Number of Participants With Non-serious Advers...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "4241                                        NCT04718870  Dupilumab-PEdiatric Skin Barrier Function and ...       https://clinicaltrials.gov/study/NCT04718870                        PELISTAD                                          COMPLETED  Primary Objective:\\n\\n- Evaluate changes in sk...                                                YES                                  Dermatitis Atopic                          DRUG: Dupilumab SAR231893  Percent Change From Baseline in Transepidermal...  Percent Change From Baseline in TEWL After 20 ...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "4304                                        NCT04425902  Evaluation of Pharmacokinetic Interaction Betw...       https://clinicaltrials.gov/study/NCT04425902                             NaN                                          COMPLETED  This is an open-label, single sequence study t...                                                YES                                     HIV Infections  DRUG: GSK3640254 200 mg|DRUG: Caffeine 200 mg|...  Area Under the Plasma Concentration-time Curve...  Number of Participants With Adverse Events (AE...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "4327                                        NCT03553940                  H3N2 M2SR in Pediatric Population       https://clinicaltrials.gov/study/NCT03553940                             NaN                                          COMPLETED  This is a Phase I double-blind, randomized, pl...                                                YES                   Influenza|Influenza Immunisation  BIOLOGICAL: Influenza Virus Monovalent A/H3N2/...  Number of Participants With Adverse Events of ...  Frequency of Conserved Internal Viral Protein-...                                                NaN                             NaN                             NaN                                                NaN                                                NaN                     NaN                             NaN                             NaN                                                NaN                                                NaN        NaN   \n",
       "\n",
       "                                             Start Date                            Primary Completion Date                           Completion Date First Posted Results First Posted Last Update Posted Locations Study Documents  \n",
       "105                                                 NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "123                                                 NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "200                                                 NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "845                                                 NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1793                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1794                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1795                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1796                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1797                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1798                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1799                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1800                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1801                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1802                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1803                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1804                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1805                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1806                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1807                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1808                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1809                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1810                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1811                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1812                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1813                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1814                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1815                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1816                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1817                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1818                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1819                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1820                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1821                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1822                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1823                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1824                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1825                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1826                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1827                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1828                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1829                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1830                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1831                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1832                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1833                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1834                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1835                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1836                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1837                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1838                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1839                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1840                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1841                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1842                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1843                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1844                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1845                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1846                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1847                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1848                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1849                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1850                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1851                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1852                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1853                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1854                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1855                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1856                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1857                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1858                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1859                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "1860  Duke University, Durham, North Carolina, 27710...           Study Protocol|Statistical Analysis Plan                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "2180                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "2659                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "3009                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "3010                                          4/21/2020  GSK Investigational Site, Austin, Texas, 78744...  Statistical Analysis Plan|Study Protocol          NaN                  NaN                NaN       NaN             NaN  \n",
       "3667                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "3951                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "4075                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "4130                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "4241                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "4304                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  \n",
       "4327                                                NaN                                                NaN                                       NaN          NaN                  NaN                NaN       NaN             NaN  "
      ]
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Seperating rows with no locations listed. Some may have mislabled data or study has been completed.\n",
    "print(NIH_usa['Locations'].isna().sum())\n",
    "NIH_locNan = NIH_usa[NIH_usa['Locations'].isna()] \n",
    "NIH_locNan"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Looks like we are safe to drop row with NAN location for now.\n",
    "NIH_usa.dropna(subset=['Locations'], inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(123, 30)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>NCT03192488</td>\n",
       "      <td>Effect of an H1 Receptor Antagonist on Exercis...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03192488</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study seeks to determine whether a simple...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Hypoxia, Altitude</td>\n",
       "      <td>DRUG: Cetirizine|DRUG: Placebo oral capsule|OT...</td>\n",
       "      <td>Performance Time, Time to complete 8km cycling...</td>\n",
       "      <td>Plasma Histamine Concentrations at Baseline an...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>13</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>1702396373</td>\n",
       "      <td>8/31/2017</td>\n",
       "      <td>6/6/2018</td>\n",
       "      <td>6/6/2018</td>\n",
       "      <td>6/20/2017</td>\n",
       "      <td>5/7/2019</td>\n",
       "      <td>6/16/2020</td>\n",
       "      <td>Indiana University, Bloomington, Indiana, 4740...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>NCT04623242</td>\n",
       "      <td>Dominantly Inherited Alzheimer Network Trial: ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04623242</td>\n",
       "      <td>DIAN-TU</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to assess the saf...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Alzheimers Disease|Dementia|Alzheimers Disease...</td>\n",
       "      <td>DRUG: Gantenerumab|DRUG: Solanezumab|DRUG: Mat...</td>\n",
       "      <td>Assess Cognitive Efficacy in Individuals With ...</td>\n",
       "      <td>Gantenerumab: Rate of Change Over Time- Clinic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Washington University School of Medicine</td>\n",
       "      <td>Eli Lilly and Company|Hoffmann-La Roche|Alzhei...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>194</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>DIAN-TU-001 (gant-sola)|The Alzheimer's Associ...</td>\n",
       "      <td>2012-12</td>\n",
       "      <td>11/22/2019</td>\n",
       "      <td>3/6/2020</td>\n",
       "      <td>11/10/2020</td>\n",
       "      <td>2/27/2021</td>\n",
       "      <td>9/22/2022</td>\n",
       "      <td>University of Alabama in Birmingham, Birmingha...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>NCT02754661</td>\n",
       "      <td>Colon Capsule Endoscopy (CCE) Versus Computed ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02754661</td>\n",
       "      <td>TOPAZ</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective of this multicenter, pro...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colorectal Cancer Screening</td>\n",
       "      <td>DEVICE: COLON Capsule endoscopy|DEVICE: Comput...</td>\n",
       "      <td>Number of Participants With an Actionable Lesi...</td>\n",
       "      <td>Sensitivity of CCE Versus CTC in the Detection...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medtronic - MITG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>320</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>COVGIC20543|MA-213</td>\n",
       "      <td>2016-09</td>\n",
       "      <td>8/7/2018</td>\n",
       "      <td>8/7/2018</td>\n",
       "      <td>4/28/2016</td>\n",
       "      <td>8/1/2019</td>\n",
       "      <td>10/1/2019</td>\n",
       "      <td>University of South Alabama, Mobile, Alabama, ...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>NCT03132753</td>\n",
       "      <td>Developing SUPPORT, a Community-Driven, Recove...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03132753</td>\n",
       "      <td>SUPPORT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The investigators seek to develop and assess t...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Substance Use</td>\n",
       "      <td>BEHAVIORAL: SUPPORT</td>\n",
       "      <td>Number of Participants Reporting Substance Use...</td>\n",
       "      <td>Difference in Self Determination, The Self-Det...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1511731907</td>\n",
       "      <td>10/23/2017</td>\n",
       "      <td>1/30/2020</td>\n",
       "      <td>9/30/2020</td>\n",
       "      <td>4/28/2017</td>\n",
       "      <td>7/31/2020</td>\n",
       "      <td>2/3/2022</td>\n",
       "      <td>Public Advocates in Community Re-Entry (PACE),...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>234</th>\n",
       "      <td>NCT04267562</td>\n",
       "      <td>Minitouch Endometrial Ablation System Treatmen...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04267562</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The EASE Clinical Trial is prospective, multi-...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Menorrhagia|Heavy Menstrual Bleeding|Heavy Ute...</td>\n",
       "      <td>DEVICE: Minitouch System</td>\n",
       "      <td>Number of Trial Participants With Reduction in...</td>\n",
       "      <td>Number of Trial Participants That Underwent Su...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MicroCube, LLC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>219</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>TD18036</td>\n",
       "      <td>2/28/2020</td>\n",
       "      <td>7/20/2022</td>\n",
       "      <td>2023-12</td>\n",
       "      <td>2/13/2020</td>\n",
       "      <td>8/28/2023</td>\n",
       "      <td>10/23/2023</td>\n",
       "      <td>CMB Research, Newburgh, Indiana, 47630, United...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      NCT Number                                        Study Title                                     Study URL  Acronym           Study Status                                      Brief Summary Study Results                                         Conditions                                      Interventions                           Primary Outcome Measures                         Secondary Outcome Measures Other Outcome Measures                                   Sponsor                                      Collaborators     Sex                 Age         Phases Enrollment Funder Type      Study Type                                       Study Design                                          Other IDs  Start Date Primary Completion Date Completion Date First Posted Results First Posted Last Update Posted                                          Locations                                    Study Documents\n",
       "14   NCT03192488  Effect of an H1 Receptor Antagonist on Exercis...  https://clinicaltrials.gov/study/NCT03192488      NaN              COMPLETED  This study seeks to determine whether a simple...           YES                                  Hypoxia, Altitude  DRUG: Cetirizine|DRUG: Placebo oral capsule|OT...  Performance Time, Time to complete 8km cycling...  Plasma Histamine Concentrations at Baseline an...                    NaN                        Indiana University                                                NaN     ALL               ADULT         PHASE4         13       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                         1702396373   8/31/2017                6/6/2018        6/6/2018    6/20/2017             5/7/2019          6/16/2020  Indiana University, Bloomington, Indiana, 4740...       Study Protocol and Statistical Analysis Plan\n",
       "35   NCT04623242  Dominantly Inherited Alzheimer Network Trial: ...  https://clinicaltrials.gov/study/NCT04623242  DIAN-TU              COMPLETED  The purpose of this study is to assess the saf...           YES  Alzheimers Disease|Dementia|Alzheimers Disease...  DRUG: Gantenerumab|DRUG: Solanezumab|DRUG: Mat...  Assess Cognitive Efficacy in Individuals With ...  Gantenerumab: Rate of Change Over Time- Clinic...                    NaN  Washington University School of Medicine  Eli Lilly and Company|Hoffmann-La Roche|Alzhei...     ALL  ADULT, OLDER_ADULT  PHASE2|PHASE3        194       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...  DIAN-TU-001 (gant-sola)|The Alzheimer's Associ...     2012-12              11/22/2019        3/6/2020   11/10/2020            2/27/2021          9/22/2022  University of Alabama in Birmingham, Birmingha...           Study Protocol|Statistical Analysis Plan\n",
       "70   NCT02754661  Colon Capsule Endoscopy (CCE) Versus Computed ...  https://clinicaltrials.gov/study/NCT02754661    TOPAZ              COMPLETED  The primary objective of this multicenter, pro...           YES                        Colorectal Cancer Screening  DEVICE: COLON Capsule endoscopy|DEVICE: Comput...  Number of Participants With an Actionable Lesi...  Sensitivity of CCE Versus CTC in the Detection...                    NaN                          Medtronic - MITG                                                NaN     ALL  ADULT, OLDER_ADULT            NaN        320    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                 COVGIC20543|MA-213     2016-09                8/7/2018        8/7/2018    4/28/2016             8/1/2019          10/1/2019  University of South Alabama, Mobile, Alabama, ...       Study Protocol and Statistical Analysis Plan\n",
       "154  NCT03132753  Developing SUPPORT, a Community-Driven, Recove...  https://clinicaltrials.gov/study/NCT03132753  SUPPORT              COMPLETED  The investigators seek to develop and assess t...           YES                                      Substance Use                                BEHAVIORAL: SUPPORT  Number of Participants Reporting Substance Use...  Difference in Self Determination, The Self-Det...                    NaN                        Indiana University                                                NaN     ALL  ADULT, OLDER_ADULT            NaN        100       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1511731907  10/23/2017               1/30/2020       9/30/2020    4/28/2017            7/31/2020           2/3/2022  Public Advocates in Community Re-Entry (PACE),...  Study Protocol and Statistical Analysis Plan|I...\n",
       "234  NCT04267562  Minitouch Endometrial Ablation System Treatmen...  https://clinicaltrials.gov/study/NCT04267562      NaN  ACTIVE_NOT_RECRUITING  The EASE Clinical Trial is prospective, multi-...           YES  Menorrhagia|Heavy Menstrual Bleeding|Heavy Ute...                           DEVICE: Minitouch System  Number of Trial Participants With Reduction in...  Number of Trial Participants That Underwent Su...                    NaN                            MicroCube, LLC                                                NaN  FEMALE               ADULT            NaN        219    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                            TD18036   2/28/2020               7/20/2022         2023-12    2/13/2020            8/28/2023         10/23/2023  CMB Research, Newburgh, Indiana, 47630, United...       Study Protocol and Statistical Analysis Plan"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "NIH_IN = NIH_usa[NIH_usa['Locations'].str.contains('Indiana')]\n",
    "print(NIH_IN.shape)\n",
    "NIH_IN.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can see that these are not exclusively Indiana based trials but if we explore one of the location values, it appears that some of the trials have many locations so we can be inclusive but we don't know exactly how much of the study is Indiana based. We may want to add a column for mult-location trials."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "University of Alabama in Birmingham, Birmingham, Alabama, 35294, United States|University of California San Diego Medical Center, La Jolla, California, 92037, United States|Yale University School of Medicine, New Haven, Connecticut, 06510, United States|Emory University, Atlanta, Georgia, 30329, United States|Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States|Washington University in St. Louis, Saint Louis, Missouri, 63110, United States|Columbia University, New York, New York, 10032, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|Butler Hospital, Providence, Rhode Island, 02096, United States|University of Washington, Seattle, Washington, 98195, United States|Neuroscience Research Australia, Randwick, New South Wales, 2031, Australia|Mental Health Research Institute, Melbourne, Victoria, 3010, Australia|The McCuster Foundation of Alzheimer's Disease Research, Nedlands, Western Australia, 6009, Australia|UBC Hospital, Vancouver, British Columbia, V6T 2B5, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|McGill Center for Studies in Aging, Verdun, Quebec, H4H 1R3, Canada|CHU de Toulouse - Hôpital Purpan, Toulouse, Haute Garonne, 31059, France|Hopital Roger Salengro - CHU Lille, Lille, Nord, 59037, France|Groupe Hospitalier Pitie-Salpetriere, Paris cedex 13, Paris, 69677, France|Hopital Neurologique Pierre Wertheimer, Bron cedex, Rhone, 69677, France|CHU de Rouen - Hôpital Charles Nicolle, Rouen, Seine Maritime, 76031, France|St Vincent's University Hospital, Dublin, DUBLIN 4, Ireland|University of Puerto Rico, School of Medicine, San Juan, 00936, Puerto Rico|Hospital Clínic I Provincial de Barcelona, Barcelona, 8036, Spain|The National Hospital for Neurology and Neurosurgery, London, Greater London, WC1B 3BG, United Kingdom\n"
     ]
    }
   ],
   "source": [
    "print(NIH_IN['Locations'].iloc[1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "NIH_IN.to_csv(r'./NIH_IN.csv', index = False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The next step will be pinpointing the county for each of the IN based studies. Best approach seems to pull the zipcodes and then connect those zipcodes to the applicable county."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Start by creating a list of Indiana zip codes to match with the clinical trial locations. \n",
    "#More info on uszipcode python library: https://uszipcode.readthedocs.io/02-Advanced-Tutorial/index.html#search-by-state\n",
    "engine = SearchEngine()\n",
    "IN_zipcodes = engine.by_state(state=\"Indiana\", returns=2000)\n",
    "zip_dict = {}\n",
    "for z in IN_zipcodes:\n",
    "    zip1 = z.zipcode\n",
    "    county1 = z.county\n",
    "    zip_dict.update({zip1:county1})\n",
    "\n",
    "# zip_dict\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "700\n",
      "700\n"
     ]
    }
   ],
   "source": [
    "print(len(IN_zipcodes))\n",
    "print(len(zip_dict))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now that we have a dictionary with zips and county names we need to add the county names to our NIH_IN dataframe based on the zipcodes in the locations column. Since we know there are potentially multiple locations we need to include all Indiana counties. We also wnat to include all the zips for mapping later."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\pvste\\AppData\\Local\\Temp\\ipykernel_37132\\3847499415.py:4: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  NIH_IN['IN Zip'] = None\n"
     ]
    }
   ],
   "source": [
    "# del zip_list\n",
    "zip_list= []\n",
    "\n",
    "NIH_IN['IN Zip'] = None\n",
    "\n",
    "for index, row in NIH_IN.iterrows():\n",
    "    locations = row['Locations']\n",
    "    zip_list = []\n",
    "    \n",
    "    for z in zip_dict.keys():\n",
    "        if z in str(locations):\n",
    "            zip_list.append(z)\n",
    "\n",
    "    if zip_list:\n",
    "        NIH_IN.at[index, 'IN Zip'] = zip_list\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>IN Zip</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>875</th>\n",
       "      <td>NCT02576847</td>\n",
       "      <td>[46202]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1970</th>\n",
       "      <td>NCT02277990</td>\n",
       "      <td>[46260]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2734</th>\n",
       "      <td>NCT02325791</td>\n",
       "      <td>[46601]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2999</th>\n",
       "      <td>NCT02576860</td>\n",
       "      <td>[46168]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3047</th>\n",
       "      <td>NCT02547441</td>\n",
       "      <td>[46032]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3061</th>\n",
       "      <td>NCT02431702</td>\n",
       "      <td>[46202]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3989</th>\n",
       "      <td>NCT03320057</td>\n",
       "      <td>[46202]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3997</th>\n",
       "      <td>NCT05056870</td>\n",
       "      <td>[47401]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4337</th>\n",
       "      <td>NCT02569398</td>\n",
       "      <td>[46514, 46202]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number          IN Zip\n",
       "875   NCT02576847         [46202]\n",
       "1970  NCT02277990         [46260]\n",
       "2734  NCT02325791         [46601]\n",
       "2999  NCT02576860         [46168]\n",
       "3047  NCT02547441         [46032]\n",
       "3061  NCT02431702         [46202]\n",
       "3989  NCT03320057         [46202]\n",
       "3997  NCT05056870         [47401]\n",
       "4337  NCT02569398  [46514, 46202]"
      ]
     },
     "execution_count": 107,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# For the few rows with no zip codes it made the most sense to manually look up the locations listed and create a list to match the locations of each row.\n",
    "# del zip_fix_df\n",
    "\n",
    "nan_zip_subset = NIH_IN[NIH_IN['IN Zip'].isna()| (NIH_IN['IN Zip'] == np.nan)]\n",
    "zip_fix_df = nan_zip_subset[['NCT Number']].copy()  \n",
    "zip_list_manual = [[str(46202)],[str(46260)],[str(46601)],[str(46168)],[str(46032)],[str(46202)],[str(46202)],[str(47401)],[str(46514),str(46202)]]\n",
    "zip_fix_df['IN Zip'] = zip_list_manual\n",
    "zip_fix_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>IN Zip</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT Number</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>NCT03192488</th>\n",
       "      <td>Effect of an H1 Receptor Antagonist on Exercis...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03192488</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study seeks to determine whether a simple...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Hypoxia, Altitude</td>\n",
       "      <td>DRUG: Cetirizine|DRUG: Placebo oral capsule|OT...</td>\n",
       "      <td>Performance Time, Time to complete 8km cycling...</td>\n",
       "      <td>Plasma Histamine Concentrations at Baseline an...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>13</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>1702396373</td>\n",
       "      <td>8/31/2017</td>\n",
       "      <td>6/6/2018</td>\n",
       "      <td>6/6/2018</td>\n",
       "      <td>6/20/2017</td>\n",
       "      <td>5/7/2019</td>\n",
       "      <td>6/16/2020</td>\n",
       "      <td>Indiana University, Bloomington, Indiana, 4740...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47401]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04623242</th>\n",
       "      <td>Dominantly Inherited Alzheimer Network Trial: ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04623242</td>\n",
       "      <td>DIAN-TU</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to assess the saf...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Alzheimers Disease|Dementia|Alzheimers Disease...</td>\n",
       "      <td>DRUG: Gantenerumab|DRUG: Solanezumab|DRUG: Mat...</td>\n",
       "      <td>Assess Cognitive Efficacy in Individuals With ...</td>\n",
       "      <td>Gantenerumab: Rate of Change Over Time- Clinic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Washington University School of Medicine</td>\n",
       "      <td>Eli Lilly and Company|Hoffmann-La Roche|Alzhei...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>194</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>DIAN-TU-001 (gant-sola)|The Alzheimer's Associ...</td>\n",
       "      <td>2012-12</td>\n",
       "      <td>11/22/2019</td>\n",
       "      <td>3/6/2020</td>\n",
       "      <td>11/10/2020</td>\n",
       "      <td>2/27/2021</td>\n",
       "      <td>9/22/2022</td>\n",
       "      <td>University of Alabama in Birmingham, Birmingha...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02754661</th>\n",
       "      <td>Colon Capsule Endoscopy (CCE) Versus Computed ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02754661</td>\n",
       "      <td>TOPAZ</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective of this multicenter, pro...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colorectal Cancer Screening</td>\n",
       "      <td>DEVICE: COLON Capsule endoscopy|DEVICE: Comput...</td>\n",
       "      <td>Number of Participants With an Actionable Lesi...</td>\n",
       "      <td>Sensitivity of CCE Versus CTC in the Detection...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medtronic - MITG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>320</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>COVGIC20543|MA-213</td>\n",
       "      <td>2016-09</td>\n",
       "      <td>8/7/2018</td>\n",
       "      <td>8/7/2018</td>\n",
       "      <td>4/28/2016</td>\n",
       "      <td>8/1/2019</td>\n",
       "      <td>10/1/2019</td>\n",
       "      <td>University of South Alabama, Mobile, Alabama, ...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202, 46237]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03132753</th>\n",
       "      <td>Developing SUPPORT, a Community-Driven, Recove...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03132753</td>\n",
       "      <td>SUPPORT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The investigators seek to develop and assess t...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Substance Use</td>\n",
       "      <td>BEHAVIORAL: SUPPORT</td>\n",
       "      <td>Number of Participants Reporting Substance Use...</td>\n",
       "      <td>Difference in Self Determination, The Self-Det...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1511731907</td>\n",
       "      <td>10/23/2017</td>\n",
       "      <td>1/30/2020</td>\n",
       "      <td>9/30/2020</td>\n",
       "      <td>4/28/2017</td>\n",
       "      <td>7/31/2020</td>\n",
       "      <td>2/3/2022</td>\n",
       "      <td>Public Advocates in Community Re-Entry (PACE),...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46218]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04267562</th>\n",
       "      <td>Minitouch Endometrial Ablation System Treatmen...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04267562</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The EASE Clinical Trial is prospective, multi-...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Menorrhagia|Heavy Menstrual Bleeding|Heavy Ute...</td>\n",
       "      <td>DEVICE: Minitouch System</td>\n",
       "      <td>Number of Trial Participants With Reduction in...</td>\n",
       "      <td>Number of Trial Participants That Underwent Su...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MicroCube, LLC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>219</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>TD18036</td>\n",
       "      <td>2/28/2020</td>\n",
       "      <td>7/20/2022</td>\n",
       "      <td>2023-12</td>\n",
       "      <td>2/13/2020</td>\n",
       "      <td>8/28/2023</td>\n",
       "      <td>10/23/2023</td>\n",
       "      <td>CMB Research, Newburgh, Indiana, 47630, United...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47630]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   Study Title                                     Study URL  Acronym           Study Status                                      Brief Summary Study Results                                         Conditions                                      Interventions                           Primary Outcome Measures                         Secondary Outcome Measures Other Outcome Measures                                   Sponsor                                      Collaborators     Sex                 Age         Phases Enrollment Funder Type      Study Type                                       Study Design                                          Other IDs  Start Date Primary Completion Date Completion Date First Posted Results First Posted Last Update Posted                                          Locations                                    Study Documents          IN Zip\n",
       "NCT Number                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "NCT03192488  Effect of an H1 Receptor Antagonist on Exercis...  https://clinicaltrials.gov/study/NCT03192488      NaN              COMPLETED  This study seeks to determine whether a simple...           YES                                  Hypoxia, Altitude  DRUG: Cetirizine|DRUG: Placebo oral capsule|OT...  Performance Time, Time to complete 8km cycling...  Plasma Histamine Concentrations at Baseline an...                    NaN                        Indiana University                                                NaN     ALL               ADULT         PHASE4         13       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                         1702396373   8/31/2017                6/6/2018        6/6/2018    6/20/2017             5/7/2019          6/16/2020  Indiana University, Bloomington, Indiana, 4740...       Study Protocol and Statistical Analysis Plan         [47401]\n",
       "NCT04623242  Dominantly Inherited Alzheimer Network Trial: ...  https://clinicaltrials.gov/study/NCT04623242  DIAN-TU              COMPLETED  The purpose of this study is to assess the saf...           YES  Alzheimers Disease|Dementia|Alzheimers Disease...  DRUG: Gantenerumab|DRUG: Solanezumab|DRUG: Mat...  Assess Cognitive Efficacy in Individuals With ...  Gantenerumab: Rate of Change Over Time- Clinic...                    NaN  Washington University School of Medicine  Eli Lilly and Company|Hoffmann-La Roche|Alzhei...     ALL  ADULT, OLDER_ADULT  PHASE2|PHASE3        194       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...  DIAN-TU-001 (gant-sola)|The Alzheimer's Associ...     2012-12              11/22/2019        3/6/2020   11/10/2020            2/27/2021          9/22/2022  University of Alabama in Birmingham, Birmingha...           Study Protocol|Statistical Analysis Plan         [46202]\n",
       "NCT02754661  Colon Capsule Endoscopy (CCE) Versus Computed ...  https://clinicaltrials.gov/study/NCT02754661    TOPAZ              COMPLETED  The primary objective of this multicenter, pro...           YES                        Colorectal Cancer Screening  DEVICE: COLON Capsule endoscopy|DEVICE: Comput...  Number of Participants With an Actionable Lesi...  Sensitivity of CCE Versus CTC in the Detection...                    NaN                          Medtronic - MITG                                                NaN     ALL  ADULT, OLDER_ADULT            NaN        320    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                 COVGIC20543|MA-213     2016-09                8/7/2018        8/7/2018    4/28/2016             8/1/2019          10/1/2019  University of South Alabama, Mobile, Alabama, ...       Study Protocol and Statistical Analysis Plan  [46202, 46237]\n",
       "NCT03132753  Developing SUPPORT, a Community-Driven, Recove...  https://clinicaltrials.gov/study/NCT03132753  SUPPORT              COMPLETED  The investigators seek to develop and assess t...           YES                                      Substance Use                                BEHAVIORAL: SUPPORT  Number of Participants Reporting Substance Use...  Difference in Self Determination, The Self-Det...                    NaN                        Indiana University                                                NaN     ALL  ADULT, OLDER_ADULT            NaN        100       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1511731907  10/23/2017               1/30/2020       9/30/2020    4/28/2017            7/31/2020           2/3/2022  Public Advocates in Community Re-Entry (PACE),...  Study Protocol and Statistical Analysis Plan|I...         [46218]\n",
       "NCT04267562  Minitouch Endometrial Ablation System Treatmen...  https://clinicaltrials.gov/study/NCT04267562      NaN  ACTIVE_NOT_RECRUITING  The EASE Clinical Trial is prospective, multi-...           YES  Menorrhagia|Heavy Menstrual Bleeding|Heavy Ute...                           DEVICE: Minitouch System  Number of Trial Participants With Reduction in...  Number of Trial Participants That Underwent Su...                    NaN                            MicroCube, LLC                                                NaN  FEMALE               ADULT            NaN        219    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                            TD18036   2/28/2020               7/20/2022         2023-12    2/13/2020            8/28/2023         10/23/2023  CMB Research, Newburgh, Indiana, 47630, United...       Study Protocol and Statistical Analysis Plan         [47630]"
      ]
     },
     "execution_count": 108,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#join the manually added zip codes with the main dataframe. To make it easier we will set the NCT Numbers as the index.\n",
    "NIH_IN.set_index('NCT Number', inplace=True)\n",
    "zip_fix_df.set_index('NCT Number', inplace=True)\n",
    "NIH_IN.update(zip_fix_df['IN Zip'])\n",
    "NIH_IN.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\pvste\\AppData\\Local\\Temp\\ipykernel_37132\\140362035.py:2: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  NIH_IN['County'] = None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>IN Zip</th>\n",
       "      <th>County</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT Number</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>NCT03192488</th>\n",
       "      <td>Effect of an H1 Receptor Antagonist on Exercis...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03192488</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study seeks to determine whether a simple...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Hypoxia, Altitude</td>\n",
       "      <td>DRUG: Cetirizine|DRUG: Placebo oral capsule|OT...</td>\n",
       "      <td>Performance Time, Time to complete 8km cycling...</td>\n",
       "      <td>Plasma Histamine Concentrations at Baseline an...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>13</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>1702396373</td>\n",
       "      <td>8/31/2017</td>\n",
       "      <td>6/6/2018</td>\n",
       "      <td>6/6/2018</td>\n",
       "      <td>6/20/2017</td>\n",
       "      <td>5/7/2019</td>\n",
       "      <td>6/16/2020</td>\n",
       "      <td>Indiana University, Bloomington, Indiana, 4740...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47401]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04623242</th>\n",
       "      <td>Dominantly Inherited Alzheimer Network Trial: ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04623242</td>\n",
       "      <td>DIAN-TU</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to assess the saf...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Alzheimers Disease|Dementia|Alzheimers Disease...</td>\n",
       "      <td>DRUG: Gantenerumab|DRUG: Solanezumab|DRUG: Mat...</td>\n",
       "      <td>Assess Cognitive Efficacy in Individuals With ...</td>\n",
       "      <td>Gantenerumab: Rate of Change Over Time- Clinic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Washington University School of Medicine</td>\n",
       "      <td>Eli Lilly and Company|Hoffmann-La Roche|Alzhei...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>194</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>DIAN-TU-001 (gant-sola)|The Alzheimer's Associ...</td>\n",
       "      <td>2012-12</td>\n",
       "      <td>11/22/2019</td>\n",
       "      <td>3/6/2020</td>\n",
       "      <td>11/10/2020</td>\n",
       "      <td>2/27/2021</td>\n",
       "      <td>9/22/2022</td>\n",
       "      <td>University of Alabama in Birmingham, Birmingha...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02754661</th>\n",
       "      <td>Colon Capsule Endoscopy (CCE) Versus Computed ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02754661</td>\n",
       "      <td>TOPAZ</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective of this multicenter, pro...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colorectal Cancer Screening</td>\n",
       "      <td>DEVICE: COLON Capsule endoscopy|DEVICE: Comput...</td>\n",
       "      <td>Number of Participants With an Actionable Lesi...</td>\n",
       "      <td>Sensitivity of CCE Versus CTC in the Detection...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medtronic - MITG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>320</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>COVGIC20543|MA-213</td>\n",
       "      <td>2016-09</td>\n",
       "      <td>8/7/2018</td>\n",
       "      <td>8/7/2018</td>\n",
       "      <td>4/28/2016</td>\n",
       "      <td>8/1/2019</td>\n",
       "      <td>10/1/2019</td>\n",
       "      <td>University of South Alabama, Mobile, Alabama, ...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202, 46237]</td>\n",
       "      <td>[Marion County, Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03132753</th>\n",
       "      <td>Developing SUPPORT, a Community-Driven, Recove...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03132753</td>\n",
       "      <td>SUPPORT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The investigators seek to develop and assess t...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Substance Use</td>\n",
       "      <td>BEHAVIORAL: SUPPORT</td>\n",
       "      <td>Number of Participants Reporting Substance Use...</td>\n",
       "      <td>Difference in Self Determination, The Self-Det...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1511731907</td>\n",
       "      <td>10/23/2017</td>\n",
       "      <td>1/30/2020</td>\n",
       "      <td>9/30/2020</td>\n",
       "      <td>4/28/2017</td>\n",
       "      <td>7/31/2020</td>\n",
       "      <td>2/3/2022</td>\n",
       "      <td>Public Advocates in Community Re-Entry (PACE),...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46218]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04267562</th>\n",
       "      <td>Minitouch Endometrial Ablation System Treatmen...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04267562</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The EASE Clinical Trial is prospective, multi-...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Menorrhagia|Heavy Menstrual Bleeding|Heavy Ute...</td>\n",
       "      <td>DEVICE: Minitouch System</td>\n",
       "      <td>Number of Trial Participants With Reduction in...</td>\n",
       "      <td>Number of Trial Participants That Underwent Su...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MicroCube, LLC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>219</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>TD18036</td>\n",
       "      <td>2/28/2020</td>\n",
       "      <td>7/20/2022</td>\n",
       "      <td>2023-12</td>\n",
       "      <td>2/13/2020</td>\n",
       "      <td>8/28/2023</td>\n",
       "      <td>10/23/2023</td>\n",
       "      <td>CMB Research, Newburgh, Indiana, 47630, United...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47630]</td>\n",
       "      <td>[Warrick County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03418662</th>\n",
       "      <td>EndoRings Colonoscopy vs Standard Colonoscopy</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03418662</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study aims to compare the results between ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colorectal Adenoma|Colorectal Polyp|Colon Cancer</td>\n",
       "      <td>DEVICE: EndoRings device</td>\n",
       "      <td>Adenoma Detection Rates, Number of participant...</td>\n",
       "      <td>Polyp Detection Rate, Number of subjects with ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>US Endoscopy</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>592</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1711224972</td>\n",
       "      <td>1/19/2018</td>\n",
       "      <td>9/13/2018</td>\n",
       "      <td>9/13/2018</td>\n",
       "      <td>2/1/2018</td>\n",
       "      <td>7/30/2019</td>\n",
       "      <td>9/20/2019</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03059810</th>\n",
       "      <td>Clinical Evaluation of Investigational Multifo...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03059810</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>3-visit dispensing study to evaluate the subje...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Visual Acuity</td>\n",
       "      <td>DEVICE: etafilcon A</td>\n",
       "      <td>Overall Vision, Overall vision was assessed us...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Johnson &amp; Johnson Vision Care, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>72</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>CR-5903</td>\n",
       "      <td>1/27/2017</td>\n",
       "      <td>4/25/2017</td>\n",
       "      <td>4/25/2017</td>\n",
       "      <td>2/23/2017</td>\n",
       "      <td>12/6/2019</td>\n",
       "      <td>12/24/2019</td>\n",
       "      <td>EYE Center Optometric, Rocklin, California, 95...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04516746</th>\n",
       "      <td>Phase III Double-blind, Placebo-controlled Stu...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04516746</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The aim of the study is to assess the safety, ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>COVID-19|SARS-CoV-2</td>\n",
       "      <td>BIOLOGICAL: AZD1222|BIOLOGICAL: Placebo</td>\n",
       "      <td>Number of Participants Achieving Binary Respon...</td>\n",
       "      <td>Number of Participants With First Post-interve...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Iqvia Pty Ltd</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>32459</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>D8110C00001</td>\n",
       "      <td>8/28/2020</td>\n",
       "      <td>3/5/2021</td>\n",
       "      <td>2/10/2023</td>\n",
       "      <td>8/18/2020</td>\n",
       "      <td>3/3/2022</td>\n",
       "      <td>4/7/2023</td>\n",
       "      <td>Research Site, Phoenix, Arizona, 85018, United...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04811664</th>\n",
       "      <td>A Study of SARS CoV-2 Infection and Potential ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04811664</td>\n",
       "      <td>CoVPN 3006</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to assess SARS Co...</td>\n",
       "      <td>YES</td>\n",
       "      <td>SARS-CoV-2 Infection</td>\n",
       "      <td>BIOLOGICAL: Moderna COVID-19 Vaccine</td>\n",
       "      <td>Efficacy of Moderna COVID-19 Vaccine Against S...</td>\n",
       "      <td>Efficacy of Moderna COVID-19 Vaccine Against C...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>National Institute of Allergy and Infectious D...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>1923</td>\n",
       "      <td>NIH</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>CoVPN 3006</td>\n",
       "      <td>3/24/2021</td>\n",
       "      <td>12/30/2021</td>\n",
       "      <td>12/30/2021</td>\n",
       "      <td>3/23/2021</td>\n",
       "      <td>5/30/2023</td>\n",
       "      <td>8/2/2023</td>\n",
       "      <td>Alabama CRS, Birmingham, Alabama, 35222, Unite...</td>\n",
       "      <td>Study Protocol and Informed Consent Form|Stati...</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03131453</th>\n",
       "      <td>A Study of CNP520 Versus Placebo in Participan...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03131453</td>\n",
       "      <td>GS2</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The purpose of this study is to determine the ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Alzheimers Disease</td>\n",
       "      <td>DRUG: CNP520 50mg|DRUG: CNP520 15mg|OTHER: Mat...</td>\n",
       "      <td>Time to Event (Diagnosis of Mild Cognitive Imp...</td>\n",
       "      <td>Change in Clinical Dementia Rating Scale Sum o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novartis Pharmaceuticals</td>\n",
       "      <td>Amgen|Banner Alzheimer's Institute</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>1145</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CCNP520A2202J|2016-002976-28</td>\n",
       "      <td>8/3/2017</td>\n",
       "      <td>3/26/2020</td>\n",
       "      <td>3/26/2020</td>\n",
       "      <td>4/27/2017</td>\n",
       "      <td>3/25/2021</td>\n",
       "      <td>8/5/2021</td>\n",
       "      <td>Banner Alzheimer's Institute, 901 East Willett...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03547167</th>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03547167</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study is designed to 1) describe the safe...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pneumococcal Infections</td>\n",
       "      <td>BIOLOGICAL: V114|BIOLOGICAL: Prevnar 13™|BIOLO...</td>\n",
       "      <td>Percentage of Participants With Solicited Inje...</td>\n",
       "      <td>Percentage of Participants With Solicited Inje...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>1515</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>V114-017|2017-004915-38|V114-017</td>\n",
       "      <td>7/16/2018</td>\n",
       "      <td>1/20/2020</td>\n",
       "      <td>1/20/2020</td>\n",
       "      <td>6/6/2018</td>\n",
       "      <td>12/14/2020</td>\n",
       "      <td>1/15/2021</td>\n",
       "      <td>Chinle Comprehensive Health Care Facility ( Si...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47374]</td>\n",
       "      <td>[Wayne County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05091307</th>\n",
       "      <td>A Study of Ad26.COV2.S and Influenza Vaccines ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05091307</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to demonstrate th...</td>\n",
       "      <td>YES</td>\n",
       "      <td>COVID-19 Prevention</td>\n",
       "      <td>BIOLOGICAL: Ad26.COV2.S|OTHER: Placebo|BIOLOGI...</td>\n",
       "      <td>Groups 1 and 2: Geometric Mean Titers (GMTs) o...</td>\n",
       "      <td>Number of Participants With Solicited Local Ad...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Janssen Vaccines &amp; Prevention B.V.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>861</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CR109083|2021-003953-43|VAC31518COV3005</td>\n",
       "      <td>11/2/2021</td>\n",
       "      <td>6/17/2022</td>\n",
       "      <td>11/15/2022</td>\n",
       "      <td>10/25/2021</td>\n",
       "      <td>6/16/2023</td>\n",
       "      <td>8/8/2023</td>\n",
       "      <td>Fiel Family and Sports Medicine Clinical Resea...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan|Infor...</td>\n",
       "      <td>[47714]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03182920</th>\n",
       "      <td>A Study of Lasmiditan in Healthy Participants</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03182920</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to look at the am...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Healthy</td>\n",
       "      <td>DRUG: Lasmiditan|DRUG: Placebo</td>\n",
       "      <td>Pharmacokinetics (PK): Maximum Observed Drug C...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>35</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>16852|H8H-MC-LAHA</td>\n",
       "      <td>6/16/2017</td>\n",
       "      <td>8/14/2017</td>\n",
       "      <td>8/14/2017</td>\n",
       "      <td>6/9/2017</td>\n",
       "      <td>11/8/2019</td>\n",
       "      <td>1/7/2020</td>\n",
       "      <td>Covance Daytona Beach, Daytona Beach, Florida,...</td>\n",
       "      <td>Statistical Analysis Plan|Study Protocol</td>\n",
       "      <td>[47710]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05051982</th>\n",
       "      <td>Sedline EEG Guided Depth of Anesthesia</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05051982</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of our study is to determine if mo...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Anesthesia|Surgery</td>\n",
       "      <td>DEVICE: Sedline EEG in View</td>\n",
       "      <td>Total Average Anesthetic, total average percen...</td>\n",
       "      <td>Total Hypnotic agents, the total dosage of hyp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>110</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>10708</td>\n",
       "      <td>6/30/2021</td>\n",
       "      <td>11/14/2022</td>\n",
       "      <td>11/14/2022</td>\n",
       "      <td>9/21/2021</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7/11/2023</td>\n",
       "      <td>IU Health University Hospital, Indianapolis, I...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03822182</th>\n",
       "      <td>Single Shot Liposomal Bupivicaine in Rotator C...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03822182</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This document is a protocol for a human resear...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Rotator Cuff Tear|Pain, Postoperative</td>\n",
       "      <td>DRUG: liposomal bupivicaine|DRUG: Dexamethasone</td>\n",
       "      <td>Patient Reported Postoperative Pain: VAS, Pati...</td>\n",
       "      <td>Patient Reported Post Operative Opioid Use, Pa...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>78</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1806933448</td>\n",
       "      <td>10/24/2018</td>\n",
       "      <td>1/22/2020</td>\n",
       "      <td>1/22/2020</td>\n",
       "      <td>1/30/2019</td>\n",
       "      <td>4/28/2020</td>\n",
       "      <td>11/12/2020</td>\n",
       "      <td>American Health Network, Avon, Indiana, 46123,...</td>\n",
       "      <td>Informed Consent Form|Study Protocol and Stati...</td>\n",
       "      <td>[46123]</td>\n",
       "      <td>[Hendricks County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT01781975</th>\n",
       "      <td>Imatinib Treatment in Recent Onset Type 1 Diab...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01781975</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Type 1 diabetes mellitus (T1DM) results from t...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Diabetes Mellitus, Type I|Diabetes Mellitus, I...</td>\n",
       "      <td>DRUG: Imatinib Mesylate|DRUG: Placebo (For ima...</td>\n",
       "      <td>Area Under the Stimulated C-peptide Curve (AUC...</td>\n",
       "      <td>Area Under the Stimulated C-peptide Curve (AUC...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of California, San Francisco</td>\n",
       "      <td>Juvenile Diabetes Research Foundation</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>67</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>17-2013-6</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2017-05</td>\n",
       "      <td>2018-05</td>\n",
       "      <td>2/1/2013</td>\n",
       "      <td>5/25/2018</td>\n",
       "      <td>2/11/2020</td>\n",
       "      <td>University of California-San Francisco, San Fr...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04208750</th>\n",
       "      <td>Clinical Investigation of the Vision-R800 Device.</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04208750</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Randomized, bilateral, cross-over dispensing s...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Myopia|Hyperopia|Astigmatism|Presbyopia</td>\n",
       "      <td>DEVICE: Vision R-800 Phoropter|DEVICE: Standar...</td>\n",
       "      <td>Subjective Questionnaire Response, Patient que...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pete Kollbaum, OD, PhD</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>119</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>Kollbaum003</td>\n",
       "      <td>11/18/2019</td>\n",
       "      <td>2/1/2021</td>\n",
       "      <td>2/1/2021</td>\n",
       "      <td>12/23/2019</td>\n",
       "      <td>1/6/2022</td>\n",
       "      <td>3/14/2022</td>\n",
       "      <td>Indiana University Clinical Optics Research La...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT01779375</th>\n",
       "      <td>RISE Pediatric Medication Study</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01779375</td>\n",
       "      <td>RISE Peds</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The RISE Pediatric Medication Study is a 2-arm...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Prediabetes|Type 2 Diabetes</td>\n",
       "      <td>DRUG: Metformin|DRUG: Glargine</td>\n",
       "      <td>ß-cell Response Measured by Hyperglycemic Clam...</td>\n",
       "      <td>ACPRg, First phase response, 3-months after a ...</td>\n",
       "      <td>OGTT Measures of ß-cell Function and Glucose T...</td>\n",
       "      <td>RISE Study Group</td>\n",
       "      <td>National Institute of Diabetes and Digestive a...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>91</td>\n",
       "      <td>NETWORK</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>RISE Pediatric|5U01DK094406-02</td>\n",
       "      <td>6/16/2013</td>\n",
       "      <td>7/12/2017</td>\n",
       "      <td>2018-04</td>\n",
       "      <td>1/30/2013</td>\n",
       "      <td>8/30/2018</td>\n",
       "      <td>4/14/2023</td>\n",
       "      <td>Childrens Hospital Colorado, Denver, Colorado,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan|Infor...</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04633837</th>\n",
       "      <td>Examining the Effectiveness of a Connective Ti...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04633837</td>\n",
       "      <td>ECM</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>This document is a protocol for a human resear...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Arthroscopic Shoulder Surgery|Pain, Postoperative</td>\n",
       "      <td>DEVICE: Extracellular Matrix Graft Injectable ...</td>\n",
       "      <td>Patient Reported Post Operative Opioid Use, Ut...</td>\n",
       "      <td>American Shoulder and Elbow Scores, To determi...</td>\n",
       "      <td>Patient Reported Single Assessment Numeric Eva...</td>\n",
       "      <td>Brian Badman</td>\n",
       "      <td>CTM Biomedical</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1294348</td>\n",
       "      <td>12/4/2020</td>\n",
       "      <td>11/7/2021</td>\n",
       "      <td>11/7/2021</td>\n",
       "      <td>11/18/2020</td>\n",
       "      <td>11/12/2021</td>\n",
       "      <td>1/6/2022</td>\n",
       "      <td>American Health Network, Avon, Indiana, 46123,...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46123]</td>\n",
       "      <td>[Hendricks County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03383783</th>\n",
       "      <td>Evaluation of the Fluoride Dose Response of a ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03383783</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to evaluate the f...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Caries</td>\n",
       "      <td>DRUG: 0 ppm F (placebo, negative control)|DRUG...</td>\n",
       "      <td>Percentage Surface Microhardness Recovery (%SM...</td>\n",
       "      <td>Net Acid Resistance (NAR), The %NAR will be ca...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Domenick Zero</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>28</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>17-I-112|208705</td>\n",
       "      <td>12/19/2017</td>\n",
       "      <td>5/2/2018</td>\n",
       "      <td>5/2/2018</td>\n",
       "      <td>12/26/2017</td>\n",
       "      <td>4/25/2019</td>\n",
       "      <td>5/20/2019</td>\n",
       "      <td>Indiana University School of Dentistry, Oral H...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04370756</th>\n",
       "      <td>Beetroot Supplementation in Women Enjoying Exe...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04370756</td>\n",
       "      <td>BEE SWEET</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This study seeks to determine the feasibility ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Aging|Postmenopause|Obesity</td>\n",
       "      <td>DIETARY_SUPPLEMENT: Beetroot Juice|OTHER: Exer...</td>\n",
       "      <td>Recruitment rate, The number of eligible parti...</td>\n",
       "      <td>Distance covered during a six-minute walk test...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>IU Health University Hospital|Indiana CTSI Cli...</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>36</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1907026303</td>\n",
       "      <td>1/30/2020</td>\n",
       "      <td>2023-12</td>\n",
       "      <td>2023-12</td>\n",
       "      <td>5/1/2020</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6/28/2023</td>\n",
       "      <td>Indiana University, Bloomington, Indiana, 4740...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47401]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05227300</th>\n",
       "      <td>Buffered vs. Unbuffered Local Anesthesia in Ma...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05227300</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this study is to determine whet...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Symptomatic Irreversible Pulpitis</td>\n",
       "      <td>DRUG: Onset Sodium Bicarbonate Inj., 8.4%, USP...</td>\n",
       "      <td>Profoundness of pulpal anesthesia, Number of P...</td>\n",
       "      <td>Onset of pulpal anesthesia, Duration of time r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>40</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>11447</td>\n",
       "      <td>2/14/2022</td>\n",
       "      <td>5/31/2022</td>\n",
       "      <td>5/31/2022</td>\n",
       "      <td>2/7/2022</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3/29/2022</td>\n",
       "      <td>Indiana University School of Dentistry Graduat...</td>\n",
       "      <td>Informed Consent Form</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03029000</th>\n",
       "      <td>Study of the Effect of a 5-Day Regimen of Stud...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03029000</td>\n",
       "      <td>GRANIX</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>A multi-center, open-label, single-arm clinica...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Healthy Participants</td>\n",
       "      <td>DRUG: Tbo-filgrastim</td>\n",
       "      <td>Percentage of Participants With at Least 2*10^...</td>\n",
       "      <td>Percentage of Participants With at Least 2*10^...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Teva Branded Pharmaceutical Products R&amp;D, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>1</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>TV44688-ONC-30054</td>\n",
       "      <td>8/2/2017</td>\n",
       "      <td>10/30/2017</td>\n",
       "      <td>10/30/2017</td>\n",
       "      <td>1/23/2017</td>\n",
       "      <td>11/14/2018</td>\n",
       "      <td>12/13/2022</td>\n",
       "      <td>Teva Investigational Site 14029, Duarte, Calif...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46107]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02618967</th>\n",
       "      <td>Single Ascending Dose Study of AMG 570 in Heal...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02618967</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to obtain initial...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Systemic Lupus Erythematosus</td>\n",
       "      <td>BIOLOGICAL: AMG 570|BIOLOGICAL: AMG 570 Matchi...</td>\n",
       "      <td>Number of Participants Who Experienced One or ...</td>\n",
       "      <td>Maximum Observed Concentration (Cmax) of AMG 5...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>56</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SIN...</td>\n",
       "      <td>20140322</td>\n",
       "      <td>3/28/2016</td>\n",
       "      <td>9/6/2018</td>\n",
       "      <td>12/3/2018</td>\n",
       "      <td>12/2/2015</td>\n",
       "      <td>8/5/2021</td>\n",
       "      <td>10/15/2021</td>\n",
       "      <td>Research Site, Evansville, Indiana, 47710, Uni...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47710]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03349567</th>\n",
       "      <td>Improving Antimicrobial-Prescribing in Emergen...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03349567</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Antimicrobial resistance is one of today's mos...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anti-Bacterial Agents|Respiratory Tract Infect...</td>\n",
       "      <td>BEHAVIORAL: Audit-and-feedback</td>\n",
       "      <td>Percentage of Patient-visits Prescribed an Ant...</td>\n",
       "      <td>Percentage of Patient-visits Prescribed a Late...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Iowa City Veterans Affairs Medical Center</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>27</td>\n",
       "      <td>FED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>201708772</td>\n",
       "      <td>10/9/2018</td>\n",
       "      <td>9/30/2019</td>\n",
       "      <td>10/31/2019</td>\n",
       "      <td>11/21/2017</td>\n",
       "      <td>1/25/2021</td>\n",
       "      <td>4/28/2021</td>\n",
       "      <td>Richard Roudebush VAMC, Indianapolis, Indiana,...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03086447</th>\n",
       "      <td>Evaluation of Astigmatic Contact Lenses</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03086447</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Randomized, double-masked, 5-visit, bilateral ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Visual Acuity</td>\n",
       "      <td>DEVICE: Investigational Contact Lens|DEVICE: M...</td>\n",
       "      <td>Monocular Distance Visual Acuity (VA), Monocul...</td>\n",
       "      <td>Overall Comfort, Overall comfort was assessed ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Johnson &amp; Johnson Vision Care, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>267</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CR-5871</td>\n",
       "      <td>3/1/2017</td>\n",
       "      <td>5/4/2017</td>\n",
       "      <td>5/4/2017</td>\n",
       "      <td>3/22/2017</td>\n",
       "      <td>4/30/2018</td>\n",
       "      <td>7/10/2018</td>\n",
       "      <td>Golden Optometric Group, Whittier, California,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03063437</th>\n",
       "      <td>A Trial of Encapsulated Fecal Microbiota for V...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03063437</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The objective of this study is to provide prel...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Antibiotic Resistant Strain</td>\n",
       "      <td>BIOLOGICAL: Encapsulated fecal microbiota prep...</td>\n",
       "      <td>Percentage of Participants With VRE Decoloniza...</td>\n",
       "      <td>Percentage of Participants With VRE Infection,...</td>\n",
       "      <td>Microbiome Disruption, To evaluate the microbi...</td>\n",
       "      <td>Microbiome Health Research Institute</td>\n",
       "      <td>University of Wisconsin, Madison|Indiana Unive...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>9</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>200-2016-91948</td>\n",
       "      <td>8/17/2017</td>\n",
       "      <td>9/19/2018</td>\n",
       "      <td>2/26/2019</td>\n",
       "      <td>2/24/2017</td>\n",
       "      <td>1/15/2020</td>\n",
       "      <td>4/13/2020</td>\n",
       "      <td>IU Health University Hospital, Indianapolis, I...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03628885</th>\n",
       "      <td>An Evaluation of Tailored Messages to Address ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03628885</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to investigate mo...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Human Papilloma Virus Vaccines|Attitude to Health</td>\n",
       "      <td>BEHAVIORAL: Top Concern Tailored Intervention|...</td>\n",
       "      <td>Intention to Vaccinate Against HPV in the Next...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>908</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: FAC...</td>\n",
       "      <td>1807664964</td>\n",
       "      <td>9/11/2018</td>\n",
       "      <td>9/27/2018</td>\n",
       "      <td>9/27/2018</td>\n",
       "      <td>8/14/2018</td>\n",
       "      <td>12/20/2018</td>\n",
       "      <td>4/2/2019</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04505722</th>\n",
       "      <td>A Study of Ad26.COV2.S for the Prevention of S...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04505722</td>\n",
       "      <td>ENSEMBLE</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study will evaluate the efficacy of Ad26.C...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Participants With or Without Stable Co-morbidi...</td>\n",
       "      <td>BIOLOGICAL: Ad26.COV2.S|OTHER: Placebo</td>\n",
       "      <td>Number of Participants With First Occurrence o...</td>\n",
       "      <td>Number of Participants With First Occurrence o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Janssen Vaccines &amp; Prevention B.V.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>44325</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CR108876|VAC31518COV3001</td>\n",
       "      <td>9/7/2020</td>\n",
       "      <td>3/31/2023</td>\n",
       "      <td>3/31/2023</td>\n",
       "      <td>8/10/2020</td>\n",
       "      <td>1/25/2022</td>\n",
       "      <td>5/6/2023</td>\n",
       "      <td>Synexus Clinical Research US, Inc, Birmingham,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46383]</td>\n",
       "      <td>[Porter County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02576847</th>\n",
       "      <td>Study to Evaluate the Long-term Safety of a On...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02576847</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study evaluates the long-term safety of o...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Rosacea</td>\n",
       "      <td>DRUG: Omiganan</td>\n",
       "      <td>Number of Subjects With 1 or More Treatment-re...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Maruho Co., Ltd.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>307</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>CLS001-CO-PR-006</td>\n",
       "      <td>2015-10</td>\n",
       "      <td>7/14/2017</td>\n",
       "      <td>2/8/2018</td>\n",
       "      <td>10/15/2015</td>\n",
       "      <td>6/13/2022</td>\n",
       "      <td>7/19/2022</td>\n",
       "      <td>Fremont, California, United States|Miami, Flor...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03427047</th>\n",
       "      <td>Comparing Surgical and Economical Parameters o...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03427047</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Randomized study comparing surgical and econom...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Osteo Arthritis Knee|Total Knee Arthroplasty</td>\n",
       "      <td>DEVICE: MyKnee with single use Efficiency Inst...</td>\n",
       "      <td>Compare Time-saving Associated With the Two Pr...</td>\n",
       "      <td>Estimated Blood Loss From Both Study Arms, Vol...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medacta USA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>82</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>MyKnee 20170612</td>\n",
       "      <td>8/1/2018</td>\n",
       "      <td>1/1/2022</td>\n",
       "      <td>1/1/2022</td>\n",
       "      <td>2/9/2018</td>\n",
       "      <td>3/17/2023</td>\n",
       "      <td>6/13/2023</td>\n",
       "      <td>Methodist Sports Medicine Research &amp; Education...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46280]</td>\n",
       "      <td>[Hamilton County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03727347</th>\n",
       "      <td>Posterior Nasal Nerve (PNN) Rhinitis Study</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03727347</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Evaluation of the Aerin Medical Device used fo...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Chronic Rhinitis</td>\n",
       "      <td>DEVICE: InSeca Stylus</td>\n",
       "      <td>Change in Reflective Total Nasal Symptom Score...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>rTNSS Responder Rate, The Reflective Total Nas...</td>\n",
       "      <td>Aerin Medical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>TP668</td>\n",
       "      <td>10/16/2018</td>\n",
       "      <td>2/1/2020</td>\n",
       "      <td>9/17/2020</td>\n",
       "      <td>11/1/2018</td>\n",
       "      <td>5/21/2021</td>\n",
       "      <td>6/16/2021</td>\n",
       "      <td>Colorado ENT and Allergy, Colorado Springs, Co...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47150]</td>\n",
       "      <td>[Floyd County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03400787</th>\n",
       "      <td>Latera RCT - Latera vs. Sham Control for Later...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03400787</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective of the LATERA RCT is to ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Nasal Valve Collapse|Nasal Breathing</td>\n",
       "      <td>DEVICE: Latera Implant|DEVICE: Sham Procedure</td>\n",
       "      <td>NOSE Responder Rate, The primary endpoint of t...</td>\n",
       "      <td>Responder Rate, Responder Rate at 7 days, 30 d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Spirox, Inc.</td>\n",
       "      <td>New Arch Consulting</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>137</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>CP 04</td>\n",
       "      <td>11/28/2017</td>\n",
       "      <td>2/1/2019</td>\n",
       "      <td>12/23/2020</td>\n",
       "      <td>1/17/2018</td>\n",
       "      <td>11/25/2019</td>\n",
       "      <td>2/9/2021</td>\n",
       "      <td>Sacramento ENT, Roseville, California, 95661, ...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46635]</td>\n",
       "      <td>[St. Joseph County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03037307</th>\n",
       "      <td>A Clinical Bite Force Study of Two Marketed Ad...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03037307</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The objective of this study will be to compare...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Denture Retention</td>\n",
       "      <td>OTHER: Test Product|OTHER: Positive Contol|OTH...</td>\n",
       "      <td>Area Over Baseline Over 12 Hours (AOB0-12) for...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>44</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>207545</td>\n",
       "      <td>2/13/2017</td>\n",
       "      <td>5/4/2017</td>\n",
       "      <td>5/4/2017</td>\n",
       "      <td>1/31/2017</td>\n",
       "      <td>4/20/2018</td>\n",
       "      <td>8/31/2018</td>\n",
       "      <td>GSK Investigational Site, Indianapolis, Indian...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03257007</th>\n",
       "      <td>Mindfulness to Enhance Quality of Life and Sup...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03257007</td>\n",
       "      <td>MEANING</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The MEANING trial is a randomized controlled m...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Mindfulness|Meditation|Metastatic Cancer|Quali...</td>\n",
       "      <td>BEHAVIORAL: Mindfulness</td>\n",
       "      <td>Change from baseline in quality of life (QoL) ...</td>\n",
       "      <td>Change from baseline in advance care planning ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>108</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1702223546</td>\n",
       "      <td>5/9/2017</td>\n",
       "      <td>12/11/2017</td>\n",
       "      <td>12/11/2017</td>\n",
       "      <td>8/22/2017</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8/12/2020</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Informed Consent Form</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT06001866</th>\n",
       "      <td>Retrieval-Based Word Learning in Developmental...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT06001866</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Children with developmental language disorder ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Developmental Language Disorder|Specific Langu...</td>\n",
       "      <td>BEHAVIORAL: Retrieval-based verb learning</td>\n",
       "      <td>Word form recall accuracy (number of verbs cor...</td>\n",
       "      <td>Number of correctly identified words on Peabod...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Purdue University</td>\n",
       "      <td>National Institute on Deafness and Other Commu...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>1603017480B|R01DC014708</td>\n",
       "      <td>3/1/2023</td>\n",
       "      <td>7/31/2026</td>\n",
       "      <td>7/31/2026</td>\n",
       "      <td>8/21/2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8/21/2023</td>\n",
       "      <td>Purdue University, West Lafayette, Indiana, 47...</td>\n",
       "      <td>Informed Consent Form</td>\n",
       "      <td>[47907]</td>\n",
       "      <td>[Tippecanoe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04699812</th>\n",
       "      <td>Atrial Fibrillation Algorithms Clinical Valida...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04699812</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of the study is to evaluate the pe...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Atrial Fibrillation</td>\n",
       "      <td>DEVICE: ELECTROCARDIOGRAM (ECG) PATCH WEAR</td>\n",
       "      <td>SENSITIVITY OF IRREGULAR RHYTHM NOTIFICATION F...</td>\n",
       "      <td>POSITIVE PREDICTIVE VALUE OF IRREGULAR RHYTHM ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>Iqvia Pty Ltd</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>573</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>099-25141</td>\n",
       "      <td>11/16/2020</td>\n",
       "      <td>4/19/2021</td>\n",
       "      <td>12/17/2021</td>\n",
       "      <td>1/7/2021</td>\n",
       "      <td>7/1/2022</td>\n",
       "      <td>8/24/2022</td>\n",
       "      <td>Clinical Research of South Florida, Coral Gabl...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46123]</td>\n",
       "      <td>[Hendricks County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03434392</th>\n",
       "      <td>QST Study: Predicting Treatment Response in Ch...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03434392</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Quantitative Sensory Testing (QST) is a novel ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Chronic Pancreatitis|Chronic Pain</td>\n",
       "      <td>DIAGNOSTIC_TEST: Quantitative Sensory Test 1|D...</td>\n",
       "      <td>Pain Pattern Assessment as assessed by the com...</td>\n",
       "      <td>Change in Mean Pain score, In Definite CP Pati...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anna Evans Phillips</td>\n",
       "      <td>Johns Hopkins University|Aalborg University</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>500</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>PRO17060648</td>\n",
       "      <td>10/24/2017</td>\n",
       "      <td>11/15/2023</td>\n",
       "      <td>11/15/2023</td>\n",
       "      <td>2/15/2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>12/20/2022</td>\n",
       "      <td>Indiana University Medical Center, Indianapoli...</td>\n",
       "      <td>Study Protocol</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04065451</th>\n",
       "      <td>Effect of Epinephrine on Post-polypectomy Pain</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04065451</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Epinephrine is widely used in endoscopic mucos...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colonic Polyp</td>\n",
       "      <td>DRUG: Epinephrine</td>\n",
       "      <td>Immediate Post-polypectomy Pain, Pain related ...</td>\n",
       "      <td>en Bloc Resection, Number of polyps removed en...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>22</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1908473351</td>\n",
       "      <td>1/6/2020</td>\n",
       "      <td>8/17/2021</td>\n",
       "      <td>8/17/2021</td>\n",
       "      <td>8/22/2019</td>\n",
       "      <td>6/23/2022</td>\n",
       "      <td>9/30/2022</td>\n",
       "      <td>Indiana University Hospital, Indianapolis, Ind...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04445155</th>\n",
       "      <td>The DECIDE Parent-Provider Intervention</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04445155</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The DECIDE Parent-Provider Intervention is des...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Modified DECIDE Intervention|Treatment as Usua...</td>\n",
       "      <td>BEHAVIORAL: Modified DECIDE Parent and Provide...</td>\n",
       "      <td>Parent Activation Measure Mental Health (P-PAM...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pre-test, 5 question survey that measures the ...</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>Smith College|University of South Florida|Nati...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>89</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>1911897011|5R21MD015150-02</td>\n",
       "      <td>10/1/2020</td>\n",
       "      <td>12/30/2022</td>\n",
       "      <td>12/30/2022</td>\n",
       "      <td>6/24/2020</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4/26/2023</td>\n",
       "      <td>Centerstone, Sarasota, Florida, 34233, United ...</td>\n",
       "      <td>Study Protocol|Informed Consent Form</td>\n",
       "      <td>[46208, 46808, 47404]</td>\n",
       "      <td>[Marion County, Allen County, Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT01887912</th>\n",
       "      <td>Study of a Candidate Clostridium Difficile Tox...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01887912</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The aim of this study was to evaluate the effi...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Clostridium Difficile Infection</td>\n",
       "      <td>BIOLOGICAL: C. difficile Toxoid Vaccine|BIOLOG...</td>\n",
       "      <td>Number of Participants With Symptomatic Polyme...</td>\n",
       "      <td>Number of Participants With Severe PCR-Confirm...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sanofi Pasteur, a Sanofi Company</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>9302</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>H-030-014|2013-000775-32|U1111-1127-7162</td>\n",
       "      <td>7/30/2013</td>\n",
       "      <td>6/12/2018</td>\n",
       "      <td>6/12/2018</td>\n",
       "      <td>6/27/2013</td>\n",
       "      <td>6/11/2019</td>\n",
       "      <td>3/28/2022</td>\n",
       "      <td>Huntsville, Alabama, 35803, United States|Inve...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46011, 47574]</td>\n",
       "      <td>[Madison County, Perry County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02374671</th>\n",
       "      <td>A Clinical Trial of The VisAbility Micro Inser...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02374671</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to evaluate the s...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Presbyopia</td>\n",
       "      <td>DEVICE: VisAbility Micro Insert</td>\n",
       "      <td>Number of Primary Eyes With Distance Corrected...</td>\n",
       "      <td>Number of Primary Eyes With DCNVA 20/40 of Bet...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Refocus Group, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>365</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>VIS-2014</td>\n",
       "      <td>11/15/2014</td>\n",
       "      <td>4/13/2018</td>\n",
       "      <td>4/13/2018</td>\n",
       "      <td>3/2/2015</td>\n",
       "      <td>10/15/2019</td>\n",
       "      <td>1/6/2020</td>\n",
       "      <td>Coastal Vision, Orange, California, 92868, Uni...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46256]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03664739</th>\n",
       "      <td>Study Comparing the Safety and Efficacy of IDP...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03664739</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>study designed to assess the safety, tolerabil...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Acne Vulgaris</td>\n",
       "      <td>DRUG: IDP-120 Gel|DRUG: IDp-120 Vehicle Gel</td>\n",
       "      <td>Absolute Change in Mean Lesion Counts at Week ...</td>\n",
       "      <td>Percentage Change in Mean Lesion Counts at Wee...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Bausch Health Americas, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>608</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>V01-120A-301</td>\n",
       "      <td>12/5/2018</td>\n",
       "      <td>3/23/2020</td>\n",
       "      <td>3/23/2020</td>\n",
       "      <td>9/10/2018</td>\n",
       "      <td>3/3/2023</td>\n",
       "      <td>3/29/2023</td>\n",
       "      <td>Valeant Site 123, Mobile, Alabama, 36608, Unit...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47715]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03345108</th>\n",
       "      <td>A Study to Investigate a Method to Measure Foo...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03345108</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to evaluate a met...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Denture Retention</td>\n",
       "      <td>DEVICE: Denture Adhesive Cream (Conventional A...</td>\n",
       "      <td>Mass of Peanuts Under Combined Maxillary and M...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>48</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>208397</td>\n",
       "      <td>11/20/2017</td>\n",
       "      <td>12/15/2017</td>\n",
       "      <td>12/15/2017</td>\n",
       "      <td>11/17/2017</td>\n",
       "      <td>12/14/2018</td>\n",
       "      <td>3/29/2019</td>\n",
       "      <td>GSK Investigational Site, Fort Wayne, Indiana,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46825]</td>\n",
       "      <td>[Allen County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02743871</th>\n",
       "      <td>Study Of PF-06817024 In Healthy Subjects, In P...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02743871</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to evaluate safet...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Healthy|Chronic Rhinosinusitis With Nasal Poly...</td>\n",
       "      <td>BIOLOGICAL: PF-06817024|OTHER: Placebo for PF-...</td>\n",
       "      <td>Number of Participants With All-causality Trea...</td>\n",
       "      <td>Maximum Observed Serum Concentration (Cmax) of...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>97</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SEQ...</td>\n",
       "      <td>C0341001</td>\n",
       "      <td>4/27/2016</td>\n",
       "      <td>3/9/2021</td>\n",
       "      <td>3/9/2021</td>\n",
       "      <td>4/19/2016</td>\n",
       "      <td>2/28/2022</td>\n",
       "      <td>5/19/2022</td>\n",
       "      <td>UC Davis Dermatology, Sacramento, California, ...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46168, 46256]</td>\n",
       "      <td>[Hendricks County, Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03227471</th>\n",
       "      <td>A Study of VX-445 in Healthy Subjects and Subj...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03227471</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a first-in-human and proof-of-concept ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Cystic Fibrosis</td>\n",
       "      <td>DRUG: IVA|DRUG: TEZ/IVA|DRUG: VX-445|DRUG: Mat...</td>\n",
       "      <td>Parts A, B and C: Number of Participants With ...</td>\n",
       "      <td>Part A: Maximum Observed Concentration (Cmax) ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Vertex Pharmaceuticals Incorporated</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1|PHASE2</td>\n",
       "      <td>225</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>VX16-445-001|2017-000797-11</td>\n",
       "      <td>1/23/2017</td>\n",
       "      <td>3/27/2018</td>\n",
       "      <td>3/27/2018</td>\n",
       "      <td>7/24/2017</td>\n",
       "      <td>11/9/2021</td>\n",
       "      <td>1/18/2022</td>\n",
       "      <td>Banner University of Arizona Medical Center, T...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47710]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03336268</th>\n",
       "      <td>Project POINT: Effectiveness and Scalability o...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03336268</td>\n",
       "      <td>POINT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The investigators seek to assess the effective...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Substance Use Disorders|Overdose</td>\n",
       "      <td>BEHAVIORAL: POINT</td>\n",
       "      <td>Opioid Overdose, Total participants presenting...</td>\n",
       "      <td>Medication for Opioid Use Disorder (MOUD) Enga...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>249</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1706859955|R33DA045850</td>\n",
       "      <td>2/12/2018</td>\n",
       "      <td>12/9/2021</td>\n",
       "      <td>12/9/2021</td>\n",
       "      <td>11/8/2017</td>\n",
       "      <td>2/20/2023</td>\n",
       "      <td>10/6/2023</td>\n",
       "      <td>Indiana University Health Methodist Hospital, ...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46202, 47303]</td>\n",
       "      <td>[Marion County, Delaware County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03231917</th>\n",
       "      <td>Water Immersion and Polyp Detection: A Randomi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03231917</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>We plan to conduct a randomized trial of tande...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Adenoma|Colonic Neoplasms</td>\n",
       "      <td>PROCEDURE: Water Infusion first|PROCEDURE: CO2...</td>\n",
       "      <td>Adenoma Miss Rate, Adenoma-level miss rates wi...</td>\n",
       "      <td>Patient-level Miss Rate, Patient-level miss ra...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>White River Junction Veterans Affairs Medical ...</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>121</td>\n",
       "      <td>FED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>1000344-1</td>\n",
       "      <td>3/1/2017</td>\n",
       "      <td>8/31/2018</td>\n",
       "      <td>8/31/2018</td>\n",
       "      <td>7/27/2017</td>\n",
       "      <td>10/1/2018</td>\n",
       "      <td>7/12/2019</td>\n",
       "      <td>University of Connecticut Health Center, Farmi...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05471726</th>\n",
       "      <td>Improving Post-discharge Antimicrobial Use</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05471726</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>One in five hospitalized patients is prescribe...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Infections</td>\n",
       "      <td>BEHAVIORAL: Prospective audit-and-feedback</td>\n",
       "      <td>Post-discharge antibiotic length of therapy, T...</td>\n",
       "      <td>Inpatient antibiotic length of therapy, Inpati...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Iowa City Veterans Affairs Medical Center</td>\n",
       "      <td>Centers for Disease Control and Prevention</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10</td>\n",
       "      <td>FED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SEQ...</td>\n",
       "      <td>IRB 202109288</td>\n",
       "      <td>5/22/2023</td>\n",
       "      <td>11/19/2023</td>\n",
       "      <td>12/19/2023</td>\n",
       "      <td>7/25/2022</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5/25/2023</td>\n",
       "      <td>Richard Roudebush VA Medical Center, Indianapo...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03355326</th>\n",
       "      <td>Evaluation of Glycerin Suppositories to Improv...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03355326</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>Gastroschisis is a congenital defect of the ab...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Gastroschisis</td>\n",
       "      <td>DRUG: Glycerin Suppository</td>\n",
       "      <td>Time to Full Enteral Feeds, time from study st...</td>\n",
       "      <td>Time to First Bowel Movement, time from study ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>16</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>IU-IRB-1611267731</td>\n",
       "      <td>10/1/2017</td>\n",
       "      <td>10/1/2020</td>\n",
       "      <td>10/1/2020</td>\n",
       "      <td>11/28/2017</td>\n",
       "      <td>7/20/2021</td>\n",
       "      <td>10/12/2021</td>\n",
       "      <td>Riley Hospital for Children, Indianapolis, Ind...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03090191</th>\n",
       "      <td>Clostridium Difficile Vaccine Efficacy Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03090191</td>\n",
       "      <td>Clover</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The Clover trial is evaluating an investigatio...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Clostridium Difficile Infection</td>\n",
       "      <td>BIOLOGICAL: Clostridium difficile vaccine|BIOL...</td>\n",
       "      <td>Number of First Primary Episodes of Clostridiu...</td>\n",
       "      <td>Number of All Episodes of CDI (Definition 1 an...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>17535</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>B5091007|2016-003866-14|CLOVER</td>\n",
       "      <td>3/29/2017</td>\n",
       "      <td>12/21/2021</td>\n",
       "      <td>12/21/2021</td>\n",
       "      <td>3/24/2017</td>\n",
       "      <td>11/30/2022</td>\n",
       "      <td>2/13/2023</td>\n",
       "      <td>North Alabama Research Center, LLC, Athens, Al...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46011, 46032, 46260, 46544, 47725]</td>\n",
       "      <td>[Madison County, Hamilton County, Marion Count...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05466617</th>\n",
       "      <td>Gamified App on Increasing Physical Activity a...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05466617</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Background: Physical activity (PA) has an impa...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Autism Spectrum Disorder|Physical Activity|Anx...</td>\n",
       "      <td>BEHAVIORAL: Mobile Health for Physical Activit...</td>\n",
       "      <td>Baseline Physical Activity and Changes from Ba...</td>\n",
       "      <td>Baseline Anxiety and Changes from Baseline Anx...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>American College of Sports Medicine Foundation</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>24</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1807483245</td>\n",
       "      <td>7/1/2019</td>\n",
       "      <td>3/15/2020</td>\n",
       "      <td>5/30/2020</td>\n",
       "      <td>7/20/2022</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7/20/2022</td>\n",
       "      <td>Indiana University School of Public Health, Bl...</td>\n",
       "      <td>Informed Consent Form</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03361917</th>\n",
       "      <td>Standard Colonoscopy Versus Colonoscopy With E...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03361917</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study seeks to compare colonoscopy result...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colorectal Polyp|Colorectal Adenoma|Colon Cancer</td>\n",
       "      <td>DEVICE: Endocuff Vision</td>\n",
       "      <td>Inspection Time Comparisons for Each Method (S...</td>\n",
       "      <td>Insertion Time Comparisons for Each Method (St...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1709336500</td>\n",
       "      <td>12/11/2017</td>\n",
       "      <td>4/18/2018</td>\n",
       "      <td>4/18/2018</td>\n",
       "      <td>12/5/2017</td>\n",
       "      <td>4/5/2019</td>\n",
       "      <td>8/6/2019</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03350217</th>\n",
       "      <td>A Comparison of Eleview Versus Hetastarch as I...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03350217</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>EMR is a technique used for the removal of fla...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Procedural Bleeding|Delayed Bleeding|Post-Poly...</td>\n",
       "      <td>DRUG: Eleview|DRUG: Hetastarch</td>\n",
       "      <td>Sydney Resection Quotient (SRQ), Comparison of...</td>\n",
       "      <td>Injected Volume Needed for Initial Lesion Lift...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>160</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1706751368</td>\n",
       "      <td>10/9/2017</td>\n",
       "      <td>1/7/2019</td>\n",
       "      <td>1/7/2019</td>\n",
       "      <td>11/22/2017</td>\n",
       "      <td>11/5/2019</td>\n",
       "      <td>12/17/2019</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04512482</th>\n",
       "      <td>Evaluation of Oral Plaque Removal Utilizing an...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04512482</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study aims to investigate the impact of a...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Dental Plaque|Dental Caries</td>\n",
       "      <td>DRUG: Bromelain|OTHER: Powdered sugar</td>\n",
       "      <td>Composite Plaque Score, The composite plaque s...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>Water Pik, Inc.|Delta Dental Foundation</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>46</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>1802369383</td>\n",
       "      <td>6/14/2018</td>\n",
       "      <td>7/24/2018</td>\n",
       "      <td>3/4/2019</td>\n",
       "      <td>8/13/2020</td>\n",
       "      <td>8/22/2020</td>\n",
       "      <td>12/3/2020</td>\n",
       "      <td>Indiana University School of Dentistry, Indian...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02277990</th>\n",
       "      <td>World-wide Randomized Antibiotic Envelope Infe...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02277990</td>\n",
       "      <td>WRAP-IT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Medtronic , Inc. is sponsoring the World-wide ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>CIED Related Infection</td>\n",
       "      <td>DEVICE: TYRX™ Absorbable Antibacterial Envelope</td>\n",
       "      <td>12 Month Kaplan-Meier Estimate of Major CIED I...</td>\n",
       "      <td>12 Month Kaplan-Meier Estimate of Major or Min...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medtronic Cardiac Rhythm and Heart Failure</td>\n",
       "      <td>The Cleveland Clinic</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>7075</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>WRAP-IT</td>\n",
       "      <td>2015-01</td>\n",
       "      <td>2018-09</td>\n",
       "      <td>2018-09</td>\n",
       "      <td>10/29/2014</td>\n",
       "      <td>10/2/2019</td>\n",
       "      <td>11/5/2019</td>\n",
       "      <td>Alaska Heart Institute, Anchorage, Alaska, Uni...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46260]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03585790</th>\n",
       "      <td>The Impact of Soft Contact Lens Attributes on ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03585790</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Despite its prevalence, the ocular causes of e...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Asthenopia|Myopia</td>\n",
       "      <td>DEVICE: Contact lens with Multifocal Optics|DE...</td>\n",
       "      <td>Subject Reported Eye Fatigue, Subjective Ratin...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pete Kollbaum, OD, PhD</td>\n",
       "      <td>Alcon Research</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>45</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>Kollbaum001</td>\n",
       "      <td>9/13/2018</td>\n",
       "      <td>11/2/2018</td>\n",
       "      <td>11/2/2018</td>\n",
       "      <td>7/13/2018</td>\n",
       "      <td>9/24/2019</td>\n",
       "      <td>1/7/2020</td>\n",
       "      <td>Indiana University Clinical Optics Research La...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05394545</th>\n",
       "      <td>Phase II Trial of Nu-V3 Non-Invasive Nerve Sti...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05394545</td>\n",
       "      <td>Nu-V3P2RCT</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>This Nu-V3 clinical study is a randomized, pha...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Chronic Pain|Anxiety|Depression|Sleeplessness</td>\n",
       "      <td>DEVICE: Nu-V3</td>\n",
       "      <td>Overall safety from unanticipated problems or ...</td>\n",
       "      <td>Effectiveness: Symptom Frequency, In the Nu-V3...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Nu-Life Solutions</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>80</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>Nu-V3 RCT Protocol</td>\n",
       "      <td>3/20/2024</td>\n",
       "      <td>5/31/2025</td>\n",
       "      <td>5/31/2025</td>\n",
       "      <td>5/27/2022</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7/28/2023</td>\n",
       "      <td>Greater Chicago Specialty Physicians (GCSP) - ...</td>\n",
       "      <td>Study Protocol|Informed Consent Form</td>\n",
       "      <td>[46143]</td>\n",
       "      <td>[Johnson County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03436615</th>\n",
       "      <td>A Study to Evaluate the Safety and Efficacy of...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03436615</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a phase 2 multi-center, randomized, do...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Molluscum Contagiosum</td>\n",
       "      <td>DRUG: SB206 4%|DRUG: SB206 8%|DRUG: SB206 12%|...</td>\n",
       "      <td>Proportion of Subjects Achieving Complete Clea...</td>\n",
       "      <td>Proportion of Subjects Achieving Complete Clea...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novan, Inc.</td>\n",
       "      <td>Premier Research Group plc</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>256</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SEQ...</td>\n",
       "      <td>NI-MC201</td>\n",
       "      <td>1/24/2018</td>\n",
       "      <td>11/3/2018</td>\n",
       "      <td>11/3/2018</td>\n",
       "      <td>2/19/2018</td>\n",
       "      <td>1/23/2023</td>\n",
       "      <td>5/6/2023</td>\n",
       "      <td>Premier Site# 266, Scottsdale, Arizona, 85255,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46256]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03762993</th>\n",
       "      <td>Controlled Phonation and Vocal Rest Programs A...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03762993</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The proposed research will investigate the mos...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Healthy</td>\n",
       "      <td>BEHAVIORAL: Vocal rest and Controlled Phonation</td>\n",
       "      <td>Phonation Threshold Pressure, Minimum air pres...</td>\n",
       "      <td>Lung Volume Excursion, The difference between ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Purdue University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>37</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>Vocal restoration programs</td>\n",
       "      <td>12/5/2018</td>\n",
       "      <td>7/1/2020</td>\n",
       "      <td>7/1/2020</td>\n",
       "      <td>12/4/2018</td>\n",
       "      <td>6/24/2021</td>\n",
       "      <td>8/5/2021</td>\n",
       "      <td>Purdue University, West Lafayette, Indiana, 47...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47906]</td>\n",
       "      <td>[Tippecanoe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04622592</th>\n",
       "      <td>Adjuvanted Seasonal Recombinant Quadrivalent V...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04622592</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This randomized, partially-blinded, active com...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Influenza</td>\n",
       "      <td>BIOLOGICAL: Instramuscular vaccine</td>\n",
       "      <td>Geometric Mean Titers (GMTs) of Hemagglutinati...</td>\n",
       "      <td>GMTs of HI Antibody Response for Each Homologo...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medicago</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>PHASE1|PHASE2</td>\n",
       "      <td>209</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CP-PRO-AdjQVLP-020</td>\n",
       "      <td>11/2/2020</td>\n",
       "      <td>4/26/2022</td>\n",
       "      <td>4/26/2022</td>\n",
       "      <td>11/10/2020</td>\n",
       "      <td>5/29/2023</td>\n",
       "      <td>7/21/2023</td>\n",
       "      <td>Optimal Sites, Huntsville, Alabama, 35802-2569...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47714]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02878330</th>\n",
       "      <td>A Study to Evaluate the Safety and Efficacy of...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02878330</td>\n",
       "      <td>MEDI8897 Ph2b</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to evaluate the e...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Respiratory Syncytial Virus Infections</td>\n",
       "      <td>DRUG: MEDI8897|DRUG: Placebo</td>\n",
       "      <td>Number of Participants With Medically Attended...</td>\n",
       "      <td>Number of Participants Hopitalized Due to Resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MedImmune LLC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>1453</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>D5290C00003</td>\n",
       "      <td>11/3/2016</td>\n",
       "      <td>7/17/2018</td>\n",
       "      <td>12/6/2018</td>\n",
       "      <td>8/25/2016</td>\n",
       "      <td>7/17/2019</td>\n",
       "      <td>10/14/2019</td>\n",
       "      <td>Research Site, Birmingham, Alabama, 35205, Uni...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46017, 46601]</td>\n",
       "      <td>[Madison County, St. Joseph County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03200366</th>\n",
       "      <td>Comparing Interventions to Increase Colorectal...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03200366</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to test different...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colorectal Cancer</td>\n",
       "      <td>BEHAVIORAL: Tailored DVD|BEHAVIORAL: Patient N...</td>\n",
       "      <td>Participants Completing CRC Screening Per Elec...</td>\n",
       "      <td>Participants Completing Colonoscopy Per Electr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>Patient-Centered Outcomes Research Institute|O...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>371</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1605880142|IHS-1507-31333</td>\n",
       "      <td>7/26/2017</td>\n",
       "      <td>10/21/2020</td>\n",
       "      <td>10/21/2020</td>\n",
       "      <td>6/27/2017</td>\n",
       "      <td>6/8/2021</td>\n",
       "      <td>9/13/2021</td>\n",
       "      <td>Eskenazi Health, Indianapolis, Indiana, 46202,...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02754492</th>\n",
       "      <td>Evaluation of Trima Version 7.0 Platelets in 1...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02754492</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>To verify that platelets collected on the Trim...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>DEVICE: Trima Accel System with Version 7.0 So...</td>\n",
       "      <td>Number of Participants With Platelet Units Con...</td>\n",
       "      <td>Number of Participants With Platelet Units Con...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Terumo BCT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>334</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>CTS-5060</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2/15/2017</td>\n",
       "      <td>2/15/2017</td>\n",
       "      <td>4/28/2016</td>\n",
       "      <td>2/8/2018</td>\n",
       "      <td>3/29/2018</td>\n",
       "      <td>San Diego Blood Bank, San Diego, California, 9...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan|Infor...</td>\n",
       "      <td>[46208]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03238352</th>\n",
       "      <td>A Study to Assess Efficacy of an Experimental ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03238352</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>To investigate the efficacy of an experimental...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Dentin Sensitivity</td>\n",
       "      <td>DEVICE: Potassium oxalate|DRUG: Sodium fluorid...</td>\n",
       "      <td>Change From Baseline in Schiff Sensitivity Sco...</td>\n",
       "      <td>Change From Baseline in Tactile Threshold, The...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>89</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>207656</td>\n",
       "      <td>8/7/2017</td>\n",
       "      <td>10/27/2017</td>\n",
       "      <td>10/27/2017</td>\n",
       "      <td>8/3/2017</td>\n",
       "      <td>10/15/2018</td>\n",
       "      <td>11/14/2018</td>\n",
       "      <td>GSK Investigational Site, Fort Wayne, Indiana,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46825]</td>\n",
       "      <td>[Allen County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04440163</th>\n",
       "      <td>MenABCWY Noninferiority Study in Healthy Parti...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04440163</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The aim of this study is to determine the immu...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Meningococcal Vaccine</td>\n",
       "      <td>BIOLOGICAL: MenABCWY|BIOLOGICAL: Saline|BIOLOG...</td>\n",
       "      <td>Percentage of Participants Achieving At Least ...</td>\n",
       "      <td>Percentage of Participants Achieving At Least ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>2431</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: FAC...</td>\n",
       "      <td>C3511001|2019-004313-13</td>\n",
       "      <td>6/17/2020</td>\n",
       "      <td>7/24/2022</td>\n",
       "      <td>7/24/2022</td>\n",
       "      <td>6/19/2020</td>\n",
       "      <td>3/22/2023</td>\n",
       "      <td>4/18/2023</td>\n",
       "      <td>Alabama Clinical Therapeutics, LLC, Birmington...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46544, 46617]</td>\n",
       "      <td>[St. Joseph County, St. Joseph County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02343263</th>\n",
       "      <td>Effect of Bupivacaine-infused Fibrin Sealant A...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02343263</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The purpose of this study is to evaluate the e...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pain, Postoperative|Postoperative Hemorrhage</td>\n",
       "      <td>DRUG: Bupivacaine|BIOLOGICAL: Fibrin Sealant</td>\n",
       "      <td>Postoperative Hemorrhage; Study Terminated Due...</td>\n",
       "      <td>Total Pain Medication Usage, The postoperative...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University School of Medicine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>18</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1501306006</td>\n",
       "      <td>2015-03</td>\n",
       "      <td>5/31/2017</td>\n",
       "      <td>5/31/2017</td>\n",
       "      <td>1/21/2015</td>\n",
       "      <td>5/20/2018</td>\n",
       "      <td>8/10/2018</td>\n",
       "      <td>Riley Childrens' Hospital, Indianapolis, India...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03462706</th>\n",
       "      <td>Quad Resection (Hot Snare vs Cold Snare vs Hot...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03462706</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study will compare the use of cold snare, ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colon Cancer|Colon Polyp|Colon Adenoma</td>\n",
       "      <td>PROCEDURE: Cold Snare|PROCEDURE: Hot Snare|PRO...</td>\n",
       "      <td>Efficacy of Resection (Central Post-Resection ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>John D. Dingell VA Medical Center|White River ...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>238</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1711062130</td>\n",
       "      <td>2/6/2018</td>\n",
       "      <td>5/14/2021</td>\n",
       "      <td>5/14/2021</td>\n",
       "      <td>3/12/2018</td>\n",
       "      <td>5/9/2022</td>\n",
       "      <td>2/15/2023</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02325791</th>\n",
       "      <td>Study to Evaluate the Efficacy and Safety of S...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02325791</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study was to evaluate the ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Respiratory Syncytial Virus Infections</td>\n",
       "      <td>DRUG: Suptavumab 30 mg/kg|DRUG: Placebo Matche...</td>\n",
       "      <td>Part A: Serum Concentration of Suptavumab Over...</td>\n",
       "      <td>Part A: Percentage of Participants With Treatm...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Regeneron Pharmaceuticals</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>1177</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>R2222-RSV-1332</td>\n",
       "      <td>7/21/2015</td>\n",
       "      <td>7/5/2017</td>\n",
       "      <td>9/26/2017</td>\n",
       "      <td>12/25/2014</td>\n",
       "      <td>7/5/2018</td>\n",
       "      <td>11/6/2018</td>\n",
       "      <td>Regeneron Investigational Site, Birmingham, Al...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan: Part...</td>\n",
       "      <td>[46601]</td>\n",
       "      <td>[St. Joseph County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03296072</th>\n",
       "      <td>In Situ Erosion Study to Investigate the Effec...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03296072</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This will be a randomized, controlled, single ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Tooth Erosion</td>\n",
       "      <td>DRUG: 0.254% w/w sodium fluoride and 5% KNO3|D...</td>\n",
       "      <td>% Surface Micro Hardness Recovery (SMHR; Compa...</td>\n",
       "      <td>% Relative Erosion Resistance (RER; Comparison...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>62</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>208166</td>\n",
       "      <td>11/13/2017</td>\n",
       "      <td>1/16/2018</td>\n",
       "      <td>1/16/2018</td>\n",
       "      <td>9/28/2017</td>\n",
       "      <td>1/3/2019</td>\n",
       "      <td>9/16/2020</td>\n",
       "      <td>GSK Investigational Site, Indianapolis, Indian...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02460172</th>\n",
       "      <td>Zip® Surgical Skin Closure Device vs. Staples ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02460172</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Study designed to compare the Zip Surgical Ski...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Arthroplasty, Knee Replacement|Wound Healing</td>\n",
       "      <td>DEVICE: Zip Surgical Skin Closure|DEVICE: Stee...</td>\n",
       "      <td>Incision Appearance / Scar Cosmesis, Patient S...</td>\n",
       "      <td>Surgeon Closure Method Satisfaction, Closure m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ZipLine Medical Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>25</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>6</td>\n",
       "      <td>2015-05</td>\n",
       "      <td>2/15/2017</td>\n",
       "      <td>2/15/2017</td>\n",
       "      <td>6/2/2015</td>\n",
       "      <td>11/26/2018</td>\n",
       "      <td>3/5/2019</td>\n",
       "      <td>Shelbourne Knee Center, Indianapolis, Indiana,...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03673462</th>\n",
       "      <td>Safety of a Quadrivalent Meningococcal Conjuga...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03673462</td>\n",
       "      <td>MET41</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective of this study was to des...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Healthy Volunteers (Meningococcal Infection)</td>\n",
       "      <td>BIOLOGICAL: Meningococcal polysaccharide (sero...</td>\n",
       "      <td>Number of Participants With Immediate Unsolici...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sanofi Pasteur, a Sanofi Company</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>2797</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>MET41|U1111-1183-6261|2019-004459-35</td>\n",
       "      <td>9/17/2018</td>\n",
       "      <td>3/16/2023</td>\n",
       "      <td>3/16/2023</td>\n",
       "      <td>9/17/2018</td>\n",
       "      <td>9/14/2023</td>\n",
       "      <td>10/5/2023</td>\n",
       "      <td>Birmingham Pediatric Associates-Site Number:84...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46544]</td>\n",
       "      <td>[St. Joseph County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05653362</th>\n",
       "      <td>Coconut Oil vs. Commercial Ultrasound Gel In O...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05653362</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The goal of this randomized controlled trial i...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pregnancy, High Risk</td>\n",
       "      <td>DEVICE: Coconut Oil|DEVICE: Commercial Ultraso...</td>\n",
       "      <td>Quality of Ultrasound Images, The quality of u...</td>\n",
       "      <td>Acceptability, Patient acceptability of coconu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>40</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>12932</td>\n",
       "      <td>12/1/2021</td>\n",
       "      <td>12/22/2021</td>\n",
       "      <td>12/22/2021</td>\n",
       "      <td>12/16/2022</td>\n",
       "      <td>1/25/2023</td>\n",
       "      <td>6/2/2023</td>\n",
       "      <td>Riley Hospital for Children at IU Health, Indi...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03009110</th>\n",
       "      <td>Preventing Adverse Incisional Outcomes at Cesa...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03009110</td>\n",
       "      <td>Prevena-C</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The Prophylactic Negative Pressure Wound Thera...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Surgical Wound Infection|Cesarean Section</td>\n",
       "      <td>DEVICE: Prophylactic NPWT|DEVICE: Standard Dre...</td>\n",
       "      <td>Number of Participants With Superficial or Dee...</td>\n",
       "      <td>Number of Participants With Superficial, Deep ...</td>\n",
       "      <td>Types and Frequency of Different Bacteria Incl...</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>Eunice Kennedy Shriver National Institute of C...</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1624</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>IRB ID #: 201603062|1R01HD086007-01A1</td>\n",
       "      <td>2/8/2017</td>\n",
       "      <td>11/13/2019</td>\n",
       "      <td>11/13/2019</td>\n",
       "      <td>1/4/2017</td>\n",
       "      <td>2/5/2021</td>\n",
       "      <td>6/1/2023</td>\n",
       "      <td>University of Alabama Medical Center, Birmingh...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT01779362</th>\n",
       "      <td>RISE Adult Medication Study</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01779362</td>\n",
       "      <td>RISE Adult</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The RISE Adult Medication Study is a 4-arm, 3-...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Prediabetes|Type 2 Diabetes</td>\n",
       "      <td>DRUG: Metformin|DRUG: Liraglutide|DRUG: Glargi...</td>\n",
       "      <td>ß-cell Response Measured by Hyperglycemic Clam...</td>\n",
       "      <td>ACPRg, First phase response from the hyperglyc...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RISE Study Group</td>\n",
       "      <td>National Institute of Diabetes and Digestive a...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>267</td>\n",
       "      <td>NETWORK</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>RISE Adult|5U01DK094406-02</td>\n",
       "      <td>2013-04</td>\n",
       "      <td>2019-02</td>\n",
       "      <td>2019-08</td>\n",
       "      <td>1/30/2013</td>\n",
       "      <td>4/12/2023</td>\n",
       "      <td>5/11/2023</td>\n",
       "      <td>Jesse Brown VA Medical Center, Chicago, Illino...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00401518</th>\n",
       "      <td>A Pivotal Study of a Facet Replacement System ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00401518</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to determine if t...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Lumbar Spinal Stenosis</td>\n",
       "      <td>DEVICE: Non-randomized ACADIA® Facet Replaceme...</td>\n",
       "      <td>Measure of Pain/Disability Using the Zurich Cl...</td>\n",
       "      <td>Mean Visual Analog Scale (VAS) Right Leg Pain,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Globus Medical Inc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>390</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1020-9052</td>\n",
       "      <td>2006-10</td>\n",
       "      <td>2017-08</td>\n",
       "      <td>2017-10</td>\n",
       "      <td>11/20/2006</td>\n",
       "      <td>8/10/2020</td>\n",
       "      <td>9/10/2020</td>\n",
       "      <td>Spine Group Beverly Hills, Beverly Hills, Cali...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46032, 46804]</td>\n",
       "      <td>[Hamilton County, Allen County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02576860</th>\n",
       "      <td>Study to Evaluate the Safety and Efficacy of a...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02576860</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study evaluates the safety and efficacy o...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Rosacea</td>\n",
       "      <td>DRUG: CLS001 (Omiganan)|DRUG: Vehicle</td>\n",
       "      <td>Efficacy Absolute Change in Inflammatory Lesio...</td>\n",
       "      <td>Efficacy The Absolute Change in Inflammatory L...</td>\n",
       "      <td>Safety Adverse Events, Subjects with 1 or more...</td>\n",
       "      <td>Maruho Co., Ltd.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>263</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CLS001-CO-PR-005</td>\n",
       "      <td>2015-10</td>\n",
       "      <td>2/27/2017</td>\n",
       "      <td>9/5/2017</td>\n",
       "      <td>10/15/2015</td>\n",
       "      <td>10/8/2020</td>\n",
       "      <td>8/2/2022</td>\n",
       "      <td>Fort Smith, Arkansas, United States|Rogers, Ar...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46168]</td>\n",
       "      <td>[Hendricks County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02547441</th>\n",
       "      <td>Study to Evaluate the Safety and Efficacy of a...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02547441</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study evaluates the safety and efficacy o...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Rosacea</td>\n",
       "      <td>DRUG: CLS001 (Omiganan)|DRUG: Vehicle</td>\n",
       "      <td>Change in Inflammatory Lesion Count From Basel...</td>\n",
       "      <td>Change in the Number of Inflammatory Lesions F...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Maruho Co., Ltd.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>463</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CLS001-CO-PR-004</td>\n",
       "      <td>2015-12</td>\n",
       "      <td>7/5/2017</td>\n",
       "      <td>4/13/2018</td>\n",
       "      <td>9/11/2015</td>\n",
       "      <td>6/13/2022</td>\n",
       "      <td>8/2/2022</td>\n",
       "      <td>Fremont, California, United States|Miami, Flor...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46032]</td>\n",
       "      <td>[Hamilton County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02431702</th>\n",
       "      <td>A Study to Compare Disease Progression and Mod...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02431702</td>\n",
       "      <td>DREaM</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of the study is to compare effecti...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Schizophrenia|Psychotic Disorders</td>\n",
       "      <td>DRUG: Aripiprazole|DRUG: Haloperidol|DRUG: Ola...</td>\n",
       "      <td>Part-2 (Disease Progression): Time to First Tr...</td>\n",
       "      <td>Part 2 (Disease Progression): Change From Base...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Janssen Scientific Affairs, LLC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>337</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CR106193|R092670SCH3013</td>\n",
       "      <td>7/8/2015</td>\n",
       "      <td>11/12/2019</td>\n",
       "      <td>11/12/2019</td>\n",
       "      <td>5/1/2015</td>\n",
       "      <td>11/11/2020</td>\n",
       "      <td>12/3/2021</td>\n",
       "      <td>Little Rock, Arkansas, United States|Garden Gr...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02933489</th>\n",
       "      <td>Abbreviated Breast MRI and Digital Tomosynthes...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02933489</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This randomized phase II trial studies how wel...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Asymptomatic</td>\n",
       "      <td>DIAGNOSTIC_TEST: Contrast-enhanced Magnetic Re...</td>\n",
       "      <td>Screen-detected Invasive Cancer Verified by Pa...</td>\n",
       "      <td>Positive Predictive Value (PPV) of Biopsies, T...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ECOG-ACRIN Cancer Research Group</td>\n",
       "      <td>National Cancer Institute (NCI)</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1516</td>\n",
       "      <td>NETWORK</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>EA1141|NCI-2016-00252|s16-01825|EA1141|ECOG-AC...</td>\n",
       "      <td>12/27/2016</td>\n",
       "      <td>1/23/2020</td>\n",
       "      <td>2023-08</td>\n",
       "      <td>10/14/2016</td>\n",
       "      <td>10/23/2020</td>\n",
       "      <td>6/26/2023</td>\n",
       "      <td>Banner MD Anderson Cancer Center, Gilbert, Ari...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46202, 46321]</td>\n",
       "      <td>[Marion County, Lake County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04431518</th>\n",
       "      <td>PK of JULUCA in Hemodialysis</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04431518</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study will compare the pharmacokinetics o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV/AIDS|ESRD</td>\n",
       "      <td>DRUG: JULUCA 50Mg-25Mg Tablet</td>\n",
       "      <td>DTG Ctau, Steady-state plasma Ctau for doluteg...</td>\n",
       "      <td>Safety of DTG and RPV, The attributable advers...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>8</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>ViiV Healthcare IIS 1837</td>\n",
       "      <td>4/23/2021</td>\n",
       "      <td>7/31/2023</td>\n",
       "      <td>7/31/2023</td>\n",
       "      <td>6/16/2020</td>\n",
       "      <td>NaN</td>\n",
       "      <td>9/28/2023</td>\n",
       "      <td>Samir Gupta, Indianapolis, Indiana, 46202, Uni...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02513940</th>\n",
       "      <td>Influence of Testosterone Administration on Dr...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02513940</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Torsades de pointes (TdP) is a potentially fat...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Long QT Syndrome</td>\n",
       "      <td>DRUG: Testosterone|DRUG: Progesterone|DRUG: Pl...</td>\n",
       "      <td>Baseline (Pre-ibutilide) Individualized Rate-c...</td>\n",
       "      <td>Area Under the QTF Versus Time Curve for 0-1 H...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>American Heart Association|Purdue University</td>\n",
       "      <td>MALE</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>14</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>1507526854</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>10/19/2017</td>\n",
       "      <td>10/19/2017</td>\n",
       "      <td>8/3/2015</td>\n",
       "      <td>2/14/2019</td>\n",
       "      <td>8/28/2019</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02956044</th>\n",
       "      <td>Interaction of Bexagliflozin With Metformin, G...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02956044</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to examine the dr...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Type2 Diabetes Mellitus</td>\n",
       "      <td>DRUG: Bexagliflozin|DRUG: Metformin|DRUG: Glim...</td>\n",
       "      <td>Cmax (Maximum Observed Plasma Concentration), ...</td>\n",
       "      <td>Urinary Glucose Excretion up to 0-72 hr, Pre-d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Theracos</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>54</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>THR-1442-C-453</td>\n",
       "      <td>2016-11</td>\n",
       "      <td>2017-03</td>\n",
       "      <td>2017-03</td>\n",
       "      <td>11/4/2016</td>\n",
       "      <td>5/21/2021</td>\n",
       "      <td>7/22/2021</td>\n",
       "      <td>Clinical Research Site, Evansville, Indiana, 4...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47710]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04763044</th>\n",
       "      <td>Evaluation of the Fluoride Dose Response Using...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04763044</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to evaluate the f...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Caries</td>\n",
       "      <td>DRUG: 0 ppm F|DRUG: 250 ppm F as MFP|DRUG: 110...</td>\n",
       "      <td>Enamel Fluoride Uptake (EFU), The EFU test wil...</td>\n",
       "      <td>Enamel Fluoride Uptake (EFU), The EFU test wil...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Procter and Gamble</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>15</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>2020154</td>\n",
       "      <td>3/1/2021</td>\n",
       "      <td>7/21/2021</td>\n",
       "      <td>7/21/2021</td>\n",
       "      <td>2/21/2021</td>\n",
       "      <td>4/13/2022</td>\n",
       "      <td>7/19/2022</td>\n",
       "      <td>Oral Health Research Institute, Indianapolis, ...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03488381</th>\n",
       "      <td>Effects of Soccer Heading on Ocular-motor Func...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03488381</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Repetitive head impacts in sports and military...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Trauma, Head</td>\n",
       "      <td>DEVICE: Soccer Heading</td>\n",
       "      <td>Changes in Brain-Derived Blood Biomarker Over ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>45</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1610743422</td>\n",
       "      <td>8/1/2017</td>\n",
       "      <td>4/9/2019</td>\n",
       "      <td>4/9/2019</td>\n",
       "      <td>4/5/2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4/17/2019</td>\n",
       "      <td>Indiana University, Bloomington, Indiana, 4740...</td>\n",
       "      <td>Study Protocol|Informed Consent Form</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03089281</th>\n",
       "      <td>Strategic Management to Optimize Response To C...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03089281</td>\n",
       "      <td>SMART CRT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective is to evaluate the benef...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>DEVICE: CRT-D</td>\n",
       "      <td>CRT Response, Comparing cardiac resynchronizat...</td>\n",
       "      <td>Change in Left Ventricular End Systolic Volume...</td>\n",
       "      <td>Change in Kansas City Cardiomyopathy Questionn...</td>\n",
       "      <td>Boston Scientific Corporation</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>699</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>C2067</td>\n",
       "      <td>8/1/2017</td>\n",
       "      <td>9/15/2020</td>\n",
       "      <td>9/15/2020</td>\n",
       "      <td>3/24/2017</td>\n",
       "      <td>9/15/2021</td>\n",
       "      <td>4/5/2022</td>\n",
       "      <td>Affinity Hospital, LLC d/b/a Granview Medical ...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47630]</td>\n",
       "      <td>[Warrick County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04366544</th>\n",
       "      <td>Effects of an 8-day Advanced Meditation, Samya...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04366544</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The purpose of this study is to investigate th...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Mental Health Wellness 1|Happiness|Depression|...</td>\n",
       "      <td>OTHER: Part A1: Survey|OTHER: Part A2: Sample ...</td>\n",
       "      <td>levels of Anandamide, Anandamide (AEA) activat...</td>\n",
       "      <td>Microbiome analysis:, Microbiome analysis: Par...</td>\n",
       "      <td>fMRI, fMRI: Functional MRI is a useful non-inv...</td>\n",
       "      <td>University of Pittsburgh</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>759</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>1801728792</td>\n",
       "      <td>1/19/2018</td>\n",
       "      <td>12/15/2023</td>\n",
       "      <td>8/15/2024</td>\n",
       "      <td>4/29/2020</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1/6/2023</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03446781</th>\n",
       "      <td>Effectiveness and Safety of EN3835 in the Trea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03446781</td>\n",
       "      <td>RELEASE-2</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Subjects will be screened for study eligibilit...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Edematous Fibrosclerotic Panniculopathy (Cellu...</td>\n",
       "      <td>BIOLOGICAL: EN3835|BIOLOGICAL: Placebo</td>\n",
       "      <td>2-level Composite Responders for the Target Bu...</td>\n",
       "      <td>1-level PR-PCSS Responders of the Target Butto...</td>\n",
       "      <td>Serum Antibody Positivity by Visit, Percent of...</td>\n",
       "      <td>Endo Pharmaceuticals</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>422</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>EN3835-303</td>\n",
       "      <td>2/8/2018</td>\n",
       "      <td>9/26/2018</td>\n",
       "      <td>9/26/2018</td>\n",
       "      <td>2/27/2018</td>\n",
       "      <td>8/5/2020</td>\n",
       "      <td>10/8/2020</td>\n",
       "      <td>Endo Clinical Trial Site #1, Glendale, Arizona...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46032]</td>\n",
       "      <td>[Hamilton County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT06026124</th>\n",
       "      <td>Retrieval-Based Word Learning in Developmental...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT06026124</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Children with developmental language disorder ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Developmental Language Disorder|Specific Langu...</td>\n",
       "      <td>BEHAVIORAL: Retrieval-based word learning</td>\n",
       "      <td>Word Form accuracy (number of words correctly ...</td>\n",
       "      <td>Number of correctly identified words on Peabod...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Purdue University</td>\n",
       "      <td>National Institute on Deafness and Other Commu...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>1603017480C|R01DC014708</td>\n",
       "      <td>9/21/2023</td>\n",
       "      <td>7/31/2026</td>\n",
       "      <td>7/31/2026</td>\n",
       "      <td>9/6/2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>9/6/2023</td>\n",
       "      <td>Purdue University's SLHS laboratories (8445 Ke...</td>\n",
       "      <td>Informed Consent Form</td>\n",
       "      <td>[46240]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03709901</th>\n",
       "      <td>Viable Allograft Supplemented Disc Regeneratio...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03709901</td>\n",
       "      <td>VAST</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The objective of this study is to evaluate the...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Degenerative Disc Disease</td>\n",
       "      <td>OTHER: Active Allograft|OTHER: Placebo</td>\n",
       "      <td>Oswestry Disability Index (ODI), To evaluate t...</td>\n",
       "      <td>MRI Assessments, To evaluate morphologic chang...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>VIVEX Biologics, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>218</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>VAST - 001-017</td>\n",
       "      <td>8/22/2017</td>\n",
       "      <td>1/31/2022</td>\n",
       "      <td>1/31/2022</td>\n",
       "      <td>10/17/2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7/7/2021</td>\n",
       "      <td>Source Health, Santa Monica, California, 90404...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46278]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03267511</th>\n",
       "      <td>A Study to Investigate the Stain and Plaque Re...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03267511</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to determine whet...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Oral Hygiene</td>\n",
       "      <td>DRUG: 5% KNO3 / 0.2542% NaF dentifrice with 0....</td>\n",
       "      <td>Change From Baseline in Overall Macpherson Mod...</td>\n",
       "      <td>Difference of Least Square Mean of Change From...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>123</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>208078</td>\n",
       "      <td>9/25/2017</td>\n",
       "      <td>12/2/2017</td>\n",
       "      <td>12/2/2017</td>\n",
       "      <td>8/30/2017</td>\n",
       "      <td>11/30/2018</td>\n",
       "      <td>1/8/2019</td>\n",
       "      <td>GSK Investigational Site, Fort Wayne, Indiana,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46825]</td>\n",
       "      <td>[Allen County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03550313</th>\n",
       "      <td>Study to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03550313</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>This is a Phase 2, randomized, active-controll...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pneumococcal Infections</td>\n",
       "      <td>BIOLOGICAL: Multivalent|BIOLOGICAL: Prevnar 13</td>\n",
       "      <td>Percentage of Participants With Local Reaction...</td>\n",
       "      <td>Pneumococcal Serotype-specific Immunoglobulin ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>565</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>C3571002|2020-005039-59</td>\n",
       "      <td>6/1/2018</td>\n",
       "      <td>11/5/2020</td>\n",
       "      <td>11/5/2020</td>\n",
       "      <td>6/8/2018</td>\n",
       "      <td>10/20/2021</td>\n",
       "      <td>11/30/2021</td>\n",
       "      <td>Mobile Pediatric Clinic, Mobile, Alabama, 3660...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46544]</td>\n",
       "      <td>[St. Joseph County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02836613</th>\n",
       "      <td>A Study of Galcanezumab in Healthy Participants.</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02836613</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The main purpose of this study is to evaluate ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Healthy</td>\n",
       "      <td>BIOLOGICAL: Galcanezumab</td>\n",
       "      <td>Pharmacokinetics (PK): Maximum Concentration (...</td>\n",
       "      <td>Pharmacodynamics (PD): Maximum Observed CGRP C...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>160</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>16203|I5Q-MC-CGAQ</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2/27/2017</td>\n",
       "      <td>11/9/2017</td>\n",
       "      <td>7/19/2016</td>\n",
       "      <td>10/19/2018</td>\n",
       "      <td>3/13/2019</td>\n",
       "      <td>Covance Clinical Research Inc, Daytona Beach, ...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47710]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04247581</th>\n",
       "      <td>ECG App Algorithms Clinical Validation Study</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04247581</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of the study is to evaluate the pe...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Atrial Fibrillation</td>\n",
       "      <td>DEVICE: 1-lead ECG</td>\n",
       "      <td>Percentage of Trials With Correct Classificati...</td>\n",
       "      <td>Percentage of Trials With Correct Classificati...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>Iqvia Pty Ltd</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>546</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>13</td>\n",
       "      <td>1/7/2020</td>\n",
       "      <td>3/20/2020</td>\n",
       "      <td>3/20/2020</td>\n",
       "      <td>1/30/2020</td>\n",
       "      <td>7/30/2021</td>\n",
       "      <td>9/28/2021</td>\n",
       "      <td>Hope Research Institute, Phoenix, Arizona, 850...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46123]</td>\n",
       "      <td>[Hendricks County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04870099</th>\n",
       "      <td>Guided Self-help for Common Mental Disorders</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04870099</td>\n",
       "      <td>DWM</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Common mental disorders (CMDs) like depression...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Bibliotherapy</td>\n",
       "      <td>BEHAVIORAL: Doing What Matters in Times of Str...</td>\n",
       "      <td>6-week Change in Kessler 6 Psychological Distr...</td>\n",
       "      <td>6-week Change in Emotion Regulation Scale (ERQ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>Indiana Clinical and Translational Sciences In...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>141</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2004321422|KL2TR002530|UL1TR002529</td>\n",
       "      <td>10/17/2020</td>\n",
       "      <td>2/21/2022</td>\n",
       "      <td>5/21/2022</td>\n",
       "      <td>5/3/2021</td>\n",
       "      <td>4/26/2023</td>\n",
       "      <td>7/11/2023</td>\n",
       "      <td>Indiana University, Bloomington, Indiana, 4740...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan|Infor...</td>\n",
       "      <td>[47408]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04189081</th>\n",
       "      <td>Improvement of Dry Mouth Sufferers After Using...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04189081</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The objective of this study is to evaluate dry...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Dry Mouth</td>\n",
       "      <td>DEVICE: dry mouth rinse|OTHER: Water Control</td>\n",
       "      <td>Response to \"Relieving the Discomfort of Dry M...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Procter and Gamble</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>137</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CSD2019158</td>\n",
       "      <td>5/13/2020</td>\n",
       "      <td>7/8/2020</td>\n",
       "      <td>7/8/2020</td>\n",
       "      <td>12/6/2019</td>\n",
       "      <td>4/15/2021</td>\n",
       "      <td>5/28/2021</td>\n",
       "      <td>Salus Research, Fort Wayne, Indiana, 46825, Un...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46825]</td>\n",
       "      <td>[Allen County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04620798</th>\n",
       "      <td>Longitudinal COVID-19 Antibody Testing in Indi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04620798</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary goal for this study is to assess w...</td>\n",
       "      <td>YES</td>\n",
       "      <td>SARS-CoV-2|Serology|Students</td>\n",
       "      <td>BEHAVIORAL: Immediate vs. delayed provision of...</td>\n",
       "      <td>Frequency of Handwashing, This outcome was dic...</td>\n",
       "      <td>Count of Participants With SARS-CoV-2 Seroconv...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1076</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2008293852</td>\n",
       "      <td>9/14/2020</td>\n",
       "      <td>11/11/2020</td>\n",
       "      <td>11/11/2020</td>\n",
       "      <td>11/9/2020</td>\n",
       "      <td>1/18/2022</td>\n",
       "      <td>1/31/2022</td>\n",
       "      <td>Indiana University, Bloomington, Indiana, 4740...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan|I...</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02654236</th>\n",
       "      <td>Effect of Heavy Alcohol Consumption on Farneso...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02654236</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The main purpose of this study is to see wheth...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Alcohol Consumption</td>\n",
       "      <td>DRUG: Placebo|DRUG: 10 mg Obeticholic Acid (OCA)</td>\n",
       "      <td>Change in Bile Salt Metabolism (C4 )Levels to ...</td>\n",
       "      <td>Change in Fasting Serum Bile Salt Levels, Base...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Suthat Liangpunsakul</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>TREAT 005</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2019-09</td>\n",
       "      <td>2019-09</td>\n",
       "      <td>1/13/2016</td>\n",
       "      <td>3/6/2023</td>\n",
       "      <td>4/25/2023</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04812184</th>\n",
       "      <td>Adhesive Tape Placement on Patients' Masks in ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04812184</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Methods 123 patients were enrolled in a random...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Covid19</td>\n",
       "      <td>DEVICE: Tape Face Mask</td>\n",
       "      <td>Proper Face Mask Use up to 60 Minutes, The pri...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>123</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>IUMASKstudy</td>\n",
       "      <td>4/1/2020</td>\n",
       "      <td>10/30/2020</td>\n",
       "      <td>10/30/2020</td>\n",
       "      <td>3/23/2021</td>\n",
       "      <td>11/9/2021</td>\n",
       "      <td>10/4/2022</td>\n",
       "      <td>Eskenazi Hospital, Indianapolis, Indiana, 4607...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46077]</td>\n",
       "      <td>[Boone County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03560128</th>\n",
       "      <td>Endocuff Vision Colonoscopy vs. AmplifEYE Colo...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03560128</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study aims to compare the results between ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colorectal Adenoma|Colorectal Polyp|Colorectal...</td>\n",
       "      <td>DEVICE: Endocuff Vision device|DEVICE: AmplifE...</td>\n",
       "      <td>Number of Adenomas Detected Per Colonoscopy (A...</td>\n",
       "      <td>Detection Rates (Adenoma Detection Rate (ADR) ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>634</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1802193017</td>\n",
       "      <td>4/12/2018</td>\n",
       "      <td>12/18/2018</td>\n",
       "      <td>12/18/2018</td>\n",
       "      <td>6/18/2018</td>\n",
       "      <td>9/20/2019</td>\n",
       "      <td>10/8/2019</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04482036</th>\n",
       "      <td>The MObile AssessMENT of Behavioral and Psycho...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04482036</td>\n",
       "      <td>MOMENT</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The purpose of this research study is to learn...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Alzheimer Disease|Mild Memory Disturbance|Mild...</td>\n",
       "      <td>OTHER: Mobile Phone Application Assessments|OT...</td>\n",
       "      <td>Number of Caregivers Who Completed Neuropsychi...</td>\n",
       "      <td>Outcome of the Change in Behavioral and Psycho...</td>\n",
       "      <td>Outcome of the Change in the Perceived Stress ...</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>National Institute on Aging (NIA)</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1907055854|1K23AG059914-01A1</td>\n",
       "      <td>10/23/2020</td>\n",
       "      <td>10/4/2021</td>\n",
       "      <td>10/4/2021</td>\n",
       "      <td>7/22/2020</td>\n",
       "      <td>2/13/2023</td>\n",
       "      <td>9/1/2023</td>\n",
       "      <td>Eskenazi Health, Indianapolis, Indiana, 46202,...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04666194</th>\n",
       "      <td>A Pilot Randomized Trial of Polypectomy Techni...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04666194</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Complete polypectomy is one of the major facto...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Colon Polyps</td>\n",
       "      <td>PROCEDURE: Cold forceps|PROCEDURE: Cold snare|...</td>\n",
       "      <td>Incomplete resection rate, Rate of recurrent n...</td>\n",
       "      <td>Efficiency of polypectomy, Time taken for each...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>American Society for Gastrointestinal Endoscopy</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>353</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1011004273/0801-16</td>\n",
       "      <td>9/1/2009</td>\n",
       "      <td>10/1/2009</td>\n",
       "      <td>10/1/2019</td>\n",
       "      <td>12/14/2020</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1/12/2021</td>\n",
       "      <td>Springmill endoscopy center, Carmel, Indiana, ...</td>\n",
       "      <td>Study Protocol, Statistical Analysis Plan, and...</td>\n",
       "      <td>[46202, 46290]</td>\n",
       "      <td>[Marion County, Hamilton County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02410902</th>\n",
       "      <td>A Trial of CM-AT in Children With Autism With ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02410902</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to determine whet...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Autism</td>\n",
       "      <td>DRUG: CM-AT|DRUG: PLACEBO</td>\n",
       "      <td>Primary Outcome Measurements to Determine Effi...</td>\n",
       "      <td>Secondary Outcome Measurements of Changes in t...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Curemark</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>190</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>103</td>\n",
       "      <td>5/13/2015</td>\n",
       "      <td>12/22/2017</td>\n",
       "      <td>12/22/2017</td>\n",
       "      <td>4/8/2015</td>\n",
       "      <td>5/3/2021</td>\n",
       "      <td>5/24/2023</td>\n",
       "      <td>Southwest Autism Research &amp; Resource Center (S...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47713]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04913636</th>\n",
       "      <td>Assessing Effects of a Denture Gel on Gum Abra...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04913636</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a parallel design study. Up to 40 subj...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Gum Injury</td>\n",
       "      <td>DEVICE: Treatment Gel|OTHER: Sham Control</td>\n",
       "      <td>Abrasion Assessment (Number), The total number...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Procter and Gamble</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>38</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2020089</td>\n",
       "      <td>6/1/2021</td>\n",
       "      <td>6/29/2021</td>\n",
       "      <td>6/29/2021</td>\n",
       "      <td>6/4/2021</td>\n",
       "      <td>5/19/2022</td>\n",
       "      <td>6/28/2022</td>\n",
       "      <td>Salus Research, Fort Wayne, Indiana, 46825, Un...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46825]</td>\n",
       "      <td>[Allen County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03257436</th>\n",
       "      <td>Strategic Management to Improve CRT Using Mult...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03257436</td>\n",
       "      <td>SMARTMSP</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Prospective, multi-center, single arm, post ap...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Left Ventricular Dysfunction</td>\n",
       "      <td>DEVICE: CRT-D</td>\n",
       "      <td>LV MSP Feature Related Complication-Free Rate,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Boston Scientific Corporation</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>586</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>92050975</td>\n",
       "      <td>1/5/2018</td>\n",
       "      <td>11/19/2020</td>\n",
       "      <td>11/19/2020</td>\n",
       "      <td>8/22/2017</td>\n",
       "      <td>12/7/2021</td>\n",
       "      <td>1/3/2022</td>\n",
       "      <td>Mobile Infirmary Medical Center, Mobile, Alaba...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46845]</td>\n",
       "      <td>[Allen County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03436784</th>\n",
       "      <td>The Indiana SNAP-Ed Long-term Study Sequel</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03436784</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The goal of the study is to determine the imme...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Nutrient Intake Inadequacy</td>\n",
       "      <td>BEHAVIORAL: Indiana SNAP-Ed</td>\n",
       "      <td>Long-term Change in Dietary Intake, The Health...</td>\n",
       "      <td>Long-term Change in Nutrient Intake, Mean Usua...</td>\n",
       "      <td>Body Mass Index (BMI), SNAP-Ed paraprofessiona...</td>\n",
       "      <td>Purdue University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>261</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1507016295</td>\n",
       "      <td>9/8/2015</td>\n",
       "      <td>5/1/2017</td>\n",
       "      <td>5/1/2017</td>\n",
       "      <td>2/19/2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3/29/2023</td>\n",
       "      <td>Purdue University, West Lafayette, Indiana, 47...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan|Infor...</td>\n",
       "      <td>[47907]</td>\n",
       "      <td>[Tippecanoe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03024970</th>\n",
       "      <td>Daily Disposable Dispensing Clinical Trial of ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03024970</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to investigate th...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Myopia</td>\n",
       "      <td>DEVICE: stenfilcon A lens with solution additi...</td>\n",
       "      <td>Subjective Ratings on Comfort, Subjects assess...</td>\n",
       "      <td>Lens Fit Acceptance, Overall fit acceptance is...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Coopervision, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>72</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>CV-16-60</td>\n",
       "      <td>2017-01</td>\n",
       "      <td>4/25/2017</td>\n",
       "      <td>6/26/2017</td>\n",
       "      <td>1/19/2017</td>\n",
       "      <td>6/19/2020</td>\n",
       "      <td>7/21/2020</td>\n",
       "      <td>Clinical Optical Research Lab (CORL), Blooming...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02754440</th>\n",
       "      <td>Evaluation of Trima Version 7.0 Platelets in PAS</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02754440</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>To verify that platelets collected on the Trim...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>DEVICE: Trima Accel System with Version 7.0 So...</td>\n",
       "      <td>Number of Participants With Platelet Units Con...</td>\n",
       "      <td>Number of Participants With Platelet Units Con...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Terumo BCT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>365</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>CTS-5059</td>\n",
       "      <td>4/20/2016</td>\n",
       "      <td>7/28/2017</td>\n",
       "      <td>7/28/2017</td>\n",
       "      <td>4/28/2016</td>\n",
       "      <td>4/9/2018</td>\n",
       "      <td>5/11/2018</td>\n",
       "      <td>San Diego Blood Bank, San Diego, California, 9...</td>\n",
       "      <td>Study Protocol|Informed Consent Form|Statistic...</td>\n",
       "      <td>[46208]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03320057</th>\n",
       "      <td>Medication Abortion Via Pharmacy Dispensing</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03320057</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This mixed-methods study follows a prospective...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pregnancy Related|Abortion Early</td>\n",
       "      <td>DRUG: Mifepristone|OTHER: Training on mifepris...</td>\n",
       "      <td>Number of Pharmacists Who Objected to Particip...</td>\n",
       "      <td>Number of Participants Who Report Being Satisf...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Daniel Grossman</td>\n",
       "      <td>University of California, San Diego|University...</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>326</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>A128753</td>\n",
       "      <td>6/1/2018</td>\n",
       "      <td>7/4/2020</td>\n",
       "      <td>7/4/2020</td>\n",
       "      <td>10/25/2017</td>\n",
       "      <td>5/21/2021</td>\n",
       "      <td>7/12/2021</td>\n",
       "      <td>Obstetrics and Gynecology Family Planning Clin...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05056870</th>\n",
       "      <td>Clinical Evaluation of Spherical Soft Contact ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05056870</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This will be a 5-visit, randomized, partially ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Visual Acuity</td>\n",
       "      <td>DEVICE: ACUVUE Oasys 1-Day with HydraLuxe Tech...</td>\n",
       "      <td>High Luminance High Contrast Monocular Visual ...</td>\n",
       "      <td>CLUE Vision Score, CLUE Vision Score was asses...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Johnson &amp; Johnson Vision Care, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>174</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>CR-6459</td>\n",
       "      <td>9/15/2021</td>\n",
       "      <td>3/3/2022</td>\n",
       "      <td>3/3/2022</td>\n",
       "      <td>9/27/2021</td>\n",
       "      <td>2/27/2023</td>\n",
       "      <td>4/27/2023</td>\n",
       "      <td>Eyecenter Optometric, Rocklin, California, 956...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47401]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03095976</th>\n",
       "      <td>Amnion-Chorion Allograft Barrier Used for Root...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03095976</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this pilot project is to evalua...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Periodontal Diseases</td>\n",
       "      <td>PROCEDURE: Amnion-Chorion allograft membrane o...</td>\n",
       "      <td>Probing Depth Change, Probing depth was measur...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>1608175133</td>\n",
       "      <td>6/14/2017</td>\n",
       "      <td>9/10/2019</td>\n",
       "      <td>9/10/2019</td>\n",
       "      <td>3/30/2017</td>\n",
       "      <td>2/27/2021</td>\n",
       "      <td>4/14/2021</td>\n",
       "      <td>Indiana University School of Dentistry, Indian...</td>\n",
       "      <td>Study Protocol, Statistical Analysis Plan, and...</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03202511</th>\n",
       "      <td>Assessment of a New \"Boosting\" Strategy for HI...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03202511</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study will be a randomized, open-label, cr...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pre-Exposure Prophylaxis</td>\n",
       "      <td>DRUG: Probenecid Oral Tablet|DRUG: Tenofovir d...</td>\n",
       "      <td>Plasma TFV AUC0-INF GMR, The geometric mean ra...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>EARLY_PHASE1</td>\n",
       "      <td>15</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>1705315090</td>\n",
       "      <td>6/23/2017</td>\n",
       "      <td>7/2/2018</td>\n",
       "      <td>7/2/2018</td>\n",
       "      <td>6/28/2017</td>\n",
       "      <td>4/24/2019</td>\n",
       "      <td>5/7/2021</td>\n",
       "      <td>Indiana University Clinical Research Center at...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03167411</th>\n",
       "      <td>Bexagliflozin Drug/Drug Interaction Study With...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03167411</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to examine the dr...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Type2 Diabetes Mellitus</td>\n",
       "      <td>DRUG: Bexagliflozin|DRUG: Exenatide Injection</td>\n",
       "      <td>Cmax (Maximum Observed Plasma Concentration), ...</td>\n",
       "      <td>Urinary Glucose Excretion (UGE), Post-dose uri...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Theracos</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>20</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>THR-1442-C-458</td>\n",
       "      <td>5/24/2017</td>\n",
       "      <td>6/29/2017</td>\n",
       "      <td>6/29/2017</td>\n",
       "      <td>5/30/2017</td>\n",
       "      <td>3/25/2021</td>\n",
       "      <td>5/28/2021</td>\n",
       "      <td>Clinical Research Site, Evansville, Indiana, 4...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47710]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03338296</th>\n",
       "      <td>Study to Evaluate the Efficacy and Safety of B...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03338296</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>This study will be conducted to demonstrate we...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Obesity</td>\n",
       "      <td>DRUG: lorcaserin hydrochloride XR|DRUG: Placebo</td>\n",
       "      <td>Change in Body Mass Index (BMI) From Baseline ...</td>\n",
       "      <td>Percentage of Participants Who Achieved at Lea...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eisai Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>278</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>APD356-A001-403</td>\n",
       "      <td>9/28/2017</td>\n",
       "      <td>4/3/2020</td>\n",
       "      <td>4/3/2020</td>\n",
       "      <td>11/9/2017</td>\n",
       "      <td>3/30/2021</td>\n",
       "      <td>7/19/2021</td>\n",
       "      <td>Phoenix Clinical LLC, Phoenix, Arizona, 85014,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46383]</td>\n",
       "      <td>[Porter County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04886596</th>\n",
       "      <td>Efficacy Study of GSK's Investigational Respir...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04886596</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This study will evaluate the efficacy of the R...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Respiratory Syncytial Virus Infections</td>\n",
       "      <td>DRUG: Placebo|BIOLOGICAL: RSVPreF3 OA vaccine</td>\n",
       "      <td>Number of Participants With First Episode of R...</td>\n",
       "      <td>Number of Participants With First Episode of R...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>26665</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>212494|2020-000753-28</td>\n",
       "      <td>5/25/2021</td>\n",
       "      <td>4/11/2022</td>\n",
       "      <td>5/31/2024</td>\n",
       "      <td>5/14/2021</td>\n",
       "      <td>4/10/2023</td>\n",
       "      <td>8/4/2023</td>\n",
       "      <td>GSK Investigational Site, Birmingham, Alabama,...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46544, 47574, 47714]</td>\n",
       "      <td>[St. Joseph County, Perry County, Vanderburgh ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03291613</th>\n",
       "      <td>Gaming Technology to Engage Adolescent Sickle ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03291613</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Sickle cell disease (SCD) is a common genetic ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Sickle Cell Disease</td>\n",
       "      <td>OTHER: Pinpoint App</td>\n",
       "      <td>System Usability Questionnaire, Ten likert-typ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Klein Buendel, Inc.</td>\n",
       "      <td>Hilton Publishing Company|National Institute o...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>13</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>1R43MD010746-01|0308|1R43MD010746-01</td>\n",
       "      <td>1/15/2017</td>\n",
       "      <td>9/30/2017</td>\n",
       "      <td>9/30/2017</td>\n",
       "      <td>9/25/2017</td>\n",
       "      <td>7/25/2018</td>\n",
       "      <td>2/6/2019</td>\n",
       "      <td>Klein Buendel, Inc., Golden, Colorado, 80401, ...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46321]</td>\n",
       "      <td>[Lake County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04295135</th>\n",
       "      <td>Chronic Pain OneSheet Clinical Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04295135</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of the study is to determine wheth...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Chronic Pain</td>\n",
       "      <td>BEHAVIORAL: Chronic Pain OneSheet</td>\n",
       "      <td>Pain and function goal-setting, Proportion of ...</td>\n",
       "      <td>Urine drug screens (UDS) ordered, Proportion o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>Eskenazi Health|Wake Forest University|Wake Fo...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>137</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1911922583|5R33DA046085-05</td>\n",
       "      <td>8/4/2020</td>\n",
       "      <td>5/18/2022</td>\n",
       "      <td>5/18/2022</td>\n",
       "      <td>3/4/2020</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6/22/2023</td>\n",
       "      <td>Indiana University, Indianapolis, Indiana, 462...</td>\n",
       "      <td>Informed Consent Form</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02172664</th>\n",
       "      <td>Clinical Evaluation of a Universal Adhesive in...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02172664</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this prospective clinical trial...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Cervical Lesions</td>\n",
       "      <td>PROCEDURE: Self etch enamel etching|PROCEDURE:...</td>\n",
       "      <td>Retention of Restorations, The primary outcome...</td>\n",
       "      <td>Number of Restoration Margins Marked as Staine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>Ivoclar Vivadent AG</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>33</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>IVOC2014</td>\n",
       "      <td>2014-06</td>\n",
       "      <td>2018-05</td>\n",
       "      <td>2018-05</td>\n",
       "      <td>6/24/2014</td>\n",
       "      <td>5/23/2019</td>\n",
       "      <td>5/28/2019</td>\n",
       "      <td>Indiana University School of Dentistry, Indian...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03881670</th>\n",
       "      <td>On-Eye Optical Quality of Lotrafilcon B Lenses...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03881670</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The current study aims to systematically inves...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Hyperopia|Myopia</td>\n",
       "      <td>DEVICE: Lotrafilcon B|DEVICE: lotrafilcon B wi...</td>\n",
       "      <td>Higher Order Aberrations, Higher-order Root Me...</td>\n",
       "      <td>Subjective Stability of Vision Rating, Subject...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>Alcon Research</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>24</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>Kollbaum002</td>\n",
       "      <td>12/7/2018</td>\n",
       "      <td>2/8/2019</td>\n",
       "      <td>2/8/2019</td>\n",
       "      <td>3/19/2019</td>\n",
       "      <td>2/3/2020</td>\n",
       "      <td>3/10/2020</td>\n",
       "      <td>Indiana University Clinical Optics Research La...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02569398</th>\n",
       "      <td>An Efficacy and Safety Study of Atabecestat in...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02569398</td>\n",
       "      <td>EARLY</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The purpose of this study is to evaluate wheth...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Asymptomatic Amyloid-positive</td>\n",
       "      <td>DRUG: Atabecestat, 5 mg|DRUG: Atabecestat, 25 ...</td>\n",
       "      <td>Change From Baseline in Preclinical Alzheimer ...</td>\n",
       "      <td>Change From Baseline in Cognitive Function Ind...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Janssen Research &amp; Development, LLC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>557</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CR107373|2015-000948-42|54861911ALZ2003</td>\n",
       "      <td>10/29/2015</td>\n",
       "      <td>12/20/2018</td>\n",
       "      <td>12/20/2018</td>\n",
       "      <td>10/6/2015</td>\n",
       "      <td>12/20/2019</td>\n",
       "      <td>2/10/2020</td>\n",
       "      <td>Birmingham, Alabama, United States|Phoenix, Ar...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[46514, 46202]</td>\n",
       "      <td>[Elkhart County, Marion County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03982199</th>\n",
       "      <td>A Study of an Ad26.RSV.preF-based Regimen in t...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03982199</td>\n",
       "      <td>CYPRESS</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to demonstrate th...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Respiratory Syncytial Viruses|Respiratory Trac...</td>\n",
       "      <td>BIOLOGICAL: RSV Vaccine|BIOLOGICAL: Placebo</td>\n",
       "      <td>Number of Participants With First Occurrence o...</td>\n",
       "      <td>Number of Participants With Any RT-PCR-confirm...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Janssen Vaccines &amp; Prevention B.V.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>5815</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CR108634|VAC18193RSV2001</td>\n",
       "      <td>8/1/2019</td>\n",
       "      <td>6/6/2022</td>\n",
       "      <td>5/26/2023</td>\n",
       "      <td>6/11/2019</td>\n",
       "      <td>6/6/2023</td>\n",
       "      <td>7/24/2023</td>\n",
       "      <td>Optimal Research, Huntsville, Alabama, 35802, ...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "      <td>[47714]</td>\n",
       "      <td>[Vanderburgh County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04585646</th>\n",
       "      <td>A Two-Week Crossover Dispensing Evaluation Of ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04585646</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective of the study is to evalu...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Myopia</td>\n",
       "      <td>DEVICE: Orion daily disposable contact lens|DE...</td>\n",
       "      <td>Subjective Response for Vision Satisfaction, S...</td>\n",
       "      <td>Subjective Overall Comfort Satisfaction, Overa...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Coopervision, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>64</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>CV-20-18</td>\n",
       "      <td>9/14/2020</td>\n",
       "      <td>11/30/2020</td>\n",
       "      <td>12/31/2020</td>\n",
       "      <td>10/14/2020</td>\n",
       "      <td>3/14/2022</td>\n",
       "      <td>5/10/2022</td>\n",
       "      <td>CORL, Indiana University, Bloomington, Indiana...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[47405]</td>\n",
       "      <td>[Monroe County]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02345889</th>\n",
       "      <td>A 4-arm Clinical Trial of Fuse®, EndoCuff™, En...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02345889</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Adenoma detection rate (ADR) is a validated ma...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Colorectal Neoplasms</td>\n",
       "      <td>DEVICE: Colonoscopy with EndoCuff™|DEVICE: FUS...</td>\n",
       "      <td>Adenomas Per Colonoscopy, During Procedure</td>\n",
       "      <td>Number of Participants With Detected Adenoma, ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1262</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1412036333</td>\n",
       "      <td>2015-02</td>\n",
       "      <td>2017-12</td>\n",
       "      <td>2017-12</td>\n",
       "      <td>1/26/2015</td>\n",
       "      <td>12/31/2018</td>\n",
       "      <td>3/12/2019</td>\n",
       "      <td>Indiana University Hospital, Indianapolis, Ind...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "      <td>[46202]</td>\n",
       "      <td>[Marion County]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   Study Title                                     Study URL        Acronym           Study Status                                      Brief Summary Study Results                                         Conditions                                      Interventions                           Primary Outcome Measures                         Secondary Outcome Measures                             Other Outcome Measures                                            Sponsor                                      Collaborators     Sex                        Age         Phases Enrollment Funder Type      Study Type                                       Study Design                                          Other IDs  Start Date Primary Completion Date Completion Date First Posted Results First Posted Last Update Posted                                          Locations                                    Study Documents  \\\n",
       "NCT Number                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "NCT03192488  Effect of an H1 Receptor Antagonist on Exercis...  https://clinicaltrials.gov/study/NCT03192488            NaN              COMPLETED  This study seeks to determine whether a simple...           YES                                  Hypoxia, Altitude  DRUG: Cetirizine|DRUG: Placebo oral capsule|OT...  Performance Time, Time to complete 8km cycling...  Plasma Histamine Concentrations at Baseline an...                                                NaN                                 Indiana University                                                NaN     ALL                      ADULT         PHASE4         13       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                         1702396373   8/31/2017                6/6/2018        6/6/2018    6/20/2017             5/7/2019          6/16/2020  Indiana University, Bloomington, Indiana, 4740...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04623242  Dominantly Inherited Alzheimer Network Trial: ...  https://clinicaltrials.gov/study/NCT04623242        DIAN-TU              COMPLETED  The purpose of this study is to assess the saf...           YES  Alzheimers Disease|Dementia|Alzheimers Disease...  DRUG: Gantenerumab|DRUG: Solanezumab|DRUG: Mat...  Assess Cognitive Efficacy in Individuals With ...  Gantenerumab: Rate of Change Over Time- Clinic...                                                NaN           Washington University School of Medicine  Eli Lilly and Company|Hoffmann-La Roche|Alzhei...     ALL         ADULT, OLDER_ADULT  PHASE2|PHASE3        194       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...  DIAN-TU-001 (gant-sola)|The Alzheimer's Associ...     2012-12              11/22/2019        3/6/2020   11/10/2020            2/27/2021          9/22/2022  University of Alabama in Birmingham, Birmingha...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02754661  Colon Capsule Endoscopy (CCE) Versus Computed ...  https://clinicaltrials.gov/study/NCT02754661          TOPAZ              COMPLETED  The primary objective of this multicenter, pro...           YES                        Colorectal Cancer Screening  DEVICE: COLON Capsule endoscopy|DEVICE: Comput...  Number of Participants With an Actionable Lesi...  Sensitivity of CCE Versus CTC in the Detection...                                                NaN                                   Medtronic - MITG                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        320    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                 COVGIC20543|MA-213     2016-09                8/7/2018        8/7/2018    4/28/2016             8/1/2019          10/1/2019  University of South Alabama, Mobile, Alabama, ...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03132753  Developing SUPPORT, a Community-Driven, Recove...  https://clinicaltrials.gov/study/NCT03132753        SUPPORT              COMPLETED  The investigators seek to develop and assess t...           YES                                      Substance Use                                BEHAVIORAL: SUPPORT  Number of Participants Reporting Substance Use...  Difference in Self Determination, The Self-Det...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        100       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1511731907  10/23/2017               1/30/2020       9/30/2020    4/28/2017            7/31/2020           2/3/2022  Public Advocates in Community Re-Entry (PACE),...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT04267562  Minitouch Endometrial Ablation System Treatmen...  https://clinicaltrials.gov/study/NCT04267562            NaN  ACTIVE_NOT_RECRUITING  The EASE Clinical Trial is prospective, multi-...           YES  Menorrhagia|Heavy Menstrual Bleeding|Heavy Ute...                           DEVICE: Minitouch System  Number of Trial Participants With Reduction in...  Number of Trial Participants That Underwent Su...                                                NaN                                     MicroCube, LLC                                                NaN  FEMALE                      ADULT            NaN        219    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                            TD18036   2/28/2020               7/20/2022         2023-12    2/13/2020            8/28/2023         10/23/2023  CMB Research, Newburgh, Indiana, 47630, United...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03418662      EndoRings Colonoscopy vs Standard Colonoscopy  https://clinicaltrials.gov/study/NCT03418662            NaN              COMPLETED  The study aims to compare the results between ...           YES   Colorectal Adenoma|Colorectal Polyp|Colon Cancer                           DEVICE: EndoRings device  Adenoma Detection Rates, Number of participant...  Polyp Detection Rate, Number of subjects with ...                                                NaN                                 Indiana University                                       US Endoscopy     ALL  CHILD, ADULT, OLDER_ADULT            NaN        592       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1711224972   1/19/2018               9/13/2018       9/13/2018     2/1/2018            7/30/2019          9/20/2019  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03059810  Clinical Evaluation of Investigational Multifo...  https://clinicaltrials.gov/study/NCT03059810            NaN              COMPLETED  3-visit dispensing study to evaluate the subje...           YES                                      Visual Acuity                                DEVICE: etafilcon A  Overall Vision, Overall vision was assessed us...                                                NaN                                                NaN                Johnson & Johnson Vision Care, Inc.                                                NaN     ALL         ADULT, OLDER_ADULT            NaN         72    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                            CR-5903   1/27/2017               4/25/2017       4/25/2017    2/23/2017            12/6/2019         12/24/2019  EYE Center Optometric, Rocklin, California, 95...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04516746  Phase III Double-blind, Placebo-controlled Stu...  https://clinicaltrials.gov/study/NCT04516746            NaN              COMPLETED  The aim of the study is to assess the safety, ...           YES                                COVID-19|SARS-CoV-2            BIOLOGICAL: AZD1222|BIOLOGICAL: Placebo  Number of Participants Achieving Binary Respon...  Number of Participants With First Post-interve...                                                NaN                                        AstraZeneca                                      Iqvia Pty Ltd     ALL         ADULT, OLDER_ADULT         PHASE3      32459    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                        D8110C00001   8/28/2020                3/5/2021       2/10/2023    8/18/2020             3/3/2022           4/7/2023  Research Site, Phoenix, Arizona, 85018, United...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04811664  A Study of SARS CoV-2 Infection and Potential ...  https://clinicaltrials.gov/study/NCT04811664     CoVPN 3006              COMPLETED  The purpose of this study is to assess SARS Co...           YES                               SARS-CoV-2 Infection               BIOLOGICAL: Moderna COVID-19 Vaccine  Efficacy of Moderna COVID-19 Vaccine Against S...  Efficacy of Moderna COVID-19 Vaccine Against C...                                                NaN  National Institute of Allergy and Infectious D...                                                NaN     ALL                      ADULT         PHASE3       1923         NIH  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                         CoVPN 3006   3/24/2021              12/30/2021      12/30/2021    3/23/2021            5/30/2023           8/2/2023  Alabama CRS, Birmingham, Alabama, 35222, Unite...  Study Protocol and Informed Consent Form|Stati...   \n",
       "NCT03131453  A Study of CNP520 Versus Placebo in Participan...  https://clinicaltrials.gov/study/NCT03131453            GS2             TERMINATED  The purpose of this study is to determine the ...           YES                                 Alzheimers Disease  DRUG: CNP520 50mg|DRUG: CNP520 15mg|OTHER: Mat...  Time to Event (Diagnosis of Mild Cognitive Imp...  Change in Clinical Dementia Rating Scale Sum o...                                                NaN                           Novartis Pharmaceuticals                 Amgen|Banner Alzheimer's Institute     ALL         ADULT, OLDER_ADULT  PHASE2|PHASE3       1145    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                       CCNP520A2202J|2016-002976-28    8/3/2017               3/26/2020       3/26/2020    4/27/2017            3/25/2021           8/5/2021  Banner Alzheimer's Institute, 901 East Willett...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03547167  A Study to Evaluate the Safety, Tolerability, ...  https://clinicaltrials.gov/study/NCT03547167            NaN              COMPLETED  This study is designed to 1) describe the safe...           YES                            Pneumococcal Infections  BIOLOGICAL: V114|BIOLOGICAL: Prevnar 13™|BIOLO...  Percentage of Participants With Solicited Inje...  Percentage of Participants With Solicited Inje...                                                NaN                            Merck Sharp & Dohme LLC                                                NaN     ALL                      ADULT         PHASE3       1515    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                   V114-017|2017-004915-38|V114-017   7/16/2018               1/20/2020       1/20/2020     6/6/2018           12/14/2020          1/15/2021  Chinle Comprehensive Health Care Facility ( Si...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT05091307  A Study of Ad26.COV2.S and Influenza Vaccines ...  https://clinicaltrials.gov/study/NCT05091307            NaN              COMPLETED  The purpose of this study is to demonstrate th...           YES                                COVID-19 Prevention  BIOLOGICAL: Ad26.COV2.S|OTHER: Placebo|BIOLOGI...  Groups 1 and 2: Geometric Mean Titers (GMTs) o...  Number of Participants With Solicited Local Ad...                                                NaN                 Janssen Vaccines & Prevention B.V.                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3        861    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...            CR109083|2021-003953-43|VAC31518COV3005   11/2/2021               6/17/2022      11/15/2022   10/25/2021            6/16/2023           8/8/2023  Fiel Family and Sports Medicine Clinical Resea...  Study Protocol|Statistical Analysis Plan|Infor...   \n",
       "NCT03182920      A Study of Lasmiditan in Healthy Participants  https://clinicaltrials.gov/study/NCT03182920            NaN              COMPLETED  The purpose of this study is to look at the am...           YES                                            Healthy                     DRUG: Lasmiditan|DRUG: Placebo  Pharmacokinetics (PK): Maximum Observed Drug C...                                                NaN                                                NaN                              Eli Lilly and Company                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE1         35    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                  16852|H8H-MC-LAHA   6/16/2017               8/14/2017       8/14/2017     6/9/2017            11/8/2019           1/7/2020  Covance Daytona Beach, Daytona Beach, Florida,...           Statistical Analysis Plan|Study Protocol   \n",
       "NCT05051982             Sedline EEG Guided Depth of Anesthesia  https://clinicaltrials.gov/study/NCT05051982            NaN              COMPLETED  The purpose of our study is to determine if mo...            NO                                 Anesthesia|Surgery                        DEVICE: Sedline EEG in View  Total Average Anesthetic, total average percen...  Total Hypnotic agents, the total dosage of hyp...                                                NaN                                 Indiana University                                                NaN     ALL                OLDER_ADULT            NaN        110       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                              10708   6/30/2021              11/14/2022      11/14/2022    9/21/2021                  NaN          7/11/2023  IU Health University Hospital, Indianapolis, I...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03822182  Single Shot Liposomal Bupivicaine in Rotator C...  https://clinicaltrials.gov/study/NCT03822182            NaN              COMPLETED  This document is a protocol for a human resear...           YES              Rotator Cuff Tear|Pain, Postoperative    DRUG: liposomal bupivicaine|DRUG: Dexamethasone  Patient Reported Postoperative Pain: VAS, Pati...  Patient Reported Post Operative Opioid Use, Pa...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE4         78       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1806933448  10/24/2018               1/22/2020       1/22/2020    1/30/2019            4/28/2020         11/12/2020  American Health Network, Avon, Indiana, 46123,...  Informed Consent Form|Study Protocol and Stati...   \n",
       "NCT01781975  Imatinib Treatment in Recent Onset Type 1 Diab...  https://clinicaltrials.gov/study/NCT01781975            NaN              COMPLETED  Type 1 diabetes mellitus (T1DM) results from t...           YES  Diabetes Mellitus, Type I|Diabetes Mellitus, I...  DRUG: Imatinib Mesylate|DRUG: Placebo (For ima...  Area Under the Stimulated C-peptide Curve (AUC...  Area Under the Stimulated C-peptide Curve (AUC...                                                NaN            University of California, San Francisco              Juvenile Diabetes Research Foundation     ALL                      ADULT         PHASE2         67       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                          17-2013-6     2014-01                 2017-05         2018-05     2/1/2013            5/25/2018          2/11/2020  University of California-San Francisco, San Fr...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04208750  Clinical Investigation of the Vision-R800 Device.  https://clinicaltrials.gov/study/NCT04208750            NaN              COMPLETED  Randomized, bilateral, cross-over dispensing s...           YES            Myopia|Hyperopia|Astigmatism|Presbyopia  DEVICE: Vision R-800 Phoropter|DEVICE: Standar...  Subjective Questionnaire Response, Patient que...                                                NaN                                                NaN                             Pete Kollbaum, OD, PhD                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE4        119       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                        Kollbaum003  11/18/2019                2/1/2021        2/1/2021   12/23/2019             1/6/2022          3/14/2022  Indiana University Clinical Optics Research La...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT01779375                    RISE Pediatric Medication Study  https://clinicaltrials.gov/study/NCT01779375      RISE Peds              COMPLETED  The RISE Pediatric Medication Study is a 2-arm...           YES                        Prediabetes|Type 2 Diabetes                     DRUG: Metformin|DRUG: Glargine  ß-cell Response Measured by Hyperglycemic Clam...  ACPRg, First phase response, 3-months after a ...  OGTT Measures of ß-cell Function and Glucose T...                                   RISE Study Group  National Institute of Diabetes and Digestive a...     ALL               CHILD, ADULT         PHASE3         91     NETWORK  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                     RISE Pediatric|5U01DK094406-02   6/16/2013               7/12/2017         2018-04    1/30/2013            8/30/2018          4/14/2023  Childrens Hospital Colorado, Denver, Colorado,...  Study Protocol|Statistical Analysis Plan|Infor...   \n",
       "NCT04633837  Examining the Effectiveness of a Connective Ti...  https://clinicaltrials.gov/study/NCT04633837            ECM             TERMINATED  This document is a protocol for a human resear...           YES  Arthroscopic Shoulder Surgery|Pain, Postoperative  DEVICE: Extracellular Matrix Graft Injectable ...  Patient Reported Post Operative Opioid Use, Ut...  American Shoulder and Elbow Scores, To determi...  Patient Reported Single Assessment Numeric Eva...                                       Brian Badman                                     CTM Biomedical     ALL                      ADULT            NaN         15       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                            1294348   12/4/2020               11/7/2021       11/7/2021   11/18/2020           11/12/2021           1/6/2022  American Health Network, Avon, Indiana, 46123,...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT03383783  Evaluation of the Fluoride Dose Response of a ...  https://clinicaltrials.gov/study/NCT03383783            NaN              COMPLETED  The purpose of this study is to evaluate the f...           YES                                             Caries  DRUG: 0 ppm F (placebo, negative control)|DRUG...  Percentage Surface Microhardness Recovery (%SM...  Net Acid Resistance (NAR), The %NAR will be ca...                                                NaN                                      Domenick Zero                                    GlaxoSmithKline     ALL         ADULT, OLDER_ADULT         PHASE3         28       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                    17-I-112|208705  12/19/2017                5/2/2018        5/2/2018   12/26/2017            4/25/2019          5/20/2019  Indiana University School of Dentistry, Oral H...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04370756  Beetroot Supplementation in Women Enjoying Exe...  https://clinicaltrials.gov/study/NCT04370756      BEE SWEET  ACTIVE_NOT_RECRUITING  This study seeks to determine the feasibility ...            NO                        Aging|Postmenopause|Obesity  DIETARY_SUPPLEMENT: Beetroot Juice|OTHER: Exer...  Recruitment rate, The number of eligible parti...  Distance covered during a six-minute walk test...                                                NaN                                 Indiana University  IU Health University Hospital|Indiana CTSI Cli...  FEMALE         ADULT, OLDER_ADULT            NaN         36       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1907026303   1/30/2020                 2023-12         2023-12     5/1/2020                  NaN          6/28/2023  Indiana University, Bloomington, Indiana, 4740...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT05227300  Buffered vs. Unbuffered Local Anesthesia in Ma...  https://clinicaltrials.gov/study/NCT05227300            NaN             RECRUITING  The purpose of this study is to determine whet...            NO                  Symptomatic Irreversible Pulpitis  DRUG: Onset Sodium Bicarbonate Inj., 8.4%, USP...  Profoundness of pulpal anesthesia, Number of P...  Onset of pulpal anesthesia, Duration of time r...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE4         40       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                              11447   2/14/2022               5/31/2022       5/31/2022     2/7/2022                  NaN          3/29/2022  Indiana University School of Dentistry Graduat...                              Informed Consent Form   \n",
       "NCT03029000  Study of the Effect of a 5-Day Regimen of Stud...  https://clinicaltrials.gov/study/NCT03029000         GRANIX             TERMINATED  A multi-center, open-label, single-arm clinica...           YES                               Healthy Participants                               DRUG: Tbo-filgrastim  Percentage of Participants With at Least 2*10^...  Percentage of Participants With at Least 2*10^...                                                NaN     Teva Branded Pharmaceutical Products R&D, Inc.                                                NaN     ALL                      ADULT         PHASE3          1    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                  TV44688-ONC-30054    8/2/2017              10/30/2017      10/30/2017    1/23/2017           11/14/2018         12/13/2022  Teva Investigational Site 14029, Duarte, Calif...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02618967  Single Ascending Dose Study of AMG 570 in Heal...  https://clinicaltrials.gov/study/NCT02618967            NaN              COMPLETED  The purpose of this study is to obtain initial...           YES                       Systemic Lupus Erythematosus  BIOLOGICAL: AMG 570|BIOLOGICAL: AMG 570 Matchi...  Number of Participants Who Experienced One or ...  Maximum Observed Concentration (Cmax) of AMG 5...                                                NaN                                              Amgen                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE1         56    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: SIN...                                           20140322   3/28/2016                9/6/2018       12/3/2018    12/2/2015             8/5/2021         10/15/2021  Research Site, Evansville, Indiana, 47710, Uni...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03349567  Improving Antimicrobial-Prescribing in Emergen...  https://clinicaltrials.gov/study/NCT03349567            NaN              COMPLETED  Antimicrobial resistance is one of today's mos...           YES  Anti-Bacterial Agents|Respiratory Tract Infect...                     BEHAVIORAL: Audit-and-feedback  Percentage of Patient-visits Prescribed an Ant...  Percentage of Patient-visits Prescribed a Late...                                                NaN          Iowa City Veterans Affairs Medical Center                            Merck Sharp & Dohme LLC     ALL  CHILD, ADULT, OLDER_ADULT            NaN         27         FED  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                                          201708772   10/9/2018               9/30/2019      10/31/2019   11/21/2017            1/25/2021          4/28/2021  Richard Roudebush VAMC, Indianapolis, Indiana,...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03086447            Evaluation of Astigmatic Contact Lenses  https://clinicaltrials.gov/study/NCT03086447            NaN              COMPLETED  Randomized, double-masked, 5-visit, bilateral ...           YES                                      Visual Acuity  DEVICE: Investigational Contact Lens|DEVICE: M...  Monocular Distance Visual Acuity (VA), Monocul...  Overall Comfort, Overall comfort was assessed ...                                                NaN                Johnson & Johnson Vision Care, Inc.                                                NaN     ALL                      ADULT            NaN        267    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                            CR-5871    3/1/2017                5/4/2017        5/4/2017    3/22/2017            4/30/2018          7/10/2018  Golden Optometric Group, Whittier, California,...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03063437  A Trial of Encapsulated Fecal Microbiota for V...  https://clinicaltrials.gov/study/NCT03063437            NaN              COMPLETED  The objective of this study is to provide prel...           YES                        Antibiotic Resistant Strain  BIOLOGICAL: Encapsulated fecal microbiota prep...  Percentage of Participants With VRE Decoloniza...  Percentage of Participants With VRE Infection,...  Microbiome Disruption, To evaluate the microbi...               Microbiome Health Research Institute  University of Wisconsin, Madison|Indiana Unive...     ALL         ADULT, OLDER_ADULT         PHASE2          9       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                     200-2016-91948   8/17/2017               9/19/2018       2/26/2019    2/24/2017            1/15/2020          4/13/2020  IU Health University Hospital, Indianapolis, I...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03628885  An Evaluation of Tailored Messages to Address ...  https://clinicaltrials.gov/study/NCT03628885            NaN              COMPLETED  The purpose of this study is to investigate mo...           YES  Human Papilloma Virus Vaccines|Attitude to Health  BEHAVIORAL: Top Concern Tailored Intervention|...  Intention to Vaccinate Against HPV in the Next...                                                NaN                                                NaN                                 Indiana University                                                NaN  FEMALE         ADULT, OLDER_ADULT            NaN        908       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: FAC...                                         1807664964   9/11/2018               9/27/2018       9/27/2018    8/14/2018           12/20/2018           4/2/2019  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04505722  A Study of Ad26.COV2.S for the Prevention of S...  https://clinicaltrials.gov/study/NCT04505722       ENSEMBLE              COMPLETED  The study will evaluate the efficacy of Ad26.C...           YES  Participants With or Without Stable Co-morbidi...             BIOLOGICAL: Ad26.COV2.S|OTHER: Placebo  Number of Participants With First Occurrence o...  Number of Participants With First Occurrence o...                                                NaN                 Janssen Vaccines & Prevention B.V.                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3      44325    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                           CR108876|VAC31518COV3001    9/7/2020               3/31/2023       3/31/2023    8/10/2020            1/25/2022           5/6/2023  Synexus Clinical Research US, Inc, Birmingham,...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02576847  Study to Evaluate the Long-term Safety of a On...  https://clinicaltrials.gov/study/NCT02576847            NaN              COMPLETED  This study evaluates the long-term safety of o...           YES                                            Rosacea                                     DRUG: Omiganan  Number of Subjects With 1 or More Treatment-re...                                                NaN                                                NaN                                   Maruho Co., Ltd.                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3        307    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                   CLS001-CO-PR-006     2015-10               7/14/2017        2/8/2018   10/15/2015            6/13/2022          7/19/2022  Fremont, California, United States|Miami, Flor...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03427047  Comparing Surgical and Economical Parameters o...  https://clinicaltrials.gov/study/NCT03427047            NaN              COMPLETED  Randomized study comparing surgical and econom...           YES       Osteo Arthritis Knee|Total Knee Arthroplasty  DEVICE: MyKnee with single use Efficiency Inst...  Compare Time-saving Associated With the Two Pr...  Estimated Blood Loss From Both Study Arms, Vol...                                                NaN                                        Medacta USA                                                NaN     ALL  CHILD, ADULT, OLDER_ADULT            NaN         82    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                    MyKnee 20170612    8/1/2018                1/1/2022        1/1/2022     2/9/2018            3/17/2023          6/13/2023  Methodist Sports Medicine Research & Education...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03727347         Posterior Nasal Nerve (PNN) Rhinitis Study  https://clinicaltrials.gov/study/NCT03727347            NaN              COMPLETED  Evaluation of the Aerin Medical Device used fo...           YES                                   Chronic Rhinitis                              DEVICE: InSeca Stylus  Change in Reflective Total Nasal Symptom Score...                                                NaN  rTNSS Responder Rate, The Reflective Total Nas...                                      Aerin Medical                                                NaN     ALL         ADULT, OLDER_ADULT            NaN         50    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                              TP668  10/16/2018                2/1/2020       9/17/2020    11/1/2018            5/21/2021          6/16/2021  Colorado ENT and Allergy, Colorado Springs, Co...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03400787  Latera RCT - Latera vs. Sham Control for Later...  https://clinicaltrials.gov/study/NCT03400787            NaN              COMPLETED  The primary objective of the LATERA RCT is to ...           YES               Nasal Valve Collapse|Nasal Breathing      DEVICE: Latera Implant|DEVICE: Sham Procedure  NOSE Responder Rate, The primary endpoint of t...  Responder Rate, Responder Rate at 7 days, 30 d...                                                NaN                                       Spirox, Inc.                                New Arch Consulting     ALL         ADULT, OLDER_ADULT            NaN        137    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                              CP 04  11/28/2017                2/1/2019      12/23/2020    1/17/2018           11/25/2019           2/9/2021  Sacramento ENT, Roseville, California, 95661, ...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03037307  A Clinical Bite Force Study of Two Marketed Ad...  https://clinicaltrials.gov/study/NCT03037307            NaN              COMPLETED  The objective of this study will be to compare...           YES                                  Denture Retention  OTHER: Test Product|OTHER: Positive Contol|OTH...  Area Over Baseline Over 12 Hours (AOB0-12) for...                                                NaN                                                NaN                                    GlaxoSmithKline                                                NaN     ALL         ADULT, OLDER_ADULT            NaN         44    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                             207545   2/13/2017                5/4/2017        5/4/2017    1/31/2017            4/20/2018          8/31/2018  GSK Investigational Site, Indianapolis, Indian...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03257007  Mindfulness to Enhance Quality of Life and Sup...  https://clinicaltrials.gov/study/NCT03257007        MEANING              COMPLETED  The MEANING trial is a randomized controlled m...            NO  Mindfulness|Meditation|Metastatic Cancer|Quali...                            BEHAVIORAL: Mindfulness  Change from baseline in quality of life (QoL) ...  Change from baseline in advance care planning ...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        108       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1702223546    5/9/2017              12/11/2017      12/11/2017    8/22/2017                  NaN          8/12/2020  Indiana University, Indianapolis, Indiana, 462...                              Informed Consent Form   \n",
       "NCT06001866  Retrieval-Based Word Learning in Developmental...  https://clinicaltrials.gov/study/NCT06001866            NaN             RECRUITING  Children with developmental language disorder ...            NO  Developmental Language Disorder|Specific Langu...          BEHAVIORAL: Retrieval-based verb learning  Word form recall accuracy (number of verbs cor...  Number of correctly identified words on Peabod...                                                NaN                                  Purdue University  National Institute on Deafness and Other Commu...     ALL                      CHILD            NaN         32       OTHER  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                            1603017480B|R01DC014708    3/1/2023               7/31/2026       7/31/2026    8/21/2023                  NaN          8/21/2023  Purdue University, West Lafayette, Indiana, 47...                              Informed Consent Form   \n",
       "NCT04699812  Atrial Fibrillation Algorithms Clinical Valida...  https://clinicaltrials.gov/study/NCT04699812            NaN              COMPLETED  The purpose of the study is to evaluate the pe...           YES                                Atrial Fibrillation         DEVICE: ELECTROCARDIOGRAM (ECG) PATCH WEAR  SENSITIVITY OF IRREGULAR RHYTHM NOTIFICATION F...  POSITIVE PREDICTIVE VALUE OF IRREGULAR RHYTHM ...                                                NaN                                         Apple Inc.                                      Iqvia Pty Ltd     ALL         ADULT, OLDER_ADULT            NaN        573    INDUSTRY  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                                          099-25141  11/16/2020               4/19/2021      12/17/2021     1/7/2021             7/1/2022          8/24/2022  Clinical Research of South Florida, Coral Gabl...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03434392  QST Study: Predicting Treatment Response in Ch...  https://clinicaltrials.gov/study/NCT03434392            NaN             RECRUITING  Quantitative Sensory Testing (QST) is a novel ...            NO                  Chronic Pancreatitis|Chronic Pain  DIAGNOSTIC_TEST: Quantitative Sensory Test 1|D...  Pain Pattern Assessment as assessed by the com...  Change in Mean Pain score, In Definite CP Pati...                                                NaN                                Anna Evans Phillips        Johns Hopkins University|Aalborg University     ALL         ADULT, OLDER_ADULT            NaN        500       OTHER  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                                        PRO17060648  10/24/2017              11/15/2023      11/15/2023    2/15/2018                  NaN         12/20/2022  Indiana University Medical Center, Indianapoli...                                     Study Protocol   \n",
       "NCT04065451     Effect of Epinephrine on Post-polypectomy Pain  https://clinicaltrials.gov/study/NCT04065451            NaN              COMPLETED  Epinephrine is widely used in endoscopic mucos...           YES                                      Colonic Polyp                                  DRUG: Epinephrine  Immediate Post-polypectomy Pain, Pain related ...  en Bloc Resection, Number of polyps removed en...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE4         22       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1908473351    1/6/2020               8/17/2021       8/17/2021    8/22/2019            6/23/2022          9/30/2022  Indiana University Hospital, Indianapolis, Ind...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04445155            The DECIDE Parent-Provider Intervention  https://clinicaltrials.gov/study/NCT04445155            NaN              COMPLETED  The DECIDE Parent-Provider Intervention is des...            NO  Modified DECIDE Intervention|Treatment as Usua...  BEHAVIORAL: Modified DECIDE Parent and Provide...  Parent Activation Measure Mental Health (P-PAM...                                                NaN  Pre-test, 5 question survey that measures the ...                                 Indiana University  Smith College|University of South Florida|Nati...     ALL         ADULT, OLDER_ADULT            NaN         89       OTHER  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                         1911897011|5R21MD015150-02   10/1/2020              12/30/2022      12/30/2022    6/24/2020                  NaN          4/26/2023  Centerstone, Sarasota, Florida, 34233, United ...               Study Protocol|Informed Consent Form   \n",
       "NCT01887912  Study of a Candidate Clostridium Difficile Tox...  https://clinicaltrials.gov/study/NCT01887912            NaN             TERMINATED  The aim of this study was to evaluate the effi...           YES                    Clostridium Difficile Infection  BIOLOGICAL: C. difficile Toxoid Vaccine|BIOLOG...  Number of Participants With Symptomatic Polyme...  Number of Participants With Severe PCR-Confirm...                                                NaN                   Sanofi Pasteur, a Sanofi Company                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3       9302    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...           H-030-014|2013-000775-32|U1111-1127-7162   7/30/2013               6/12/2018       6/12/2018    6/27/2013            6/11/2019          3/28/2022  Huntsville, Alabama, 35803, United States|Inve...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02374671  A Clinical Trial of The VisAbility Micro Inser...  https://clinicaltrials.gov/study/NCT02374671            NaN              COMPLETED  The purpose of this study is to evaluate the s...           YES                                         Presbyopia                    DEVICE: VisAbility Micro Insert  Number of Primary Eyes With Distance Corrected...  Number of Primary Eyes With DCNVA 20/40 of Bet...                                                NaN                                Refocus Group, Inc.                                                NaN     ALL                      ADULT            NaN        365    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                           VIS-2014  11/15/2014               4/13/2018       4/13/2018     3/2/2015           10/15/2019           1/6/2020  Coastal Vision, Orange, California, 92868, Uni...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03664739  Study Comparing the Safety and Efficacy of IDP...  https://clinicaltrials.gov/study/NCT03664739            NaN              COMPLETED  study designed to assess the safety, tolerabil...           YES                                      Acne Vulgaris        DRUG: IDP-120 Gel|DRUG: IDp-120 Vehicle Gel  Absolute Change in Mean Lesion Counts at Week ...  Percentage Change in Mean Lesion Counts at Wee...                                                NaN                       Bausch Health Americas, Inc.                                                NaN     ALL  CHILD, ADULT, OLDER_ADULT         PHASE3        608    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                       V01-120A-301   12/5/2018               3/23/2020       3/23/2020    9/10/2018             3/3/2023          3/29/2023  Valeant Site 123, Mobile, Alabama, 36608, Unit...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03345108  A Study to Investigate a Method to Measure Foo...  https://clinicaltrials.gov/study/NCT03345108            NaN              COMPLETED  The purpose of this study is to evaluate a met...           YES                                  Denture Retention  DEVICE: Denture Adhesive Cream (Conventional A...  Mass of Peanuts Under Combined Maxillary and M...                                                NaN                                                NaN                                    GlaxoSmithKline                                                NaN     ALL         ADULT, OLDER_ADULT            NaN         48    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                             208397  11/20/2017              12/15/2017      12/15/2017   11/17/2017           12/14/2018          3/29/2019  GSK Investigational Site, Fort Wayne, Indiana,...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02743871  Study Of PF-06817024 In Healthy Subjects, In P...  https://clinicaltrials.gov/study/NCT02743871            NaN              COMPLETED  The purpose of this study is to evaluate safet...           YES  Healthy|Chronic Rhinosinusitis With Nasal Poly...  BIOLOGICAL: PF-06817024|OTHER: Placebo for PF-...  Number of Participants With All-causality Trea...  Maximum Observed Serum Concentration (Cmax) of...                                                NaN                                             Pfizer                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE1         97    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: SEQ...                                           C0341001   4/27/2016                3/9/2021        3/9/2021    4/19/2016            2/28/2022          5/19/2022  UC Davis Dermatology, Sacramento, California, ...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03227471  A Study of VX-445 in Healthy Subjects and Subj...  https://clinicaltrials.gov/study/NCT03227471            NaN              COMPLETED  This is a first-in-human and proof-of-concept ...           YES                                    Cystic Fibrosis  DRUG: IVA|DRUG: TEZ/IVA|DRUG: VX-445|DRUG: Mat...  Parts A, B and C: Number of Participants With ...  Part A: Maximum Observed Concentration (Cmax) ...                                                NaN                Vertex Pharmaceuticals Incorporated                                                NaN     ALL         ADULT, OLDER_ADULT  PHASE1|PHASE2        225    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                        VX16-445-001|2017-000797-11   1/23/2017               3/27/2018       3/27/2018    7/24/2017            11/9/2021          1/18/2022  Banner University of Arizona Medical Center, T...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03336268  Project POINT: Effectiveness and Scalability o...  https://clinicaltrials.gov/study/NCT03336268          POINT              COMPLETED  The investigators seek to assess the effective...           YES                   Substance Use Disorders|Overdose                                  BEHAVIORAL: POINT  Opioid Overdose, Total participants presenting...  Medication for Opioid Use Disorder (MOUD) Enga...                                                NaN                                 Indiana University            National Institute on Drug Abuse (NIDA)     ALL         ADULT, OLDER_ADULT            NaN        249       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                             1706859955|R33DA045850   2/12/2018               12/9/2021       12/9/2021    11/8/2017            2/20/2023          10/6/2023  Indiana University Health Methodist Hospital, ...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT03231917  Water Immersion and Polyp Detection: A Randomi...  https://clinicaltrials.gov/study/NCT03231917            NaN              COMPLETED  We plan to conduct a randomized trial of tande...           YES                          Adenoma|Colonic Neoplasms  PROCEDURE: Water Infusion first|PROCEDURE: CO2...  Adenoma Miss Rate, Adenoma-level miss rates wi...  Patient-level Miss Rate, Patient-level miss ra...                                                NaN  White River Junction Veterans Affairs Medical ...                                 Indiana University     ALL         ADULT, OLDER_ADULT            NaN        121         FED  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                          1000344-1    3/1/2017               8/31/2018       8/31/2018    7/27/2017            10/1/2018          7/12/2019  University of Connecticut Health Center, Farmi...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT05471726         Improving Post-discharge Antimicrobial Use  https://clinicaltrials.gov/study/NCT05471726            NaN             RECRUITING  One in five hospitalized patients is prescribe...            NO                                         Infections         BEHAVIORAL: Prospective audit-and-feedback  Post-discharge antibiotic length of therapy, T...  Inpatient antibiotic length of therapy, Inpati...                                                NaN          Iowa City Veterans Affairs Medical Center         Centers for Disease Control and Prevention     ALL         ADULT, OLDER_ADULT            NaN         10         FED  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: SEQ...                                      IRB 202109288   5/22/2023              11/19/2023      12/19/2023    7/25/2022                  NaN          5/25/2023  Richard Roudebush VA Medical Center, Indianapo...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03355326  Evaluation of Glycerin Suppositories to Improv...  https://clinicaltrials.gov/study/NCT03355326            NaN             TERMINATED  Gastroschisis is a congenital defect of the ab...           YES                                      Gastroschisis                         DRUG: Glycerin Suppository  Time to Full Enteral Feeds, time from study st...  Time to First Bowel Movement, time from study ...                                                NaN                                 Indiana University                                                NaN     ALL                      CHILD         PHASE4         16       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                  IU-IRB-1611267731   10/1/2017               10/1/2020       10/1/2020   11/28/2017            7/20/2021         10/12/2021  Riley Hospital for Children, Indianapolis, Ind...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT03090191       Clostridium Difficile Vaccine Efficacy Trial  https://clinicaltrials.gov/study/NCT03090191         Clover              COMPLETED  The Clover trial is evaluating an investigatio...           YES                    Clostridium Difficile Infection  BIOLOGICAL: Clostridium difficile vaccine|BIOL...  Number of First Primary Episodes of Clostridiu...  Number of All Episodes of CDI (Definition 1 an...                                                NaN                                             Pfizer                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3      17535    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                     B5091007|2016-003866-14|CLOVER   3/29/2017              12/21/2021      12/21/2021    3/24/2017           11/30/2022          2/13/2023  North Alabama Research Center, LLC, Athens, Al...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT05466617  Gamified App on Increasing Physical Activity a...  https://clinicaltrials.gov/study/NCT05466617            NaN              COMPLETED  Background: Physical activity (PA) has an impa...            NO  Autism Spectrum Disorder|Physical Activity|Anx...  BEHAVIORAL: Mobile Health for Physical Activit...  Baseline Physical Activity and Changes from Ba...  Baseline Anxiety and Changes from Baseline Anx...                                                NaN                                 Indiana University     American College of Sports Medicine Foundation     ALL         ADULT, OLDER_ADULT            NaN         24       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1807483245    7/1/2019               3/15/2020       5/30/2020    7/20/2022                  NaN          7/20/2022  Indiana University School of Public Health, Bl...                              Informed Consent Form   \n",
       "NCT03361917  Standard Colonoscopy Versus Colonoscopy With E...  https://clinicaltrials.gov/study/NCT03361917            NaN              COMPLETED  This study seeks to compare colonoscopy result...           YES   Colorectal Polyp|Colorectal Adenoma|Colon Cancer                            DEVICE: Endocuff Vision  Inspection Time Comparisons for Each Method (S...  Insertion Time Comparisons for Each Method (St...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        200       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1709336500  12/11/2017               4/18/2018       4/18/2018    12/5/2017             4/5/2019           8/6/2019  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03350217  A Comparison of Eleview Versus Hetastarch as I...  https://clinicaltrials.gov/study/NCT03350217            NaN              COMPLETED  EMR is a technique used for the removal of fla...           YES  Procedural Bleeding|Delayed Bleeding|Post-Poly...                     DRUG: Eleview|DRUG: Hetastarch  Sydney Resection Quotient (SRQ), Comparison of...  Injected Volume Needed for Initial Lesion Lift...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE4        160       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1706751368   10/9/2017                1/7/2019        1/7/2019   11/22/2017            11/5/2019         12/17/2019  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04512482  Evaluation of Oral Plaque Removal Utilizing an...  https://clinicaltrials.gov/study/NCT04512482            NaN              COMPLETED  This study aims to investigate the impact of a...           YES                        Dental Plaque|Dental Caries              DRUG: Bromelain|OTHER: Powdered sugar  Composite Plaque Score, The composite plaque s...                                                NaN                                                NaN                                 Indiana University            Water Pik, Inc.|Delta Dental Foundation     ALL               CHILD, ADULT         PHASE2         46       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                         1802369383   6/14/2018               7/24/2018        3/4/2019    8/13/2020            8/22/2020          12/3/2020  Indiana University School of Dentistry, Indian...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02277990  World-wide Randomized Antibiotic Envelope Infe...  https://clinicaltrials.gov/study/NCT02277990        WRAP-IT              COMPLETED  Medtronic , Inc. is sponsoring the World-wide ...           YES                             CIED Related Infection    DEVICE: TYRX™ Absorbable Antibacterial Envelope  12 Month Kaplan-Meier Estimate of Major CIED I...  12 Month Kaplan-Meier Estimate of Major or Min...                                                NaN         Medtronic Cardiac Rhythm and Heart Failure                               The Cleveland Clinic     ALL         ADULT, OLDER_ADULT         PHASE4       7075    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                            WRAP-IT     2015-01                 2018-09         2018-09   10/29/2014            10/2/2019          11/5/2019  Alaska Heart Institute, Anchorage, Alaska, Uni...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03585790  The Impact of Soft Contact Lens Attributes on ...  https://clinicaltrials.gov/study/NCT03585790            NaN              COMPLETED  Despite its prevalence, the ocular causes of e...           YES                                  Asthenopia|Myopia  DEVICE: Contact lens with Multifocal Optics|DE...  Subject Reported Eye Fatigue, Subjective Ratin...                                                NaN                                                NaN                             Pete Kollbaum, OD, PhD                                     Alcon Research     ALL                      ADULT            NaN         45       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                        Kollbaum001   9/13/2018               11/2/2018       11/2/2018    7/13/2018            9/24/2019           1/7/2020  Indiana University Clinical Optics Research La...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT05394545  Phase II Trial of Nu-V3 Non-Invasive Nerve Sti...  https://clinicaltrials.gov/study/NCT05394545     Nu-V3P2RCT              SUSPENDED  This Nu-V3 clinical study is a randomized, pha...            NO      Chronic Pain|Anxiety|Depression|Sleeplessness                                      DEVICE: Nu-V3  Overall safety from unanticipated problems or ...  Effectiveness: Symptom Frequency, In the Nu-V3...                                                NaN                                  Nu-Life Solutions                                                NaN     ALL         ADULT, OLDER_ADULT            NaN         80    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                 Nu-V3 RCT Protocol   3/20/2024               5/31/2025       5/31/2025    5/27/2022                  NaN          7/28/2023  Greater Chicago Specialty Physicians (GCSP) - ...               Study Protocol|Informed Consent Form   \n",
       "NCT03436615  A Study to Evaluate the Safety and Efficacy of...  https://clinicaltrials.gov/study/NCT03436615            NaN              COMPLETED  This is a phase 2 multi-center, randomized, do...           YES                              Molluscum Contagiosum  DRUG: SB206 4%|DRUG: SB206 8%|DRUG: SB206 12%|...  Proportion of Subjects Achieving Complete Clea...  Proportion of Subjects Achieving Complete Clea...                                                NaN                                        Novan, Inc.                         Premier Research Group plc     ALL  CHILD, ADULT, OLDER_ADULT         PHASE2        256    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: SEQ...                                           NI-MC201   1/24/2018               11/3/2018       11/3/2018    2/19/2018            1/23/2023           5/6/2023  Premier Site# 266, Scottsdale, Arizona, 85255,...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03762993  Controlled Phonation and Vocal Rest Programs A...  https://clinicaltrials.gov/study/NCT03762993            NaN              COMPLETED  The proposed research will investigate the mos...           YES                                            Healthy    BEHAVIORAL: Vocal rest and Controlled Phonation  Phonation Threshold Pressure, Minimum air pres...  Lung Volume Excursion, The difference between ...                                                NaN                                  Purdue University                                                NaN     ALL                      ADULT            NaN         37       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                         Vocal restoration programs   12/5/2018                7/1/2020        7/1/2020    12/4/2018            6/24/2021           8/5/2021  Purdue University, West Lafayette, Indiana, 47...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04622592  Adjuvanted Seasonal Recombinant Quadrivalent V...  https://clinicaltrials.gov/study/NCT04622592            NaN              COMPLETED  This randomized, partially-blinded, active com...           YES                                          Influenza                 BIOLOGICAL: Instramuscular vaccine  Geometric Mean Titers (GMTs) of Hemagglutinati...  GMTs of HI Antibody Response for Each Homologo...                                                NaN                                           Medicago                                                NaN     ALL                OLDER_ADULT  PHASE1|PHASE2        209    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                 CP-PRO-AdjQVLP-020   11/2/2020               4/26/2022       4/26/2022   11/10/2020            5/29/2023          7/21/2023  Optimal Sites, Huntsville, Alabama, 35802-2569...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02878330  A Study to Evaluate the Safety and Efficacy of...  https://clinicaltrials.gov/study/NCT02878330  MEDI8897 Ph2b              COMPLETED  The purpose of this study is to evaluate the e...           YES             Respiratory Syncytial Virus Infections                       DRUG: MEDI8897|DRUG: Placebo  Number of Participants With Medically Attended...  Number of Participants Hopitalized Due to Resp...                                                NaN                                      MedImmune LLC                                                NaN     ALL                      CHILD         PHASE2       1453    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                        D5290C00003   11/3/2016               7/17/2018       12/6/2018    8/25/2016            7/17/2019         10/14/2019  Research Site, Birmingham, Alabama, 35205, Uni...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03200366  Comparing Interventions to Increase Colorectal...  https://clinicaltrials.gov/study/NCT03200366            NaN              COMPLETED  The purpose of this study is to test different...           YES                                  Colorectal Cancer  BEHAVIORAL: Tailored DVD|BEHAVIORAL: Patient N...  Participants Completing CRC Screening Per Elec...  Participants Completing Colonoscopy Per Electr...                                                NaN                                 Indiana University  Patient-Centered Outcomes Research Institute|O...     ALL         ADULT, OLDER_ADULT            NaN        371       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                          1605880142|IHS-1507-31333   7/26/2017              10/21/2020      10/21/2020    6/27/2017             6/8/2021          9/13/2021  Eskenazi Health, Indianapolis, Indiana, 46202,...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02754492  Evaluation of Trima Version 7.0 Platelets in 1...  https://clinicaltrials.gov/study/NCT02754492            NaN              COMPLETED  To verify that platelets collected on the Trim...           YES                                 Healthy Volunteers  DEVICE: Trima Accel System with Version 7.0 So...  Number of Participants With Platelet Units Con...  Number of Participants With Platelet Units Con...                                                NaN                                         Terumo BCT                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        334    INDUSTRY  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                                           CTS-5060     2016-04               2/15/2017       2/15/2017    4/28/2016             2/8/2018          3/29/2018  San Diego Blood Bank, San Diego, California, 9...  Study Protocol|Statistical Analysis Plan|Infor...   \n",
       "NCT03238352  A Study to Assess Efficacy of an Experimental ...  https://clinicaltrials.gov/study/NCT03238352            NaN              COMPLETED  To investigate the efficacy of an experimental...           YES                                 Dentin Sensitivity  DEVICE: Potassium oxalate|DRUG: Sodium fluorid...  Change From Baseline in Schiff Sensitivity Sco...  Change From Baseline in Tactile Threshold, The...                                                NaN                                    GlaxoSmithKline                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE2         89    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                             207656    8/7/2017              10/27/2017      10/27/2017     8/3/2017           10/15/2018         11/14/2018  GSK Investigational Site, Fort Wayne, Indiana,...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04440163  MenABCWY Noninferiority Study in Healthy Parti...  https://clinicaltrials.gov/study/NCT04440163            NaN              COMPLETED  The aim of this study is to determine the immu...           YES                              Meningococcal Vaccine  BIOLOGICAL: MenABCWY|BIOLOGICAL: Saline|BIOLOG...  Percentage of Participants Achieving At Least ...  Percentage of Participants Achieving At Least ...                                                NaN                                             Pfizer                                                NaN     ALL               CHILD, ADULT         PHASE3       2431    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: FAC...                            C3511001|2019-004313-13   6/17/2020               7/24/2022       7/24/2022    6/19/2020            3/22/2023          4/18/2023  Alabama Clinical Therapeutics, LLC, Birmington...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02343263  Effect of Bupivacaine-infused Fibrin Sealant A...  https://clinicaltrials.gov/study/NCT02343263            NaN             TERMINATED  The purpose of this study is to evaluate the e...           YES       Pain, Postoperative|Postoperative Hemorrhage       DRUG: Bupivacaine|BIOLOGICAL: Fibrin Sealant  Postoperative Hemorrhage; Study Terminated Due...  Total Pain Medication Usage, The postoperative...                                                NaN              Indiana University School of Medicine                                                NaN     ALL                      CHILD         PHASE2         18       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1501306006     2015-03               5/31/2017       5/31/2017    1/21/2015            5/20/2018          8/10/2018  Riley Childrens' Hospital, Indianapolis, India...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03462706  Quad Resection (Hot Snare vs Cold Snare vs Hot...  https://clinicaltrials.gov/study/NCT03462706            NaN              COMPLETED  The study will compare the use of cold snare, ...           YES             Colon Cancer|Colon Polyp|Colon Adenoma  PROCEDURE: Cold Snare|PROCEDURE: Hot Snare|PRO...  Efficacy of Resection (Central Post-Resection ...                                                NaN                                                NaN                                 Indiana University  John D. Dingell VA Medical Center|White River ...     ALL         ADULT, OLDER_ADULT            NaN        238       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1711062130    2/6/2018               5/14/2021       5/14/2021    3/12/2018             5/9/2022          2/15/2023  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02325791  Study to Evaluate the Efficacy and Safety of S...  https://clinicaltrials.gov/study/NCT02325791            NaN              COMPLETED  The purpose of this study was to evaluate the ...           YES             Respiratory Syncytial Virus Infections  DRUG: Suptavumab 30 mg/kg|DRUG: Placebo Matche...  Part A: Serum Concentration of Suptavumab Over...  Part A: Percentage of Participants With Treatm...                                                NaN                          Regeneron Pharmaceuticals                                                NaN     ALL                      CHILD         PHASE3       1177    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                     R2222-RSV-1332   7/21/2015                7/5/2017       9/26/2017   12/25/2014             7/5/2018          11/6/2018  Regeneron Investigational Site, Birmingham, Al...  Study Protocol|Statistical Analysis Plan: Part...   \n",
       "NCT03296072  In Situ Erosion Study to Investigate the Effec...  https://clinicaltrials.gov/study/NCT03296072            NaN              COMPLETED  This will be a randomized, controlled, single ...           YES                                      Tooth Erosion  DRUG: 0.254% w/w sodium fluoride and 5% KNO3|D...  % Surface Micro Hardness Recovery (SMHR; Compa...  % Relative Erosion Resistance (RER; Comparison...                                                NaN                                    GlaxoSmithKline                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3         62    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                             208166  11/13/2017               1/16/2018       1/16/2018    9/28/2017             1/3/2019          9/16/2020  GSK Investigational Site, Indianapolis, Indian...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02460172  Zip® Surgical Skin Closure Device vs. Staples ...  https://clinicaltrials.gov/study/NCT02460172            NaN              COMPLETED  Study designed to compare the Zip Surgical Ski...           YES       Arthroplasty, Knee Replacement|Wound Healing  DEVICE: Zip Surgical Skin Closure|DEVICE: Stee...  Incision Appearance / Scar Cosmesis, Patient S...  Surgeon Closure Method Satisfaction, Closure m...                                                NaN                               ZipLine Medical Inc.                                                NaN     ALL         ADULT, OLDER_ADULT            NaN         25    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                                  6     2015-05               2/15/2017       2/15/2017     6/2/2015           11/26/2018           3/5/2019  Shelbourne Knee Center, Indianapolis, Indiana,...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03673462  Safety of a Quadrivalent Meningococcal Conjuga...  https://clinicaltrials.gov/study/NCT03673462          MET41              COMPLETED  The primary objective of this study was to des...           YES       Healthy Volunteers (Meningococcal Infection)  BIOLOGICAL: Meningococcal polysaccharide (sero...  Number of Participants With Immediate Unsolici...                                                NaN                                                NaN                   Sanofi Pasteur, a Sanofi Company                                                NaN     ALL                      CHILD         PHASE3       2797    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...               MET41|U1111-1183-6261|2019-004459-35   9/17/2018               3/16/2023       3/16/2023    9/17/2018            9/14/2023          10/5/2023  Birmingham Pediatric Associates-Site Number:84...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT05653362  Coconut Oil vs. Commercial Ultrasound Gel In O...  https://clinicaltrials.gov/study/NCT05653362            NaN              COMPLETED  The goal of this randomized controlled trial i...           YES                               Pregnancy, High Risk  DEVICE: Coconut Oil|DEVICE: Commercial Ultraso...  Quality of Ultrasound Images, The quality of u...  Acceptability, Patient acceptability of coconu...                                                NaN                                 Indiana University                                                NaN  FEMALE                      ADULT            NaN         40       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                              12932   12/1/2021              12/22/2021      12/22/2021   12/16/2022            1/25/2023           6/2/2023  Riley Hospital for Children at IU Health, Indi...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT03009110  Preventing Adverse Incisional Outcomes at Cesa...  https://clinicaltrials.gov/study/NCT03009110      Prevena-C             TERMINATED  The Prophylactic Negative Pressure Wound Thera...           YES          Surgical Wound Infection|Cesarean Section  DEVICE: Prophylactic NPWT|DEVICE: Standard Dre...  Number of Participants With Superficial or Dee...  Number of Participants With Superficial, Deep ...  Types and Frequency of Different Bacteria Incl...                                 Indiana University  Eunice Kennedy Shriver National Institute of C...  FEMALE  CHILD, ADULT, OLDER_ADULT            NaN       1624       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...              IRB ID #: 201603062|1R01HD086007-01A1    2/8/2017              11/13/2019      11/13/2019     1/4/2017             2/5/2021           6/1/2023  University of Alabama Medical Center, Birmingh...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT01779362                        RISE Adult Medication Study  https://clinicaltrials.gov/study/NCT01779362     RISE Adult              COMPLETED  The RISE Adult Medication Study is a 4-arm, 3-...           YES                        Prediabetes|Type 2 Diabetes  DRUG: Metformin|DRUG: Liraglutide|DRUG: Glargi...  ß-cell Response Measured by Hyperglycemic Clam...  ACPRg, First phase response from the hyperglyc...                                                NaN                                   RISE Study Group  National Institute of Diabetes and Digestive a...     ALL         ADULT, OLDER_ADULT         PHASE3        267     NETWORK  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                         RISE Adult|5U01DK094406-02     2013-04                 2019-02         2019-08    1/30/2013            4/12/2023          5/11/2023  Jesse Brown VA Medical Center, Chicago, Illino...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT00401518  A Pivotal Study of a Facet Replacement System ...  https://clinicaltrials.gov/study/NCT00401518            NaN              COMPLETED  The purpose of this study is to determine if t...           YES                             Lumbar Spinal Stenosis  DEVICE: Non-randomized ACADIA® Facet Replaceme...  Measure of Pain/Disability Using the Zurich Cl...  Mean Visual Analog Scale (VAS) Right Leg Pain,...                                                NaN                                 Globus Medical Inc                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        390    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                          1020-9052     2006-10                 2017-08         2017-10   11/20/2006            8/10/2020          9/10/2020  Spine Group Beverly Hills, Beverly Hills, Cali...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02576860  Study to Evaluate the Safety and Efficacy of a...  https://clinicaltrials.gov/study/NCT02576860            NaN              COMPLETED  This study evaluates the safety and efficacy o...           YES                                            Rosacea              DRUG: CLS001 (Omiganan)|DRUG: Vehicle  Efficacy Absolute Change in Inflammatory Lesio...  Efficacy The Absolute Change in Inflammatory L...  Safety Adverse Events, Subjects with 1 or more...                                   Maruho Co., Ltd.                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3        263    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                   CLS001-CO-PR-005     2015-10               2/27/2017        9/5/2017   10/15/2015            10/8/2020           8/2/2022  Fort Smith, Arkansas, United States|Rogers, Ar...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02547441  Study to Evaluate the Safety and Efficacy of a...  https://clinicaltrials.gov/study/NCT02547441            NaN              COMPLETED  This study evaluates the safety and efficacy o...           YES                                            Rosacea              DRUG: CLS001 (Omiganan)|DRUG: Vehicle  Change in Inflammatory Lesion Count From Basel...  Change in the Number of Inflammatory Lesions F...                                                NaN                                   Maruho Co., Ltd.                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3        463    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                   CLS001-CO-PR-004     2015-12                7/5/2017       4/13/2018    9/11/2015            6/13/2022           8/2/2022  Fremont, California, United States|Miami, Flor...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02431702  A Study to Compare Disease Progression and Mod...  https://clinicaltrials.gov/study/NCT02431702          DREaM              COMPLETED  The purpose of the study is to compare effecti...           YES                  Schizophrenia|Psychotic Disorders  DRUG: Aripiprazole|DRUG: Haloperidol|DRUG: Ola...  Part-2 (Disease Progression): Time to First Tr...  Part 2 (Disease Progression): Change From Base...                                                NaN                    Janssen Scientific Affairs, LLC                                                NaN     ALL                      ADULT         PHASE3        337    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                            CR106193|R092670SCH3013    7/8/2015              11/12/2019      11/12/2019     5/1/2015           11/11/2020          12/3/2021  Little Rock, Arkansas, United States|Garden Gr...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02933489  Abbreviated Breast MRI and Digital Tomosynthes...  https://clinicaltrials.gov/study/NCT02933489            NaN  ACTIVE_NOT_RECRUITING  This randomized phase II trial studies how wel...           YES                                       Asymptomatic  DIAGNOSTIC_TEST: Contrast-enhanced Magnetic Re...  Screen-detected Invasive Cancer Verified by Pa...  Positive Predictive Value (PPV) of Biopsies, T...                                                NaN                   ECOG-ACRIN Cancer Research Group                    National Cancer Institute (NCI)  FEMALE         ADULT, OLDER_ADULT            NaN       1516     NETWORK  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...  EA1141|NCI-2016-00252|s16-01825|EA1141|ECOG-AC...  12/27/2016               1/23/2020         2023-08   10/14/2016           10/23/2020          6/26/2023  Banner MD Anderson Cancer Center, Gilbert, Ari...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT04431518                       PK of JULUCA in Hemodialysis  https://clinicaltrials.gov/study/NCT04431518            NaN              COMPLETED  This study will compare the pharmacokinetics o...            NO                                      HIV/AIDS|ESRD                      DRUG: JULUCA 50Mg-25Mg Tablet  DTG Ctau, Steady-state plasma Ctau for doluteg...  Safety of DTG and RPV, The attributable advers...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE4          8       OTHER  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                           ViiV Healthcare IIS 1837   4/23/2021               7/31/2023       7/31/2023    6/16/2020                  NaN          9/28/2023  Samir Gupta, Indianapolis, Indiana, 46202, Uni...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT02513940  Influence of Testosterone Administration on Dr...  https://clinicaltrials.gov/study/NCT02513940            NaN              COMPLETED  Torsades de pointes (TdP) is a potentially fat...           YES                                   Long QT Syndrome  DRUG: Testosterone|DRUG: Progesterone|DRUG: Pl...  Baseline (Pre-ibutilide) Individualized Rate-c...  Area Under the QTF Versus Time Curve for 0-1 H...                                                NaN                                 Indiana University       American Heart Association|Purdue University    MALE                OLDER_ADULT         PHASE4         14       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                         1507526854     2016-05              10/19/2017      10/19/2017     8/3/2015            2/14/2019          8/28/2019  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02956044  Interaction of Bexagliflozin With Metformin, G...  https://clinicaltrials.gov/study/NCT02956044            NaN              COMPLETED  The purpose of this study is to examine the dr...           YES                            Type2 Diabetes Mellitus  DRUG: Bexagliflozin|DRUG: Metformin|DRUG: Glim...  Cmax (Maximum Observed Plasma Concentration), ...  Urinary Glucose Excretion up to 0-72 hr, Pre-d...                                                NaN                                           Theracos                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE1         54    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                     THR-1442-C-453     2016-11                 2017-03         2017-03    11/4/2016            5/21/2021          7/22/2021  Clinical Research Site, Evansville, Indiana, 4...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04763044  Evaluation of the Fluoride Dose Response Using...  https://clinicaltrials.gov/study/NCT04763044            NaN              COMPLETED  The purpose of this study is to evaluate the f...           YES                                             Caries  DRUG: 0 ppm F|DRUG: 250 ppm F as MFP|DRUG: 110...  Enamel Fluoride Uptake (EFU), The EFU test wil...  Enamel Fluoride Uptake (EFU), The EFU test wil...                                                NaN                                 Procter and Gamble                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE4         15    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                            2020154    3/1/2021               7/21/2021       7/21/2021    2/21/2021            4/13/2022          7/19/2022  Oral Health Research Institute, Indianapolis, ...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03488381  Effects of Soccer Heading on Ocular-motor Func...  https://clinicaltrials.gov/study/NCT03488381            NaN              COMPLETED  Repetitive head impacts in sports and military...            NO                                       Trauma, Head                             DEVICE: Soccer Heading  Changes in Brain-Derived Blood Biomarker Over ...                                                NaN                                                NaN                                 Indiana University                                                NaN     ALL                      ADULT            NaN         45       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1610743422    8/1/2017                4/9/2019        4/9/2019     4/5/2018                  NaN          4/17/2019  Indiana University, Bloomington, Indiana, 4740...               Study Protocol|Informed Consent Form   \n",
       "NCT03089281  Strategic Management to Optimize Response To C...  https://clinicaltrials.gov/study/NCT03089281      SMART CRT              COMPLETED  The primary objective is to evaluate the benef...           YES                                      Heart Failure                                      DEVICE: CRT-D  CRT Response, Comparing cardiac resynchronizat...  Change in Left Ventricular End Systolic Volume...  Change in Kansas City Cardiomyopathy Questionn...                      Boston Scientific Corporation                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        699    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                              C2067    8/1/2017               9/15/2020       9/15/2020    3/24/2017            9/15/2021           4/5/2022  Affinity Hospital, LLC d/b/a Granview Medical ...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04366544  Effects of an 8-day Advanced Meditation, Samya...  https://clinicaltrials.gov/study/NCT04366544            NaN  ACTIVE_NOT_RECRUITING  The purpose of this study is to investigate th...            NO  Mental Health Wellness 1|Happiness|Depression|...  OTHER: Part A1: Survey|OTHER: Part A2: Sample ...  levels of Anandamide, Anandamide (AEA) activat...  Microbiome analysis:, Microbiome analysis: Par...  fMRI, fMRI: Functional MRI is a useful non-inv...                           University of Pittsburgh                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        759       OTHER  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                                         1801728792   1/19/2018              12/15/2023       8/15/2024    4/29/2020                  NaN           1/6/2023  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03446781  Effectiveness and Safety of EN3835 in the Trea...  https://clinicaltrials.gov/study/NCT03446781      RELEASE-2              COMPLETED  Subjects will be screened for study eligibilit...           YES  Edematous Fibrosclerotic Panniculopathy (Cellu...             BIOLOGICAL: EN3835|BIOLOGICAL: Placebo  2-level Composite Responders for the Target Bu...  1-level PR-PCSS Responders of the Target Butto...  Serum Antibody Positivity by Visit, Percent of...                               Endo Pharmaceuticals                                                NaN  FEMALE         ADULT, OLDER_ADULT         PHASE3        422    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         EN3835-303    2/8/2018               9/26/2018       9/26/2018    2/27/2018             8/5/2020          10/8/2020  Endo Clinical Trial Site #1, Glendale, Arizona...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT06026124  Retrieval-Based Word Learning in Developmental...  https://clinicaltrials.gov/study/NCT06026124            NaN             RECRUITING  Children with developmental language disorder ...            NO  Developmental Language Disorder|Specific Langu...          BEHAVIORAL: Retrieval-based word learning  Word Form accuracy (number of words correctly ...  Number of correctly identified words on Peabod...                                                NaN                                  Purdue University  National Institute on Deafness and Other Commu...     ALL                      CHILD            NaN         32       OTHER  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                            1603017480C|R01DC014708   9/21/2023               7/31/2026       7/31/2026     9/6/2023                  NaN           9/6/2023  Purdue University's SLHS laboratories (8445 Ke...                              Informed Consent Form   \n",
       "NCT03709901  Viable Allograft Supplemented Disc Regeneratio...  https://clinicaltrials.gov/study/NCT03709901           VAST                UNKNOWN  The objective of this study is to evaluate the...            NO                          Degenerative Disc Disease             OTHER: Active Allograft|OTHER: Placebo  Oswestry Disability Index (ODI), To evaluate t...  MRI Assessments, To evaluate morphologic chang...                                                NaN                              VIVEX Biologics, Inc.                                                NaN     ALL                      ADULT            NaN        218    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                     VAST - 001-017   8/22/2017               1/31/2022       1/31/2022   10/17/2018                  NaN           7/7/2021  Source Health, Santa Monica, California, 90404...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03267511  A Study to Investigate the Stain and Plaque Re...  https://clinicaltrials.gov/study/NCT03267511            NaN              COMPLETED  The purpose of this study is to determine whet...           YES                                       Oral Hygiene  DRUG: 5% KNO3 / 0.2542% NaF dentifrice with 0....  Change From Baseline in Overall Macpherson Mod...  Difference of Least Square Mean of Change From...                                                NaN                                    GlaxoSmithKline                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE2        123    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                             208078   9/25/2017               12/2/2017       12/2/2017    8/30/2017           11/30/2018           1/8/2019  GSK Investigational Site, Fort Wayne, Indiana,...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03550313  Study to Evaluate the Safety and Immunogenicit...  https://clinicaltrials.gov/study/NCT03550313            NaN             TERMINATED  This is a Phase 2, randomized, active-controll...           YES                            Pneumococcal Infections     BIOLOGICAL: Multivalent|BIOLOGICAL: Prevnar 13  Percentage of Participants With Local Reaction...  Pneumococcal Serotype-specific Immunoglobulin ...                                                NaN                                             Pfizer                                                NaN     ALL                      CHILD         PHASE2        565    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                            C3571002|2020-005039-59    6/1/2018               11/5/2020       11/5/2020     6/8/2018           10/20/2021         11/30/2021  Mobile Pediatric Clinic, Mobile, Alabama, 3660...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT02836613   A Study of Galcanezumab in Healthy Participants.  https://clinicaltrials.gov/study/NCT02836613            NaN              COMPLETED  The main purpose of this study is to evaluate ...           YES                                            Healthy                           BIOLOGICAL: Galcanezumab  Pharmacokinetics (PK): Maximum Concentration (...  Pharmacodynamics (PD): Maximum Observed CGRP C...                                                NaN                              Eli Lilly and Company                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE1        160    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                  16203|I5Q-MC-CGAQ     2016-07               2/27/2017       11/9/2017    7/19/2016           10/19/2018          3/13/2019  Covance Clinical Research Inc, Daytona Beach, ...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04247581       ECG App Algorithms Clinical Validation Study  https://clinicaltrials.gov/study/NCT04247581            NaN              COMPLETED  The purpose of the study is to evaluate the pe...           YES                                Atrial Fibrillation                                 DEVICE: 1-lead ECG  Percentage of Trials With Correct Classificati...  Percentage of Trials With Correct Classificati...                                                NaN                                         Apple Inc.                                      Iqvia Pty Ltd     ALL         ADULT, OLDER_ADULT            NaN        546    INDUSTRY  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                                                 13    1/7/2020               3/20/2020       3/20/2020    1/30/2020            7/30/2021          9/28/2021  Hope Research Institute, Phoenix, Arizona, 850...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04870099       Guided Self-help for Common Mental Disorders  https://clinicaltrials.gov/study/NCT04870099            DWM              COMPLETED  Common mental disorders (CMDs) like depression...           YES                                      Bibliotherapy  BEHAVIORAL: Doing What Matters in Times of Str...  6-week Change in Kessler 6 Psychological Distr...  6-week Change in Emotion Regulation Scale (ERQ...                                                NaN                                 Indiana University  Indiana Clinical and Translational Sciences In...     ALL         ADULT, OLDER_ADULT            NaN        141       OTHER  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                 2004321422|KL2TR002530|UL1TR002529  10/17/2020               2/21/2022       5/21/2022     5/3/2021            4/26/2023          7/11/2023  Indiana University, Bloomington, Indiana, 4740...  Study Protocol|Statistical Analysis Plan|Infor...   \n",
       "NCT04189081  Improvement of Dry Mouth Sufferers After Using...  https://clinicaltrials.gov/study/NCT04189081            NaN              COMPLETED  The objective of this study is to evaluate dry...           YES                                          Dry Mouth       DEVICE: dry mouth rinse|OTHER: Water Control  Response to \"Relieving the Discomfort of Dry M...                                                NaN                                                NaN                                 Procter and Gamble                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        137    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         CSD2019158   5/13/2020                7/8/2020        7/8/2020    12/6/2019            4/15/2021          5/28/2021  Salus Research, Fort Wayne, Indiana, 46825, Un...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04620798  Longitudinal COVID-19 Antibody Testing in Indi...  https://clinicaltrials.gov/study/NCT04620798            NaN              COMPLETED  The primary goal for this study is to assess w...           YES                       SARS-CoV-2|Serology|Students  BEHAVIORAL: Immediate vs. delayed provision of...  Frequency of Handwashing, This outcome was dic...  Count of Participants With SARS-CoV-2 Seroconv...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN       1076       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         2008293852   9/14/2020              11/11/2020      11/11/2020    11/9/2020            1/18/2022          1/31/2022  Indiana University, Bloomington, Indiana, 4740...  Study Protocol and Statistical Analysis Plan|I...   \n",
       "NCT02654236  Effect of Heavy Alcohol Consumption on Farneso...  https://clinicaltrials.gov/study/NCT02654236            NaN              COMPLETED  The main purpose of this study is to see wheth...           YES                                Alcohol Consumption   DRUG: Placebo|DRUG: 10 mg Obeticholic Acid (OCA)  Change in Bile Salt Metabolism (C4 )Levels to ...  Change in Fasting Serum Bile Salt Levels, Base...                                                NaN                               Suthat Liangpunsakul  National Institute on Alcohol Abuse and Alcoho...     ALL         ADULT, OLDER_ADULT            NaN         30       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                          TREAT 005     2016-04                 2019-09         2019-09    1/13/2016             3/6/2023          4/25/2023  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04812184  Adhesive Tape Placement on Patients' Masks in ...  https://clinicaltrials.gov/study/NCT04812184            NaN              COMPLETED  Methods 123 patients were enrolled in a random...           YES                                            Covid19                             DEVICE: Tape Face Mask  Proper Face Mask Use up to 60 Minutes, The pri...                                                NaN                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        123       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                        IUMASKstudy    4/1/2020              10/30/2020      10/30/2020    3/23/2021            11/9/2021          10/4/2022  Eskenazi Hospital, Indianapolis, Indiana, 4607...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03560128  Endocuff Vision Colonoscopy vs. AmplifEYE Colo...  https://clinicaltrials.gov/study/NCT03560128            NaN              COMPLETED  The study aims to compare the results between ...           YES  Colorectal Adenoma|Colorectal Polyp|Colorectal...  DEVICE: Endocuff Vision device|DEVICE: AmplifE...  Number of Adenomas Detected Per Colonoscopy (A...  Detection Rates (Adenoma Detection Rate (ADR) ...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        634       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1802193017   4/12/2018              12/18/2018      12/18/2018    6/18/2018            9/20/2019          10/8/2019  Indiana University, Indianapolis, Indiana, 462...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04482036  The MObile AssessMENT of Behavioral and Psycho...  https://clinicaltrials.gov/study/NCT04482036         MOMENT             TERMINATED  The purpose of this research study is to learn...           YES  Alzheimer Disease|Mild Memory Disturbance|Mild...  OTHER: Mobile Phone Application Assessments|OT...  Number of Caregivers Who Completed Neuropsychi...  Outcome of the Change in Behavioral and Psycho...  Outcome of the Change in the Perceived Stress ...                                 Indiana University                  National Institute on Aging (NIA)     ALL         ADULT, OLDER_ADULT            NaN         20       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                       1907055854|1K23AG059914-01A1  10/23/2020               10/4/2021       10/4/2021    7/22/2020            2/13/2023           9/1/2023  Eskenazi Health, Indianapolis, Indiana, 46202,...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT04666194  A Pilot Randomized Trial of Polypectomy Techni...  https://clinicaltrials.gov/study/NCT04666194            NaN              COMPLETED  Complete polypectomy is one of the major facto...            NO                                       Colon Polyps  PROCEDURE: Cold forceps|PROCEDURE: Cold snare|...  Incomplete resection rate, Rate of recurrent n...  Efficiency of polypectomy, Time taken for each...                                                NaN                                 Indiana University    American Society for Gastrointestinal Endoscopy     ALL         ADULT, OLDER_ADULT            NaN        353       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                 1011004273/0801-16    9/1/2009               10/1/2009       10/1/2019   12/14/2020                  NaN          1/12/2021  Springmill endoscopy center, Carmel, Indiana, ...  Study Protocol, Statistical Analysis Plan, and...   \n",
       "NCT02410902  A Trial of CM-AT in Children With Autism With ...  https://clinicaltrials.gov/study/NCT02410902            NaN              COMPLETED  The purpose of this study is to determine whet...           YES                                             Autism                          DRUG: CM-AT|DRUG: PLACEBO  Primary Outcome Measurements to Determine Effi...  Secondary Outcome Measurements of Changes in t...                                                NaN                                           Curemark                                                NaN     ALL                      CHILD         PHASE3        190    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                                103   5/13/2015              12/22/2017      12/22/2017     4/8/2015             5/3/2021          5/24/2023  Southwest Autism Research & Resource Center (S...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04913636  Assessing Effects of a Denture Gel on Gum Abra...  https://clinicaltrials.gov/study/NCT04913636            NaN              COMPLETED  This is a parallel design study. Up to 40 subj...           YES                                         Gum Injury          DEVICE: Treatment Gel|OTHER: Sham Control  Abrasion Assessment (Number), The total number...                                                NaN                                                NaN                                 Procter and Gamble                                                NaN     ALL         ADULT, OLDER_ADULT            NaN         38    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                            2020089    6/1/2021               6/29/2021       6/29/2021     6/4/2021            5/19/2022          6/28/2022  Salus Research, Fort Wayne, Indiana, 46825, Un...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03257436  Strategic Management to Improve CRT Using Mult...  https://clinicaltrials.gov/study/NCT03257436       SMARTMSP              COMPLETED  Prospective, multi-center, single arm, post ap...           YES                       Left Ventricular Dysfunction                                      DEVICE: CRT-D  LV MSP Feature Related Complication-Free Rate,...                                                NaN                                                NaN                      Boston Scientific Corporation                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        586    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                           92050975    1/5/2018              11/19/2020      11/19/2020    8/22/2017            12/7/2021           1/3/2022  Mobile Infirmary Medical Center, Mobile, Alaba...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03436784         The Indiana SNAP-Ed Long-term Study Sequel  https://clinicaltrials.gov/study/NCT03436784            NaN              COMPLETED  The goal of the study is to determine the imme...            NO                         Nutrient Intake Inadequacy                        BEHAVIORAL: Indiana SNAP-Ed  Long-term Change in Dietary Intake, The Health...  Long-term Change in Nutrient Intake, Mean Usua...  Body Mass Index (BMI), SNAP-Ed paraprofessiona...                                  Purdue University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        261       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1507016295    9/8/2015                5/1/2017        5/1/2017    2/19/2018                  NaN          3/29/2023  Purdue University, West Lafayette, Indiana, 47...  Study Protocol|Statistical Analysis Plan|Infor...   \n",
       "NCT03024970  Daily Disposable Dispensing Clinical Trial of ...  https://clinicaltrials.gov/study/NCT03024970            NaN              COMPLETED  The purpose of this study is to investigate th...           YES                                             Myopia  DEVICE: stenfilcon A lens with solution additi...  Subjective Ratings on Comfort, Subjects assess...  Lens Fit Acceptance, Overall fit acceptance is...                                                NaN                                 Coopervision, Inc.                                                NaN     ALL         ADULT, OLDER_ADULT            NaN         72    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                           CV-16-60     2017-01               4/25/2017       6/26/2017    1/19/2017            6/19/2020          7/21/2020  Clinical Optical Research Lab (CORL), Blooming...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02754440   Evaluation of Trima Version 7.0 Platelets in PAS  https://clinicaltrials.gov/study/NCT02754440            NaN              COMPLETED  To verify that platelets collected on the Trim...           YES                                 Healthy Volunteers  DEVICE: Trima Accel System with Version 7.0 So...  Number of Participants With Platelet Units Con...  Number of Participants With Platelet Units Con...                                                NaN                                         Terumo BCT                                                NaN     ALL         ADULT, OLDER_ADULT            NaN        365    INDUSTRY  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                                           CTS-5059   4/20/2016               7/28/2017       7/28/2017    4/28/2016             4/9/2018          5/11/2018  San Diego Blood Bank, San Diego, California, 9...  Study Protocol|Informed Consent Form|Statistic...   \n",
       "NCT03320057        Medication Abortion Via Pharmacy Dispensing  https://clinicaltrials.gov/study/NCT03320057            NaN              COMPLETED  This mixed-methods study follows a prospective...           YES                   Pregnancy Related|Abortion Early  DRUG: Mifepristone|OTHER: Training on mifepris...  Number of Pharmacists Who Objected to Particip...  Number of Participants Who Report Being Satisf...                                                NaN                                    Daniel Grossman  University of California, San Diego|University...  FEMALE  CHILD, ADULT, OLDER_ADULT         PHASE4        326       OTHER  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...                                            A128753    6/1/2018                7/4/2020        7/4/2020   10/25/2017            5/21/2021          7/12/2021  Obstetrics and Gynecology Family Planning Clin...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT05056870  Clinical Evaluation of Spherical Soft Contact ...  https://clinicaltrials.gov/study/NCT05056870            NaN              COMPLETED  This will be a 5-visit, randomized, partially ...           YES                                      Visual Acuity  DEVICE: ACUVUE Oasys 1-Day with HydraLuxe Tech...  High Luminance High Contrast Monocular Visual ...  CLUE Vision Score, CLUE Vision Score was asses...                                                NaN                Johnson & Johnson Vision Care, Inc.                                                NaN     ALL                      ADULT            NaN        174    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                            CR-6459   9/15/2021                3/3/2022        3/3/2022    9/27/2021            2/27/2023          4/27/2023  Eyecenter Optometric, Rocklin, California, 956...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03095976  Amnion-Chorion Allograft Barrier Used for Root...  https://clinicaltrials.gov/study/NCT03095976            NaN              COMPLETED  The purpose of this pilot project is to evalua...           YES                               Periodontal Diseases  PROCEDURE: Amnion-Chorion allograft membrane o...  Probing Depth Change, Probing depth was measur...                                                NaN                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN          4       OTHER  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...                                         1608175133   6/14/2017               9/10/2019       9/10/2019    3/30/2017            2/27/2021          4/14/2021  Indiana University School of Dentistry, Indian...  Study Protocol, Statistical Analysis Plan, and...   \n",
       "NCT03202511  Assessment of a New \"Boosting\" Strategy for HI...  https://clinicaltrials.gov/study/NCT03202511            NaN              COMPLETED  The study will be a randomized, open-label, cr...           YES                           Pre-Exposure Prophylaxis  DRUG: Probenecid Oral Tablet|DRUG: Tenofovir d...  Plasma TFV AUC0-INF GMR, The geometric mean ra...                                                NaN                                                NaN                                 Indiana University                                                NaN    MALE                      ADULT   EARLY_PHASE1         15       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                         1705315090   6/23/2017                7/2/2018        7/2/2018    6/28/2017            4/24/2019           5/7/2021  Indiana University Clinical Research Center at...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03167411  Bexagliflozin Drug/Drug Interaction Study With...  https://clinicaltrials.gov/study/NCT03167411            NaN              COMPLETED  The purpose of this study is to examine the dr...           YES                            Type2 Diabetes Mellitus      DRUG: Bexagliflozin|DRUG: Exenatide Injection  Cmax (Maximum Observed Plasma Concentration), ...  Urinary Glucose Excretion (UGE), Post-dose uri...                                                NaN                                           Theracos                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE1         20    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                     THR-1442-C-458   5/24/2017               6/29/2017       6/29/2017    5/30/2017            3/25/2021          5/28/2021  Clinical Research Site, Evansville, Indiana, 4...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03338296  Study to Evaluate the Efficacy and Safety of B...  https://clinicaltrials.gov/study/NCT03338296            NaN             TERMINATED  This study will be conducted to demonstrate we...           YES                                            Obesity    DRUG: lorcaserin hydrochloride XR|DRUG: Placebo  Change in Body Mass Index (BMI) From Baseline ...  Percentage of Participants Who Achieved at Lea...                                                NaN                                         Eisai Inc.                                                NaN     ALL                      CHILD         PHASE4        278    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                    APD356-A001-403   9/28/2017                4/3/2020        4/3/2020    11/9/2017            3/30/2021          7/19/2021  Phoenix Clinical LLC, Phoenix, Arizona, 85014,...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04886596  Efficacy Study of GSK's Investigational Respir...  https://clinicaltrials.gov/study/NCT04886596            NaN  ACTIVE_NOT_RECRUITING  This study will evaluate the efficacy of the R...           YES             Respiratory Syncytial Virus Infections      DRUG: Placebo|BIOLOGICAL: RSVPreF3 OA vaccine  Number of Participants With First Episode of R...  Number of Participants With First Episode of R...                                                NaN                                    GlaxoSmithKline                                                NaN     ALL         ADULT, OLDER_ADULT         PHASE3      26665    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                              212494|2020-000753-28   5/25/2021               4/11/2022       5/31/2024    5/14/2021            4/10/2023           8/4/2023  GSK Investigational Site, Birmingham, Alabama,...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03291613  Gaming Technology to Engage Adolescent Sickle ...  https://clinicaltrials.gov/study/NCT03291613            NaN              COMPLETED  Sickle cell disease (SCD) is a common genetic ...           YES                                Sickle Cell Disease                                OTHER: Pinpoint App  System Usability Questionnaire, Ten likert-typ...                                                NaN                                                NaN                                Klein Buendel, Inc.  Hilton Publishing Company|National Institute o...     ALL  CHILD, ADULT, OLDER_ADULT            NaN         13    INDUSTRY  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...               1R43MD010746-01|0308|1R43MD010746-01   1/15/2017               9/30/2017       9/30/2017    9/25/2017            7/25/2018           2/6/2019  Klein Buendel, Inc., Golden, Colorado, 80401, ...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04295135               Chronic Pain OneSheet Clinical Trial  https://clinicaltrials.gov/study/NCT04295135            NaN              COMPLETED  The purpose of the study is to determine wheth...            NO                                       Chronic Pain                  BEHAVIORAL: Chronic Pain OneSheet  Pain and function goal-setting, Proportion of ...  Urine drug screens (UDS) ordered, Proportion o...                                                NaN                                 Indiana University  Eskenazi Health|Wake Forest University|Wake Fo...     ALL         ADULT, OLDER_ADULT            NaN        137       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                         1911922583|5R33DA046085-05    8/4/2020               5/18/2022       5/18/2022     3/4/2020                  NaN          6/22/2023  Indiana University, Indianapolis, Indiana, 462...                              Informed Consent Form   \n",
       "NCT02172664  Clinical Evaluation of a Universal Adhesive in...  https://clinicaltrials.gov/study/NCT02172664            NaN              COMPLETED  The purpose of this prospective clinical trial...           YES                                   Cervical Lesions  PROCEDURE: Self etch enamel etching|PROCEDURE:...  Retention of Restorations, The primary outcome...  Number of Restoration Margins Marked as Staine...                                                NaN                                 Indiana University                                Ivoclar Vivadent AG     ALL         ADULT, OLDER_ADULT            NaN         33       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                           IVOC2014     2014-06                 2018-05         2018-05    6/24/2014            5/23/2019          5/28/2019  Indiana University School of Dentistry, Indian...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT03881670  On-Eye Optical Quality of Lotrafilcon B Lenses...  https://clinicaltrials.gov/study/NCT03881670            NaN              COMPLETED  The current study aims to systematically inves...           YES                                   Hyperopia|Myopia  DEVICE: Lotrafilcon B|DEVICE: lotrafilcon B wi...  Higher Order Aberrations, Higher-order Root Me...  Subjective Stability of Vision Rating, Subject...                                                NaN                                 Indiana University                                     Alcon Research     ALL                      ADULT         PHASE4         24       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                        Kollbaum002   12/7/2018                2/8/2019        2/8/2019    3/19/2019             2/3/2020          3/10/2020  Indiana University Clinical Optics Research La...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02569398  An Efficacy and Safety Study of Atabecestat in...  https://clinicaltrials.gov/study/NCT02569398          EARLY             TERMINATED  The purpose of this study is to evaluate wheth...           YES                      Asymptomatic Amyloid-positive  DRUG: Atabecestat, 5 mg|DRUG: Atabecestat, 25 ...  Change From Baseline in Preclinical Alzheimer ...  Change From Baseline in Cognitive Function Ind...                                                NaN                Janssen Research & Development, LLC                                                NaN     ALL         ADULT, OLDER_ADULT  PHASE2|PHASE3        557    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...            CR107373|2015-000948-42|54861911ALZ2003  10/29/2015              12/20/2018      12/20/2018    10/6/2015           12/20/2019          2/10/2020  Birmingham, Alabama, United States|Phoenix, Ar...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT03982199  A Study of an Ad26.RSV.preF-based Regimen in t...  https://clinicaltrials.gov/study/NCT03982199        CYPRESS              COMPLETED  The purpose of this study is to demonstrate th...           YES  Respiratory Syncytial Viruses|Respiratory Trac...        BIOLOGICAL: RSV Vaccine|BIOLOGICAL: Placebo  Number of Participants With First Occurrence o...  Number of Participants With Any RT-PCR-confirm...                                                NaN                 Janssen Vaccines & Prevention B.V.                                                NaN     ALL                OLDER_ADULT         PHASE2       5815    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                           CR108634|VAC18193RSV2001    8/1/2019                6/6/2022       5/26/2023    6/11/2019             6/6/2023          7/24/2023  Optimal Research, Huntsville, Alabama, 35802, ...           Study Protocol|Statistical Analysis Plan   \n",
       "NCT04585646  A Two-Week Crossover Dispensing Evaluation Of ...  https://clinicaltrials.gov/study/NCT04585646            NaN              COMPLETED  The primary objective of the study is to evalu...           YES                                             Myopia  DEVICE: Orion daily disposable contact lens|DE...  Subjective Response for Vision Satisfaction, S...  Subjective Overall Comfort Satisfaction, Overa...                                                NaN                                 Coopervision, Inc.                                                NaN     ALL                      ADULT            NaN         64    INDUSTRY  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...                                           CV-20-18   9/14/2020              11/30/2020      12/31/2020   10/14/2020            3/14/2022          5/10/2022  CORL, Indiana University, Bloomington, Indiana...       Study Protocol and Statistical Analysis Plan   \n",
       "NCT02345889  A 4-arm Clinical Trial of Fuse®, EndoCuff™, En...  https://clinicaltrials.gov/study/NCT02345889            NaN              COMPLETED  Adenoma detection rate (ADR) is a validated ma...           YES                               Colorectal Neoplasms  DEVICE: Colonoscopy with EndoCuff™|DEVICE: FUS...         Adenomas Per Colonoscopy, During Procedure  Number of Participants With Detected Adenoma, ...                                                NaN                                 Indiana University                                                NaN     ALL         ADULT, OLDER_ADULT            NaN       1262       OTHER  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...                                         1412036333     2015-02                 2017-12         2017-12    1/26/2015           12/31/2018          3/12/2019  Indiana University Hospital, Indianapolis, Ind...       Study Protocol and Statistical Analysis Plan   \n",
       "\n",
       "                                          IN Zip                                             County  \n",
       "NCT Number                                                                                           \n",
       "NCT03192488                              [47401]                                    [Monroe County]  \n",
       "NCT04623242                              [46202]                                    [Marion County]  \n",
       "NCT02754661                       [46202, 46237]                     [Marion County, Marion County]  \n",
       "NCT03132753                              [46218]                                    [Marion County]  \n",
       "NCT04267562                              [47630]                                   [Warrick County]  \n",
       "NCT03418662                              [46202]                                    [Marion County]  \n",
       "NCT03059810                              [47405]                                    [Monroe County]  \n",
       "NCT04516746                              [46202]                                    [Marion County]  \n",
       "NCT04811664                              [47405]                                    [Monroe County]  \n",
       "NCT03131453                              [46202]                                    [Marion County]  \n",
       "NCT03547167                              [47374]                                     [Wayne County]  \n",
       "NCT05091307                              [47714]                               [Vanderburgh County]  \n",
       "NCT03182920                              [47710]                               [Vanderburgh County]  \n",
       "NCT05051982                              [46202]                                    [Marion County]  \n",
       "NCT03822182                              [46123]                                 [Hendricks County]  \n",
       "NCT01781975                              [46202]                                    [Marion County]  \n",
       "NCT04208750                              [47405]                                    [Monroe County]  \n",
       "NCT01779375                              [46202]                                    [Marion County]  \n",
       "NCT04633837                              [46123]                                 [Hendricks County]  \n",
       "NCT03383783                              [46202]                                    [Marion County]  \n",
       "NCT04370756                              [47401]                                    [Monroe County]  \n",
       "NCT05227300                              [46202]                                    [Marion County]  \n",
       "NCT03029000                              [46107]                                    [Marion County]  \n",
       "NCT02618967                              [47710]                               [Vanderburgh County]  \n",
       "NCT03349567                              [46202]                                    [Marion County]  \n",
       "NCT03086447                              [47405]                                    [Monroe County]  \n",
       "NCT03063437                              [46202]                                    [Marion County]  \n",
       "NCT03628885                              [46202]                                    [Marion County]  \n",
       "NCT04505722                              [46383]                                    [Porter County]  \n",
       "NCT02576847                              [46202]                                    [Marion County]  \n",
       "NCT03427047                              [46280]                                  [Hamilton County]  \n",
       "NCT03727347                              [47150]                                     [Floyd County]  \n",
       "NCT03400787                              [46635]                                [St. Joseph County]  \n",
       "NCT03037307                              [46202]                                    [Marion County]  \n",
       "NCT03257007                              [46202]                                    [Marion County]  \n",
       "NCT06001866                              [47907]                                [Tippecanoe County]  \n",
       "NCT04699812                              [46123]                                 [Hendricks County]  \n",
       "NCT03434392                              [46202]                                    [Marion County]  \n",
       "NCT04065451                              [46202]                                    [Marion County]  \n",
       "NCT04445155                [46208, 46808, 47404]       [Marion County, Allen County, Monroe County]  \n",
       "NCT01887912                       [46011, 47574]                     [Madison County, Perry County]  \n",
       "NCT02374671                              [46256]                                    [Marion County]  \n",
       "NCT03664739                              [47715]                               [Vanderburgh County]  \n",
       "NCT03345108                              [46825]                                     [Allen County]  \n",
       "NCT02743871                       [46168, 46256]                  [Hendricks County, Marion County]  \n",
       "NCT03227471                              [47710]                               [Vanderburgh County]  \n",
       "NCT03336268                       [46202, 47303]                   [Marion County, Delaware County]  \n",
       "NCT03231917                              [46202]                                    [Marion County]  \n",
       "NCT05471726                              [46202]                                    [Marion County]  \n",
       "NCT03355326                              [46202]                                    [Marion County]  \n",
       "NCT03090191  [46011, 46032, 46260, 46544, 47725]  [Madison County, Hamilton County, Marion Count...  \n",
       "NCT05466617                              [47405]                                    [Monroe County]  \n",
       "NCT03361917                              [46202]                                    [Marion County]  \n",
       "NCT03350217                              [46202]                                    [Marion County]  \n",
       "NCT04512482                              [46202]                                    [Marion County]  \n",
       "NCT02277990                              [46260]                                    [Marion County]  \n",
       "NCT03585790                              [47405]                                    [Monroe County]  \n",
       "NCT05394545                              [46143]                                   [Johnson County]  \n",
       "NCT03436615                              [46256]                                    [Marion County]  \n",
       "NCT03762993                              [47906]                                [Tippecanoe County]  \n",
       "NCT04622592                              [47714]                               [Vanderburgh County]  \n",
       "NCT02878330                       [46017, 46601]                [Madison County, St. Joseph County]  \n",
       "NCT03200366                              [46202]                                    [Marion County]  \n",
       "NCT02754492                              [46208]                                    [Marion County]  \n",
       "NCT03238352                              [46825]                                     [Allen County]  \n",
       "NCT04440163                       [46544, 46617]             [St. Joseph County, St. Joseph County]  \n",
       "NCT02343263                              [46202]                                    [Marion County]  \n",
       "NCT03462706                              [46202]                                    [Marion County]  \n",
       "NCT02325791                              [46601]                                [St. Joseph County]  \n",
       "NCT03296072                              [46202]                                    [Marion County]  \n",
       "NCT02460172                              [46202]                                    [Marion County]  \n",
       "NCT03673462                              [46544]                                [St. Joseph County]  \n",
       "NCT05653362                              [46202]                                    [Marion County]  \n",
       "NCT03009110                              [46202]                                    [Marion County]  \n",
       "NCT01779362                              [46202]                                    [Marion County]  \n",
       "NCT00401518                       [46032, 46804]                    [Hamilton County, Allen County]  \n",
       "NCT02576860                              [46168]                                 [Hendricks County]  \n",
       "NCT02547441                              [46032]                                  [Hamilton County]  \n",
       "NCT02431702                              [46202]                                    [Marion County]  \n",
       "NCT02933489                       [46202, 46321]                       [Marion County, Lake County]  \n",
       "NCT04431518                              [46202]                                    [Marion County]  \n",
       "NCT02513940                              [46202]                                    [Marion County]  \n",
       "NCT02956044                              [47710]                               [Vanderburgh County]  \n",
       "NCT04763044                              [46202]                                    [Marion County]  \n",
       "NCT03488381                              [47405]                                    [Monroe County]  \n",
       "NCT03089281                              [47630]                                   [Warrick County]  \n",
       "NCT04366544                              [46202]                                    [Marion County]  \n",
       "NCT03446781                              [46032]                                  [Hamilton County]  \n",
       "NCT06026124                              [46240]                                    [Marion County]  \n",
       "NCT03709901                              [46278]                                    [Marion County]  \n",
       "NCT03267511                              [46825]                                     [Allen County]  \n",
       "NCT03550313                              [46544]                                [St. Joseph County]  \n",
       "NCT02836613                              [47710]                               [Vanderburgh County]  \n",
       "NCT04247581                              [46123]                                 [Hendricks County]  \n",
       "NCT04870099                              [47408]                                    [Monroe County]  \n",
       "NCT04189081                              [46825]                                     [Allen County]  \n",
       "NCT04620798                              [47405]                                    [Monroe County]  \n",
       "NCT02654236                              [46202]                                    [Marion County]  \n",
       "NCT04812184                              [46077]                                     [Boone County]  \n",
       "NCT03560128                              [46202]                                    [Marion County]  \n",
       "NCT04482036                              [46202]                                    [Marion County]  \n",
       "NCT04666194                       [46202, 46290]                   [Marion County, Hamilton County]  \n",
       "NCT02410902                              [47713]                               [Vanderburgh County]  \n",
       "NCT04913636                              [46825]                                     [Allen County]  \n",
       "NCT03257436                              [46845]                                     [Allen County]  \n",
       "NCT03436784                              [47907]                                [Tippecanoe County]  \n",
       "NCT03024970                              [47405]                                    [Monroe County]  \n",
       "NCT02754440                              [46208]                                    [Marion County]  \n",
       "NCT03320057                              [46202]                                    [Marion County]  \n",
       "NCT05056870                              [47401]                                    [Monroe County]  \n",
       "NCT03095976                              [46202]                                    [Marion County]  \n",
       "NCT03202511                              [46202]                                    [Marion County]  \n",
       "NCT03167411                              [47710]                               [Vanderburgh County]  \n",
       "NCT03338296                              [46383]                                    [Porter County]  \n",
       "NCT04886596                [46544, 47574, 47714]  [St. Joseph County, Perry County, Vanderburgh ...  \n",
       "NCT03291613                              [46321]                                      [Lake County]  \n",
       "NCT04295135                              [46202]                                    [Marion County]  \n",
       "NCT02172664                              [46202]                                    [Marion County]  \n",
       "NCT03881670                              [47405]                                    [Monroe County]  \n",
       "NCT02569398                       [46514, 46202]                    [Elkhart County, Marion County]  \n",
       "NCT03982199                              [47714]                               [Vanderburgh County]  \n",
       "NCT04585646                              [47405]                                    [Monroe County]  \n",
       "NCT02345889                              [46202]                                    [Marion County]  "
      ]
     },
     "execution_count": 109,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Here we will assign county names based on zip codes.\n",
    "NIH_IN['County'] = None\n",
    "\n",
    "for index, row in NIH_IN.iterrows():\n",
    "    county_lst = []\n",
    "    \n",
    "    zip_values = row['IN Zip']\n",
    "\n",
    "    # Check if 'zip_values' is a list since we need to handle single zip values differently than multi zip lists.\n",
    "    if not isinstance(zip_values, list):\n",
    "        if zip_values in zip_dict:\n",
    "            county_lst.append(zip_dict[zip_values])\n",
    "    \n",
    "    else:\n",
    "        for z in zip_values:\n",
    "            if z in zip_dict:\n",
    "                county_lst.append(zip_dict[z])\n",
    "    \n",
    "\n",
    "    NIH_IN.at[index, 'County'] = county_lst\n",
    "\n",
    "NIH_IN"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {},
   "outputs": [],
   "source": [
    "NIH_IN.to_csv(r'./NIH_IN.csv', index = False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
